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1.1. General anatomy and physiology of the cerebrovascular system
1.1.1. The anatomy of the cerebral circulation
1.1.1.1. The macrovascular supply to the brain
Although the theme of the current thesis is the dementia- and hypertension-related
breakdown of cerebral microvessels, it is essential to have a clear view of the arborization
and regional distribution of the larger cerebral blood vessels. The microvascular network of
the brain operates strongly dependent on the blood flow and resistance of the large arteries
and the smaller, terminal arterioles.
Cerebrovascular research makes use of a range of experimental animal models such as
vessel occlusions to unravel the contribution of an optimal cerebral circulation to the
physiology and metabolism of the brain. When employing laboratory animal models (the rat
and gerbil being the most frequent ones) to tackle the pathophysiology of human
cerebrovascular diseases, it should be emphasized that although the organization of the
cerebrovascular system is in many respects similar among mammals, some differences
between species do exist. For instance, the anterior communicating artery is a well-known
anatomical unit in humans but not in rats, while the olfactory artery can be found in rats but
not in humans (Figure 1.1) (Lee, 1995). Even more remarkable is the incomplete circle of
Willis in gerbils (Mayevsky and Breuer, 1992). The description below mainly focuses on the
human situation with some remarks related to the cerebral circulation of laboratory animal
models popular in cerebrovascular research.
The brain receives its arterial blood supply via two major routes, the internal carotid
arteries and the vertebral arteries, the latter forming the unpaired basilar artery at the
junction of the medulla and the pons. The carotid system is responsible for the anterior
circulation of the brain while the basilar artery provides the blood supply to the posterior
cerebral circulation. Obviously, the anterior and posterior circuits are not independent of
each other: the two are interconnected by communicating arteries that create the circle of
Willis at the base of the brain providing potential shortcuts between the lateral as well as the
anterio-posterior cerebral circulation (Figure 1.1).
However, the vertebral and carotid systems supply distinct brain regions as demonstrated
by McDonald and Potter (1951) in rabbits. Under physiologically optimal circumstances the
blood streaming through the vertebral arteries does not mix with the blood carried by the
internal carotid arteries. This phenomenon can be demonstrated by infusing vital dyes in the
carotid or vertebral arteries, which will appear chiefly in the corresponding intracranial
vessels. Nevertheless, if the pressure gradient in the circle of Willis changes due to an
insufficient  flow  in  either  the  anterior  or  posterior circuits,  blood from  different origin canChapter 1
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Figure 1.1. The anatomy of the circle of Willis as seen in human (A) and rat (B). Abbreviations: ACA:
anterior cerebral artery; ACOA: anterior communicating artery; AICA: anterior inferior cerebellar
artery; ASA: anterior spinal artery; BA: basilar artery; ICA: internal carotid artery; MCA: middle
cerebral artery; PCA: posterior cerebral artery; PCOA: posterior communicating artery; SCA: superior
cerebellar artery; VA: vertebral artery.
be re-distributed via the collateral intercommunication in the circle. However, the degree of
compensation depends on the individual variation of vessel diameters and the symmetry of
the circle of Willis (Dickey et al., 1996). The compensatory mechanisms can play a role
when the lumen of an intracranial artery is narrowed due to severe atherosclerosis
(Hartkamp et al, 1999) or when the common carotid arteries or the middle cerebral arteries
of laboratory animals are experimentally occluded to create a model for cerebral ischemia
(Weinachter et al., 1990; Coyle and Heistad, 1991; Mhairi Macrae, 1992).
Arteries emanating from the posterior route, that is from the basilar artery, predominantly
furnish the brainstem and midbrain with fresh blood whereas the cerebral hemispheres are
vascularized from both the anterior (internal carotid origin) and posterior vessels. The two
large pairs of vessels originating from the internal carotid arteries are the anterior and the
middle cerebral arteries, the latter carrying 80% of the blood that reaches the cerebralGeneral Introduction
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hemispheres. Without presenting a complete and comprehensive list of target areas, it is
worth following the major routes of the larger arteries. The anterior cerebral arteries send
their arborization to the frontal lobe, the preoptic and supraoptic areas, the globus pallidus
and the amygdala, while the ramifications of the middle cerebral arteries are responsible for
the blood supply to the temporal and parietal cortex, important subcortical nuclei such as the
basal nuclei and the choroid plexus in the lateral ventricles. The posterior route reaches the
occipital lobe of the hemispheres and the diencephalon containing the sensory thalamus and
the vital autonomic hypothalamic nuclei.
The major arteries enter the skull at the base of the brain and their branches
consequently advance dorsally and spread on the surface of the cerebrum in the
subarachnoid space above the pia mater. They perforate the brain parenchyma
perpendicular to the cerebral surface without establishing anastomoses with each other. As
a narrowed continuum of the subarachnoid space, the vessels are surrounded by the so-
called Virchow-Robin space, which is embraced by leptomeningeal cells. The space
gradually disappears as the artery penetrates deeper in the brain tissue; only the
leptomeningeal cell layer remains to form the first, very thin layer of the artery, the tunica
adventitia. The second and the thickest layer of the vessel wall, the tunica media, consists of
one or two layers of smooth muscle cells which are separated from the tunica adventitia by
elastin and collagen fibers, the lamina elastica externa. The smooth muscle cells can
regulate the flow in the vessel by contracting or relaxing, which specifies the most important
function of arteries in controlling blood pressure and flow. Finally, the luminal layer of the
artery is practically equivalent to the endothelial cell layer and is often referred to as tunica
intima.
1.1.1.2. The microvascular system and the blood-brain barrier
The network of fine cerebral vessels and capillary function in the brain inherently differs
from that of arteries. The general notion that arteries regulate blood pressure while brain
capillaries maintain the blood-brain barrier (BBB) and sustain continuous nutrient, electrolyte
and waste product trafficking between neural tissue and blood is apparently reflected in the
microvascular anatomy.
Cerebral capillaries represent the finest branches of the vascular tree and, unlike
arteries, they form anastomoses and create a three dimensional vascular network. The
density of this mesh perforating the substance of the brain is highly variable. As a general
rule, capillary density in the gray matter was found about three times as much as that of the
white matter but it may be more appropriate to note that the observed differences in densityChapter 1
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apparently correlate with the activity and nutrient demand of the particular brain region.
Experimental data supporting this conclusion showed a prominent correlation between
capillary length per brain volume and local cerebral blood flow (Gjedde and Diemer, 1985)
and between the number of capillaries, local blood flow and glucose utilization in a given
brain area (Klein et al., 1986). The phenomenon that metabolically active brain regions are
more heavily vascularized than less active zones is supported by the observation that
capillary density appears to be most pronounced in areas rich in synapses, followed by cell
body populations and finally neural fiber bundles. Furthermore, microvascular density also
seems to coincide with the main task of the given brain regions: the sensory and association
centers are usually more densely vascularized than motor centers. The laminar structure of
the cerebral cortex also displays a typical layer-dependent density pattern where lamina IV
followed by lamina I receive the densest vascularization. In addition to this density pattern,
the orientation of microvessels can also show a laminar arrangement shown by the cortical
capillaries, which run parallel to the surface in lamina I but form a multi-oriented network in
lamina IV (Hudetz, 1997).
The cerebral capillaries display a typical ultrastructure crucial to execute BBB function
(Figure 1.2). The three cellular building blocks that participate in the formation of the
capillaries are the  endothelial cells,  the  irregularly  occurring  pericytes  and  the  astrocytic
Figure 1.2. The ultrastructure of cerebral capillaries observed with electron microscopy. A: an
electron microscopic image of a typical cortical capillary from the frontoparietal cortex of a Wistar-
Kyoto rat. B: graphic reconstruction of the vessel. Abbreviations: a: astrocytic endfeet; bm: basement
membrane; em: endothelial mitochondria; en: endothelial nucleus; ep: endothelial cytoplasm; l:
capillary lumen; p: pericytes; tj: tight junction.General Introduction
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Figure 1.3. Schematic drawing of the cerebral capillary basement membrane. Abbreviations: HSPG:
heparan sulfate proteoglycan.
endfeet attached to the vessels’ abluminal surface. The capillary endothelial cells form one
layer around the capillary lumen and create tight junctions (also called zonulae occludens)
where they are opposed to each other. The tight junctions seal the space between the
meeting endothelial surfaces and are considered as the morphological basis for the BBB
gaining their full functional integrity with the maturation of the animal (Rubin and Staddon,
1999; Kniesel and Wolburg, 2000; Saunders et al., 2000). Other features that take care of
the selective isolation of the brain from the blood are the lack of endothelial fenestrations
and an insignificant transport via pinocytic vesicles. The capillary endothelial cells are further
characterized by a relatively high number of mitochondria, which can provide the energy
needed for the working of the specific BBB transport proteins (e.g. glucose- and amino acid
transporters).
The endothelial cells are surrounded by a 30-40 nm thick basement membrane (BM)
(Figure 1.3), which is often a target of investigation due to its frequently observed
malformations under pathophysiological conditions (for example Alzheimer’s disease)
(Perlmutter and Chui, 1990; Claudio, 1996; Kalaria, 1996). The extracellular matrix
components of the BM, namely the intrinsic collagen type IV, heparan sulfate proteoglycan
(HSPG), laminin and the extrinsic fibronectin are known to be produced by the cell types of
the capillaries. These BM constituents are arranged into a trilaminar structure with an
endothelial layer (lamina rara interna), an astrocytic layer (lamina rara externa) and a
transitory, fused layer in-between the two (lamina densa) (Figure 1.3). Collagen type IV, the
major structural element of the BM is preferentially located in the lamina densa while the
proteins laminin and HSPG are more closely associated with the two lamina rarae, whichChapter 1
16
promote cell adhesion and attachment (Perlmutter and Chui, 1990). Besides the widely cited
BM elements, additional proteins that are deposited in the BM have also been identified.
Cablin, synthesized by the endothelial and smooth muscle cells, is such a molecule (Charron
et al., 1999), suited to cross-link cells and matrix constituents. The BM has been suggested
to provide physical support to the microvessels, control cellular migration, filter
macromolecules, influence endothelial function, promote cell adhesion and protect the brain
against extravasated proteins (Perlmutter and Chui, 1990).
The second, heterogeneous cell type of cerebral capillaries, the pericyte is inserted in the
BM and covers the vascular wall by its extended processes. Some investigators differentiate
granular and filamentous pericytes and attribute a phagocytotic role to the granular type
(Tagami et al., 1990). The size and appearance of pericytic profiles seen with the electron
microscope is highly variable depending on the level of slicing. When compared to
endothelial cells, the density and composition of the cytoplasm looks very similar but the
pericytes also contain dense bodies or lysosomes. The pericytes are often considered as a
supporting cell type of capillaries, which can regulate capillary tone (Kelley et al., 1987).
They also participate in the immune response as shown by their relationship with
macrophages and their ability to transform into microglia. These proposals were further
substantiated by the demonstration of the presence of macrophage markers on the pericytic
surface, their phagocytotic activity and antigen presentation (Thomas, 1999). Furthermore,
the pericytes can contribute to the regulation of vascular development by inhibiting
endothelial cell proliferation and differentiation via chemical signaling (Shepro and Morel,
1993; Hirschi and D’Amore, 1996; Balabanov and Dore-Duffy, 1998; Rucker et al., 2000;
Martin et al., 2000).
The cerebral microvessels are supported by astrocytic processes, which are intimately
apposed to the abluminal vascular surface. These astrocytic endfeet are thought to play a
dominant role in the ontogenesis and maintenance of the BBB (Janzer, 1993). In vitro
studies have demonstrated that the close apposition of astrocytes to endothelial cells is
necessary for the development of typical BBB features such as the formation of tight
junctions or the expression of BBB specific proteins (Arthur et al., 1987; Minakawa et al.,
1991; Rauh et al., 1992; Hurwitz et al., 1993). The induction of an endothelial BBB
phenotype marker, the so-called HT7 surface glycoprotein by an astrocyte-conditioned
medium is an adequate example for the latter (Janzer et al., 1993). Furthermore, astrocytes
were implicated in the intracerebral regulation of vascular tone and cerebral blood flow
indicated by the expression of serotonergic and cholinergic receptors on the perivascular
endfeet (Luiten et al., 1996; Cohen et al., 1996; Elhusseiny et a., 1999; Cohen et al., 1999)General Introduction
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and the close apposition of noradrenergic nerve endings to the vascular astrocytic sheath
(Cohen et al., 1997). Besides receiving neuronal innervation, the astrocytes stand in
constant biochemical interaction with the endothelial cells (Goldstein, 1988; Abbott et al.,
1992) shown for example by their substance-P immunoreactivity (Michel et al., 1986), the
presence of endothelial NOS in their cytoplasm (Wienecken and Casagrande, 1999) and the
detection of astrocytic NO release (Janigro et al., 1996).
These examples demonstrate that although the anatomical organization of the cerebral
microvascular domain appears to be relatively simple at first sight, the functional implications
are far more complex. The vascular system of the brain is designed to perform fine and
ready adjustments of vascular tone, cerebral blood flow, BBB penetration and immunological
status depending on the needs of the neural tissue and environmental changes. In the next
chapter, the dynamics and physiological aspects of the cerebral blood supply stand in focus.
1.1.2.  The physiology of cerebral blood supply
1.1.2.1. Flow pattern and rheological factors
The physical pattern of cerebral blood flow (CBF) and its pathological changes in brain
microvessels have been reviewed with reference to the general rules of fluid dynamics
extended to biologically active systems (de la Torre and Mussivand, 1993). As previously
summarized (de la Torre and Mussivand, 1993), a number of major parameters can help
characterize the dynamics of blood flow in the cerebral vessels, such as flow velocity,
microturbulent flow, viscosity of the blood, shear stress created by the vascular wall and
vascular resistance. These factors are inseparably and dynamically interrelated.
The blood flow velocity, which can be routinely determined in larger brain arteries with the
use of Doppler sonography (Maulik, 1995) and can also be measured in the cerebral
capillary bed with the sophisticated intravital microscopy (Hudetz, 1997), is not equal at all
points in the vessel lumen throughout its transversal profile. A flow gradient can be
characterized with a decreasing flow velocity approaching from the midline of a vessel
towards the vascular wall when looking at the cross section of the vessel. Moreover, near
the vascular wall, the blood flow is reduced to a near standstill where the blood has a cell-
free plasma layer (Fung, 1981; Fung, 1984). The plasma layer next to the vessel wall also
serves a significant biological purpose, namely to allow nutrient and mineral transport from
the blood to the brain parenchyma from this slow moving layer thus supplying the brain with
energy substrates.
Microturbulent flow can disturb the regular passage of blood and can develop when the
usual shape of the vascular lumen becomes irregular e.g. locally thickened (fibrotic arteries,Chapter 1
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capillaries with local basement membrane thickening), partially obstructed (atherosclerosis)
or compressed (Figure 1.4). The flow pattern in this case becomes disrupted and random
swirls can build up compromising the slow flow of the cell free layer near the vessel wall
(Fung, 1984). When such abnormalities occur in microvessels, the optimal nutrient transport
through the BBB is in jeopardy and can lead to a suboptimal cerebral metabolism.
Figure 1.4. The development of
microturbulent flow in cerebral vessels
The third rheological factor of importance is the viscosity of the blood. The viscosity
stands in an inverse relationship with flow velocity and CBF meaning that a higher whole
blood viscosity is associated with lower flow values. Two major factors having influence on
viscosity and thus oxygen carrying capacity of the blood have been identified as the
haematocrit value (Harrison, 1989) and the membrane fluidity and aggregation of
erythrocytes (Schmid-Schonbein, 1983). Early indications that an increased haematocrit
could contribute to a lowered CBF under neuropathological circumstances were found in
clinical studies. For example, an increased haematocrit was shown to coincide with the
occlusion of the carotid arteries and associated transient ischemic strokes in humans. In this
study, the size of cerebral strokes could be correlated with a decreased CBF, which was
suggested to be the result of a high haematocrit value (Harrison et al., 1981). However,
claiming a direct causal relationship between an increased haematocrit and the development
of ischemic strokes based on these data would well be an overinterpretation of the findings.
Yet, a causal relationship between CBF and the haematocrit was convincingly demonstrated
in patients of another study: when reducing the haematocrit, a consequent improvement in
CBF was measured (Thomas et al., 1977). Supportive animal models experimenting with
isovolemic hemodilution also showed that reducing the haematocrit without changing the
volume of circulating blood decreased blood viscosity and could consequently enhance
cerebral capillary perfusion and oxygen delivery (Lin et al., 1995; Hudetz et al., 1999).
Hence, we can conclude with certainty that a lower haematocrit caring for reduced blood
viscosity improves CBF. Other properties of erythrocytes like the rigidity of their cellGeneral Introduction
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membrane or their affinity to form aggregates can also interfere with CBF. As shown in an
experimental rat model, the aggregation of red blood cells compromises microvascular
perfusion (Mchedlishvili et al 1999). In addition, the rigidity of the erythrocyte membranes
can also affect CBF by limiting the rate of capillary perfusion. The inflexibility of the cell
membrane can hinder the passage of erythrocytes through capillaries therefore the
membrane fluidity of erythrocytes indirectly interferes with CBF.
The contribution of shear stress (due to the above described velocity gradient of flow) to
altered CBF can be accomplished through changing viscosity (Kee and Wood, 1984) and/or
having an effect on vascular autoregulation (Rubanyi et al., 1990). The alteration of CBF by
shear stress plays the most important role in curved blood vessel segments, where the
difference in flow velocity between the middle axis and the wall of the vessel is highest. The
increased shear stress can present a physical stimulus to the endothelium and may impose
slowly regenerating endothelial damage (de la Torre and Mussivand, 1993). On the other
hand, shear stress has been also suggested to stimulate mechanoreceptors presumably
present on endothelial cells, which would activate inward rectifier K
+-channels. In turn, NO
and PGI2 (prostaglandin I2) could be released initiating an increase of vascular diameter
(Rubanyi et al., 1990).
Changes in vascular diameter directly lead to alterations in vascular resistance and CBF,
two inversely related physiological parameters. Any change in lumen radius will affect the
resistance exponentially. The vascular resistance and CBF can be regulated by myogenic,
metabolic, neuronal and biochemical means, which processes are overviewed in the
following two chapters.
1.1.2.2. The myogenic and neurogenic regulation of cerebral blood flow
The brain receives probably the most constant blood supply of all body organs
maintained by a very finely tuned regulation of CBF. Physiological fluctuations in the cerebral
perfusion pressure are normally compensated by the cerebrovascular autoregulation to
sustain an optimal, uninterrupted CBF. An intact autoregulation is capable of keeping the
CBF independent of perfusion pressure provided the perfusion pressure ranges
approximately between 60 and 150 mmHg (Wagner and Traystman, 1985; Paulson et al.,
1990). Below or above the given values, the autoregulatory mechanisms become uncoupled
from perfusion pressure and lose accurate control of CBF. The dynamic maintenance of
CBF is achieved by changes in vascular resistance, which can be controlled by local-
chemical factors, endothelial factors, autacoids (e.g. histamine, prostaglandins, leukotrienes)
and neurotransmitters (Wahl, 1985; Wahl and Schilling, 1993).Chapter 1
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The basic feedback mechanisms of the autoregulatory loop in the brain have been
classified as myogenic, chemical/hormonal, neurogenic or endothelial dependent. The
myogenic component of cerebral autoregulation was defined as the intrinsic capacity of
vascular smooth muscle cells to contract in response to mechanical stress such as an
increase in transmural pressure (Ursino, 1991). This contractile response can be visualized
by manipulating the transmural pressure in arteries that triggers vasoconstriction when
increased. With the help of isolated rat or human brain artery preparations, an increased
vascular tone and a decreased lumen diameter were detected when the perfusion pressure
was gradually increased (Halpern and Osol, 1985; Wallis et al., 1996). Moreover, increased
transmural pressure caused little change in CBF unless the perfusion pressure dropped
bellow 60 mmHg, the lower limit of the autoregulatory capacity (Wagner et al., 1985). Based
on these results, one can conclude that stretch dependent vasoconstriction keeps CBF
constant when the perfusion pressure stays within the autoregulatory range. As mentioned
above, the cellular components of the myogenic autoregulation were located in the vascular
smooth muscle, which depolarizes as mechanical pressure increases (Harder, 1985). Such
a pressure-activated contraction of smooth muscle cells was described to depend on the
extracellular calcium concentration and to be mediated by an arachidonic acid signal
transduction pathway (Harder et al., 1997). A metabolite of arachidonic acid (20-
hydroxyeicosatetraenoic acid, 20-HETE) in vascular smooth muscle cells serves as a potent
vasoconstrictor by inhibiting the opening of calcium activated potassium channels or by
activating L-type calcium currents (Harder et al., 1997). However, other endothelial
substances such as endothelins released as a response to stimulation of the vascular
endothelium, which is the major focus of the next chapter, can also indirectly elicit vascular
contraction.
The neurogenic regulation of the main cerebral arteries differs from that of cerebral
microvessels in that the large vessels receive extracranial innervation while the terminal
microvascular beds of the brain lack such a neural supply. Similar to the systemic resistance
vessels, the large arteries of the brain surface and their parenchymal branches receive
sympathetic, parasympathetic and sensory fibers. A fundamental body of information was
accumulated by tract-tracing studies, which identified the superior cervical ganglion as the
major source of sympathetic fibers (Edvinsson et al., 1990) and the sphenopalatine, otic and
internal carotid ganglia as the principal origin of parasympathetic fibers (Branson, 1995). The
perivascular sympathetic fibers eliciting vasoconstriction were immuno-positive to several
compounds including the classical neurotransmitter noradrenaline and neuropeptides like
neuropeptide-Y (NPY) (Uddman and Edvinsson, 1989) while smaller pial arteries were alsoGeneral Introduction
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reported to receive serotonergic, vasoconstrictive input from the dorsal raphe nucleus
(Lincoln, 1995). On the other hand, the parasympathetic nerves showed the presence of
acetylcholine (ACh) and vasoactive intestinal polypeptide (VIP), both potent vasodilators
besides nitric oxide (NO), which also emerged as a significant neurogenic relaxing factor
(Suzuki and Hardebo, 1993; Branston, 1995). The sensory projection fibers to cerebral
arteries were shown to arise from the trigeminal ganglion and to contain additional
vasodilatory peptides such as substance-P (SP) and calcitonin gene-related peptide (CGRP)
(Uddman and Edvinsson, 1989).
The control of vasoconstriction mediated by autonomic fibers exerts a basic, global and
relatively rough modulation of CBF while the finer tuning of regional flow rates involves
several additional mechanisms depending on the vascular endothelium. Biochemical signals
acting on or released by the endothelial cells can substantially modify cerebrovascular
resistance. The receptors and functional involvement of local, chemical factors (adenosine),
endothelial factors (thromboxanes, endothelin, endothelium-derived constrictor/relaxing
factors and prostacycline), autacoids (histamine, bradykinin, eicosanoids) and hormones
(angiotensin, vasopressin) were widely investigated and discussed (Wahl and Schilling,
1993). Here, we present a selection of the most important findings of this research that are
relevant to the physiology and regulation of cerebromicrovascular blood flow.
1.1.2.3. The role of endothelial factors in cerebral blood flow regulation
The vascular endothelium plays a pivotal role in CBF regulation because an important
group of vasoactive biochemical compounds are released by and act on the endothelial
cells. These factors are traditionally named as endothelium-derived relaxing factors, nitric
oxide (NO) being one of them, and endothelium-derived contracting factors, like endothelins.
Most of the data concerning the regulatory function of NO and endothelins were collected
from arterial endothelial cells, but the release of these factors from microvascular
endothelium was also shown (Yoshimoto et al., 1991; Durieu-Trautman et al., 1993; Lovick
and Key, 1995). In microvessels, the potential targets of these factors are the perivascular
astrocytes as opposed to the smooth muscle layer in macrovessels (Durieu-Trautman et al.,
1993).
Vascular dilation mediated by nitric oxide (NO) is a well-described phenomenon. NO
relaxes vascular smooth muscle and increases regional cerebral blood flow in response to
shear stress to the endothelium or stimulation by acetylcholine, bradykinin or other
biochemical compounds (Arnal et al., 1999). The mechanical and chemical stimuli can
increase  the  cytosolic calcium  concentration and the association of  the calcium/calmodulinChapter 1
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complex to NO synthase in the endothelial cells (Fleming and Busse, 1999), which in turn
modulates NO production by increasing the gene expression and/or the activity of the
endothelial NO synthase (eNOS) (Arnal et al., 1999). The origin of NO is, however, not
restricted to the endothelium: NO released from neuronal terminals in addition to endothelial
sources can also regulate vascular relaxation. In order to visualize the effects of endothelial
NO separately from the one of neuronal origin, several methods have been applied. The
selective blockade of the endothelial NO synthase (eNOS), cell culture of endothelial cells
(Weih et al., 1998) or the use of eNOS knockout or mutant mice (Huang et al., 1995; Strauss
et al., 2000) all delivered valuable data in NO research. With the help of these models, it was
shown that eNOS mediated basal vasodilatation (Huang et al, 1995) and that endothelial NO
could buffer blood pressure variability (Strauss et al., 2000). Additional pioneer work to use
gene therapy to enhance vasorelaxation also made use of eNOS by associating its gene to
an adenovirus vector and achieving augmented NO-mediated vasorelaxation in isolated
arteries after gene transfer (Ooboshi et al., 1998; Tsutsui et al., 2000).
Endothelins, the very potent vasoconstrictor substances isolated from cultured endothelial
cells, were widely investigated for their role in subarachnoid hemorrhage (SAH)
Zimmermann and Seifert, 1998). The substances have been held responsible for the
delayed cerebral vasospasm after SAH causing considerable damage to the vascular wall.
Out of the three, presently known endothelin isoforms, ET-1 seems to be the most potent,
which probably acts primarily on the endothelin-A receptor (ET-A) (Zimmermann and Seifert,
1998). Although most data on the functional implications of endothelins come from
pathological changes after SAH, endothelins can be involved in the control of CBF under
physiological circumstances. As supporting evidence, it was demonstrated that when
cerebral perfusion pressure was increased with norepinephrine, CBF did not noticeably
follow the evoked increase, but when an endothelin-B receptor (ET-B) antagonist, bosentan
was administered in combination with norepinephrine, a remarkable rise in CBF was
recorded (Mascia et al., 1999). These findings may indicate that ET-B stimulation plays a
role in the maintenance of a constant CBF at increasing perfusion pressure under
physiological conditions. Because the ET-A and ET-B receptors, as well as the intracellular
second messenger of endothelin action, the mitogen-activated protein kinase (MAPK) were
identified in the vascular smooth muscle cells (Zimmermann and Seifert, 1998; Zubkov et al.,
2000), the suggested regulatory mechanism gains significance in cerebral arteries.General Introduction
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1.1.2.4. Metabolic cerebral blood flow regulation
Besides the global regulation of cerebral blood supply via changing the diameter of
larger brain arteries, CBF is also regulated locally at the level of microvessels, based on the
metabolic activity of the particular brain area examined. Since the brain’s fundamental
energy source is glucose and its metabolism requires oxygen, the coupling of cerebral
glucose utilization (CGU) and cerebral metabolic rate for oxygen (CMRO2) with CBF has
been widely investigated in physiological conditions, as well as in neurodegenerative
diseases. CGU is generally considered as an indicator of neuronal activity, taken that
glucose is used to maintain resting membrane potential and the restoration of ion gradients
after an action potential (Jueptner and Weiller, 1995). This theory may also explain the
results of the study where a local administration of glutamate or NMDA to the rat cerebral
cortex caused a significant rise in CMRO2 and CBF (Lu et al., 1997). Besides consuming
oxygen and metabolizing glucose, which can regulate CBF, the firing neurons also release
K
+. When the extracellular K
+ concentration is raised, the ion acts as a vasodilator on nearby
vessels and enhances CBF. At the re-establishment of neuronal resting potential, adenosine
may also come free and cause an increase in CBF by vasodilatation (Kuschinsky, 1991).
Non-invasive measurements of cerebral CMRO2 in healthy human volunteers showed a
correlation between CBF and CMRO2 (Leenders et al., 1990; Hoge et al, 1999) but these
findings by themselves may not be a sufficient evidence to prove a causal, regulatory
relationship between CMRO2 and CBF. Although additional animal studies provided
supporting data by demonstrating that reducing blood oxygen concentration elevated CBF
proportionally (Jones et al., 1981; Sato et al., 1992), the effect may not be the result of a
direct regulatory loop (e.g. the carotid chemoreceptor reflex) because the role of
chemoreceptors for blood oxygen concentration could not be unanimously verified (Miyabe
et al, 1989). Rather, the reduced oxygen concentration of blood can accompany an increase
in CBF, both potentially being a result of increased neuronal activity. Therefore the metabolic
regulation of CBF is probably mediated by other by-products of glucose metabolism, the
elevated concentration of CO2 and a consequent increase in blood pH being the most
important ones.
CO2 effect can be measured by the CO2 reactivity test, which provides information about
the functional state of brain vessels. In man, 1 mmHg increase in blood pCO2 causes 2-4 %
increase of CBF mediated by a concomitant change in pH, which acts directly on cerebral
vessels posing the basic mechanism of rCBF regulation. An increased [H
+] triggersChapter 1
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vasodilatation while a decreased [H
+] leads to vasoconstriction. Other regulatory
mechanisms can potentially modify pH reactivity.
1.2.  Pathological changes in cerebral circulation in Alzheimer’s disease
1.2.1.  The cerebral blood flow in Alzheimer’s disease
The contribution of vascular factors to the etiology of dementia, with particular attention
to Alzheimer’s disease (AD) has become a rapidly extending research field in the last
decade. Epidemiological studies emphasized the role of peripheral vascular abnormalities
like atherosclerosis or hypertension as risk factors aggravating the progression of cognitive
decline (Skoog et al., 1996; Skoog, 1997; Hofman et al., 1997; Breteler, 2000), and a further
link has been suggested between the systemic and notably (cardio)vascular pathophysiology
and disturbed brain perfusion in AD (de la Torre, 1999).
The growing literature addressing the issue of an altered CBF in AD established
unanimously a decreased global CBF typical of the disease (Table 1.1). Even though there
is a general consensus on a lower cerebral perfusion in AD, the regional distribution and
degree of the drop in CBF still appears to be dependent on several factors. To mention the
most important ones, the severity and particular symptoms of dementia, the age of the
patient and the onset and duration of dementia can, for example, influence regional CBF
(rCBF). In addition, the methodological approaches like the application of different imaging
techniques (H2
15O PET, 
99mTc-HM-PAO SPECT) or the choice of the reference region
(occipital lobe, cerebellum, and whole brain) may also deliver some variation in the data.
Despite the number of sources that can interfere with rCBF readings, the parietal and
temporal cortices were consistently shown to be affected (Komatani et al., 1988; Costa et al.,
1988; Montaldi et al., 1990; Eberling et al., 1992; O’Brien et al., 1992; Ohnishi et al., 1995;
Ishii et al., 1997; Imran et al., 1999). Reduced rCBF in the frontal cortex in AD was also
reported but with less consistency (Montaldi et al., 1990; O’Brien et al., 1992; Imran et al.,
1999). In some cases, even though a significant decrease in rCBF in the frontal cortex
compared to age-matched controls could not be established, the flow rate in the AD group
still correlated with the assessed dementia score (Hasegawa’s Dementia Scale, HDS)
(Komatani  et   al.,  1988). Others   showed   a  significant reduction  in   frontal  rCBF   when
comparing mild AD to moderate AD but not when AD patients and controls were weighed
against each other (Eberling et al., 1992). Hence, it seems likely that lowered rCBF in the
frontal lobe becomes evident at more advanced stages of AD.
The reported degree of rCBF reduction appeared to be uniform among the temporal,
parietal  and  frontal  areas,  although  the  drop  of  rCBF  in  the frontal cortex seemed to beGeneral Introduction
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Table 1.1. Reduced regional cerebral blood flow in selected brain regions of Alzheimer’s disease
patients indicated as the percentage of the corresponding values of non-demented, age matched
controls
References Brain regions
Global Cerebral Cortex Thalamus Basal
Ganglia
White
Matter
Parietotemporal Frontal Cingulate Hippo-
campus
Parietal Temporal
Costa
et al., 1988.
~83.5 ~87.7%
Komatani
et al., 1988.
~72.5%
Montaldi
et al., 1990.
~88.5% ~89.5% ~82.5%
Eberling
et al., 1992.
~80% ~80%
O’Brien
et al., 1992.
~92% ~89.5% ~89% ~94.3%
Waldemar
et al., 1994.
~87.5% ~86.9% ~84.1% ~88.2% ~88.2% ~85.9%
Ohnishi
et al., 1995.
~73.8% ~72.6%
Ishii et al.,
1997.
~84.9% ~89.6% ~86.4%
Imran et al.,
1998.
reduced reduced reduced
Ishii et al.,
1998.
~79.3%
Kobari
et al., 2000.
~73.5% ~73% ~85.7% ~87.3% ~85%
slightly though not significantly less than in the parietotemporal lobe. Regional CBF values in
the parietotemporal region of AD patients ranged approximately between 80-90% in
comparison with healthy volunteers  (Komatani et  al., 1988; Costa et  al.,  1988;  Montaldi et
al., 1990; Eberling et al., 1992; O’Brien et al., 1992; Ohnishi et al., 1995; Ishii et al., 1997)
while one study reported a decrease even to 71-75% in rCBF of the hippocampus and the
parietal cortex in their cohort (Ohnishi et al, 1995).
Regarding the severity of dementia, significant reduction of rCBF in the dorsolateral
frontal cortex was measured in moderate but not in mild AD (Eberling et al., 1992).
Furthermore, correlation analysis between the cognitive status of the patients visualized by a
variety of dementia evaluating scoring systems and the degree of cerebral hypoperfusion
repeatedly provided evidence for the association of the two parameters (Komatani et al.,Chapter 1
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1988; Montaldi et al., 1990; Eberling et al., 1992; O’Brien et al., 1992; Ohnishi et al.,1995;
Imran et al., 1999). Dementia scores obtained by the Hasegawa’s Dementia Scale (HDS)
were in proportion with rCBF in the frontal, temporo-parietal and parietal cortices, and in the
hippocampus (Figure 1.5), as well as with CBF calculated for the whole brain (Komatani et
al., 1988; Ohnishi et al., 1995).
Mini Mental State Examination (MMSE) scores, in a similar way, correlated to rCBF in
the (dorsolateral) frontal cortex, the parietal cortex, and the posterior temporal lobe
(DeKosky et al., 1990; Eberling et al., 1992; O’Brien et al., 1992; Imran et al., 1999). The
results of the CAMCOG test, a similar but more extensive equivalent of MMSE, were also in
a significant relationship with rCBF in the frontal, parietal, (posterior) temporal and parieto-
temporal cortical areas (Montaldi et al., 1988; O’Brien et al., 1992). Taken together, these
data can provide compelling evidence for a reduced rCBF in the cerebral cortex, which is
proportional to the degree of cognitive decline typical for AD.
Alzheimer’s disease can be more securely established as the specific diagnosis of
dementia when the post mortem analysis of the brain delivers neuropathological
confirmation. Occasionally it is discovered only in the post mortem material  that the subject
diagnosed as an AD patient had multiple cerebral infarcts and rather belongs to the group of
multi infarct dementia cases, or conversely, dementia patients of miscellaneous origin
appear to have typical AD neuropathology. Therefore the correlation between CBF and AD-
like neuronal lesions could add supplementary aspects to the relationship between CBF and
AD. Unfortunately, no clinical study performed a correlation analysis between CBF and the
severity of neuronal breakdown in AD, but experimental models did aim at unraveling a
connection between cerebral hypoperfusion and neuronal damage. The permanent ligation
of major arteries supplying the brain has been developed as a model to investigate the
histological and behavioral effects of a reduced CBF. The bilateral occlusion of the common
carotid arteries of rats (2VO) led to a dramatic initial drop in rCBF which returned to 30-45%
of rCBF in the cortex and 20% reduction in the hippocampus 1 week after surgery (Tsuchiya
et al., 1992) while the more severe three vessel occlusion (3VO) ligating the subclavian
artery in addition to the common carotid arteries caused a dramatic 25-80% drop in the
parietal cortex and 40-60% decrease in the hippocampus at 3 or 9 weeks following the
occlusion (de la Torre et al., 1992). The histological examination of the 2VO brains after 190
days of hypoperfusion showed a significant loss of hippocampal CA1 neurons and a greater
glial fibrillary acidic protein (GFAP) immunoreaction, the sign of reactive gliosis (Pappas et
al, 1996). The hippocampal cell loss was later identified to be the result of apoptotic cell
death (Bennett et al., 1998). At the same time, the 3VO condition led to the observations thatGeneral Introduction
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Figure 1.5. Correlation between regional
cerebral blood flow (rCBF) and the severity of
dementia in Alzheimer’s disease. A:
hippocampal rCBF (adopted from Ohnishi et
al., J. Nucl. Med. 36:1163-1169, 1995); B:
frontal cortex; C: temporo-parietal cortex
(adopted from Komatani et al., J. Nucl. Med.
29(10):1621-6, 1988).
the hippocampal CA1 damage represented necrosis of pyramidal cells accompanied also
with a higher density of GFAP immunoreactivity (de la Torre et al., 1992). The discrepancy in
the nature of neuronal injury may stem from the degree of cerebral hypoperfusion created in
the two paradigms (2VO or 3VO), since apoptotic and necrotic cell death in neuronal
populations   can  be  sequential   depending  on   the   severity   of  the   insult.   Finally,  theChapter 1
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extracellular accumulation of amyloid precursor protein (APP) and its cleavage to beta-
amyloid-like fragments in the hippocampus of aging rats was described in the 2VO
paradigm, as well (Pappas et al., 1997; Bennett et al., 2000). Although all these data were
obtained by imposing a very dramatic drop in rCBF never encountered in humans (which
basically renders the strict comparison with AD limited), these experiments are very valuable
from several points of view. First, they reinforce the coincidence of decreased rCBF with
neuronal damage. Second, these animal models proposed a possible causal order of
cerebral hypoperfusion and the subsequent neuronal injury. Third, the use of the
experimental cerebral hypoperfusion models amply demonstrated the sorts of potential
neurodegenerative features that may arise as the consequence of chronically reduced CBF.
In summary, the experimental findings are arguing for a link between compromised CBF and
neuronal histopathology.
1.2.2.  Metabolic parameters and microvascular function in the Alzheimer brain
The significantly reduced CBF in AD, which may be the outcome of an impaired vascular
autoregulation, was also linked to a depressed cerebral glucose metabolism reflected by
cerebral glucose utilization measurements (CGU) (Hoyer et al., 1991; Fukuyama et al.,
1994). The affected areas exhibiting suboptimal metabolism coincided with those displaying
a marked decrease of rCBF, namely the temporal, parietal and, to a lesser degree, the
frontal lobe (Friedland et al., 1985; Friedland et al., 1989; Fukuyama et al., 1994). In
addition, the lower CGU values acquired from different cortical gyri could be related to
particular memory performances: episodic memory failure correlated with CGU in the
superior temporal gyrus, the mesial temporal cortex and the cingulate gyrus. Short-term
memory disturbance was accompanied by lower CGU in the angular gyrus, the
supramarginal gyrus and the superior temporal gyrus, while semantic memory was
associated with glucose metabolism in the left inferior frontal gyrus, the temporo-parietal
junction, the angular gyrus and the supramarginal gyrus (Desgranges et al., 1998).
To specify the sequence of events, which would account for the compromised glucose
utilization, a number of factors can be considered, of which the microvascular aspects stand
in focus here. Circulating glucose penetrates the brain via the BBB by active transport, which
employs a specific glucose transporter protein (GLUT-1) localized in the capillary endothelial
membranes at a high density. Immunolabelling and binding experiments of GLUT-1 revealed
a decrease of GLUT-1 sites in the hippocampus and the cerebral cortex of AD patients
(Kalaria and Harik, 1989; Horwood and Davies, 1994; Simpson et al., 1994). Based on these
observations, the diminishing glucose transport through the BBB due to the decreasedGeneral Introduction
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GLUT-1 density could perform as the limiting step of CGU rate. Such an explanation,
however, appears to be contradictory to the proposal that the levels of glucose transporter
expression (mRNA for GLUT-1) are regulated according to the metabolic demand and
regional CGU of the neural tissue (Vannucci et al., 1998). This theory could mean that the
neuronal damage and a concomitantly reduced CGU in AD should precede a decreased
concentration of GLUT-1. The conflicting opinions may find a compromise in the results that
the significantly reduced GLUT-1 protein concentration was not accompanied with a
proportionally lowered GLUT-1 mRNA level in AD (Mooradian et al., 1997) which infers the
following. Firstly, the GLUT-1 mRNA concentration does not necessarily indicate the density
of the actual transporter protein, and secondly, CGU regulating GLUT-1 mRNA expression is
then probably not the only factor responsible for the reduction of GLUT-1 protein density in
AD. The latter conclusion is strongly underscored by further evidence for the involvement of
brain trophic factors in the control of GLUT-1 gene expression (Boado, 1998). Thus, CGU
may not simply be a cause but also a potential result of the reduced GLUT-1 density in the
disease.
1.3.  Aims of the study
The notion that the cerebral circulation in Alzheimer’s disease suffers a setback in the
form of reduced cortical perfusion has been firmly established. Moreover, morphological
abnormalities of cerebrocortical microvessels were also repeatedly observed. The current
work has aimed at:
-  Characterizing the types of ultrastructural capillary damage in neurological disorders, as
seen in the electron microscope.
-  Establishing a causal interaction between cerebral blood flow and ultrastructural
microvascular integrity.
-  Determining if the damage to cerebrocortical microvessels is unique to Alzheimer’s
disease or occurs in other neurological disorders.
-  Investigating the effect of chronic hypertension, a potential risk factor for Alzheimer’s
disease, on the microvascular network of the brain.
-  Identifying intracellular mechanisms that play a role in the development of cerebral
capillary pathology.Chapter 1
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1.4.  Outline of the thesis
After a comprehensive review of the cerebrovascular anatomy and the physiology of
cerebral blood flow in Chapter 1,  Chapter 2 tackles the question of causality between
cerebral hypoperfusion and structural capillary wall abnormalities. An animal model for
cerebral hypoperfusion, the permanent occlusion of both common carotid arteries of rats is
introduced, where the hypothesis that reduced cerebral blood supply leads to microvascular
damage in the brain is addressed. The cerebral microvascular changes are assessed by
electron microscopy, and are correlated to cognitive performance. The learning and memory
capacity of the rats is tested in a spatial orientation paradigm.
Chapter 3 focuses on the microvascular ultrastructure in the cingulate cortex of
Alzheimer’s disease and Parkinson’s disease cases. The electron microscopical, post-
mortem study provides a quantitative analysis of the breakdown of the microvascular
network in the two neurodegenerative disorders.
Chapter 4 integrates the results of the experimental hypoperfusion model of Chapter 2
and the findings of the post-mortem analysis of Alzheimer brains in Chapter 3, and
introduces a new risk factor, chronic hypertension, that threatens cerebral capillary integrity.
The microvascular pathology in the cerebral cortex of aging, spontaneously hypertensive
stroke-prone rats (SHR-SP) is compared to that previously seen in Alzheimer’s disease and
experimental cerebral hypoperfusion. Chapter 4 strengthens the hypothesis that cerebral
hypoperfusion, also encountered in chronic hypertension, serves as a trigger to capillary
damage in the cerebral cortex.
The experiments with the SHR-SP, hypertensive rat strain are considerably extended in
Chapter 5. The microanatomical abnormalities of cerebrocortical capillaries are investigated
in two age groups. Furthermore, the potentially preventive effect of two dihydropyridine
drugs (nimodipine and nifedipine) on capillary integrity in the brain under hypertensive
conditions receives major attention. The fact that dihydropyridines are potent calcium
channel blockers, specifically at L-type calcium channels, allows speculating on the cellular
mechanisms that may underlie the development of cerebral microvascular pathology.
Finally,  Chapter 6 summarizes the data presented in this thesis. First, the forms of
capillary abnormalities of the cerebral cortex and their interaction with the blood-brain barrier
function are discussed, with particular attention to the basement membrane. The possibility
that beta-amyloid peptide typically occurring in Alzheimer brains contributes to the
breakdown of cerebral microvessels is considered. Subsequently, the comprehensive review
of animal models of cerebral hypoperfusion follows handling cerebral blood flow, neuralGeneral Introduction
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metabolic rates, vascular damage and learning capacity separately. In the end, mechanisms
possibly responsible for cerebral microvascular deficiency are suggested. The concluding
remarks close the chapter.
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Abstract
The impact of chronic cerebral hypoperfusion on cognitive function and cerebral capillary
morphology in the hippocampus was examined. Young adult Wistar rats were subjected to
permanent ligation of both common carotid arteries (two-vessel occlusion). One month after
vascular occlusion, a small but non-significant impairment in the acquisition of spatial
information was registered compared with sham-operated controls. Two months after
surgery, the occluded animals displayed an impaired performance throughout the training
period. One year after surgery, the acquisition curves demonstrated a significant attenuation
of the learning rate in the occluded rats group, whereas no significant differences in long-
term retention were observed. Thus, chronic hypoperfusion induced by two-vessel occlusion
gave rise to impairment of spatial memory. Following behavioural testing, the rats were killed
at the age of 17 months, and capillaries in the CA1 and dentate gyrus were examined using
transmission electron microscopy. Typical age-related capillary abnormalities such as
degenerative pericytes and thickened basement membranes (with or without fibrosis) were
detected in the hippocampus of sham animals. In occluded rats, the occurrence of capillaries
displaying such abnormalities almost doubled in the CA1 region, but was similar in the
dentate gyrus, compared with sham controls. A highly significant correlation was found
between the last Morris maze performance and the percentage of capillaries with deposits in
the basement membrane in the hippocampal CA1 area of occluded rats, which was not
present in the sham animals. We conclude that a long-term hypoperfusion accelerated the
development of age-related ultrastructural aberrations of capillaries in the hippocampal CA1
area, but not in the dentate gyrus. Thus, not only neurons, but also capillaries in the
hippocampal CA1 area are sensitive to an impaired microcirculation. Moreover, the cognitive
performance of hypoperfused rats correlated closely with the condition of the capillaries in
the CA1 area, suggesting that capillary integrity is one of the important determinants of brain
function in conditions that compromise cerebral microcirculation.
Key words: chronic hypoperfusion, carotid artery ligation, rat, capillary morphology,
transmission electron microscope, spatial learning.Experimental Cerebral Hypoperfusion
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Introduction
The impact of decreased cerebral blood flow on brain function has received increased
scientific interest in recent years. Disturbances of the cerebral circulation have been
associated with the decline of cognitive function in elderly subjects, as well as with the
development of several types of dementia (Habert et al., 1991; Kalaria, 1996; Donnemiller et
al., 1997). The bulk of this evidence indicates that cerebral hypoperfusion may fail to satisfy
the metabolic demands of the neuronal tissue because of suboptimal delivery of vital
nutrients to the brain. Owing to the inadequate energy supply, cognitive loss and memory
deficits may develop.
Memory function, particularly spatial information processing, has been consistently
associated with the hippocampal formation (Poucet and Benhamou, 1997). Non-invasive
scanning studies performed on Alzheimer’s disease (AD) subjects, multi-infarct dementia
patients and Parkinson’s disease patients with dementia showed that regional cerebral blood
flow was reduced most severely in the temporal cortex, including the hippo-campus, where
the observed hypoperfusion strongly correlated with the degree of dementia (Eberling et al.,
1992; Ohnishi et al., 1995). Further-more, animal studies revealed that the hippocampus,
and particularly its CA1 area, was selectively vulnerable to the consequences of
hypoperfusion (Schmidt-Kastner and Freund, 1991). All of these findings support the theory
that cerebral hypoperfusion plays a significant role in cognitive disturbances and is likely to
be an important risk factor in the development of several types of dementia, including AD (de
la Torre and Mussivand, 1993; de la Torre, 1994; De Jong et al., 1997).
Reduced cerebral blood flow appears to coincide with the well-described microvascular
aberrations, although it is still undetermined whether capillary distortions are the cause
and/or a result of altered blood flow. Most probably, the process works in both ways in a
chronic, progressive fashion. Supporting evidence for both alternatives has been reported.
When considering the relationship between vascular morphology and function, it is important
to distinguish the cerebral arterial system and the fine capillary network. Arterioles regulate
blood pressure with the help of their supporting smooth muscle, while capillaries provide the
surface for nutrient transport (Kalaria, 1996). The attention of the present study is focused on
the cerebral capillaries due to their prominent role in nutrient exchange via the blood–brain
barrier and because reduced brain perfusion in AD is associated with structural capillary
deformities (Scheibel and Duong, 1986; Perlmutter and Chui, 1990; Claudio, 1996; De Jong
et al., 1997).Chapter 2
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The angioarchitecture of the cerebral microvasculature in AD subjects was investigated at
the light microscopic level. Several larger scale pathological alterations have been defined,
such as atrophic, thin vessels, glomerular loops, fragmentation, and twisting or tortuous
vessels (Scheibel and Duong, 1986). The fine ultrastructure of cerebral capillaries in aging
and dementia was analysed at the electron microscopic level (De Jong et al., 1990;
Perlmutter and Chui, 1990; De Jong et al., 1991; De Jong et al., 1992; De Jong et al., 1997;
Claudio, 1996). Major categories of capillary aberrations encountered in these studies
include basement membrane abnormalities and degenerative pericytes. The anatomical
distortions in the vascular walls may interfere with fluid hemodynamics and alter normal flow
pattern. The decreased local blood flow is apt to reduce the efficiency of nutrient delivery
and deprive the brain of vital resources (de la Torre and Mussivand, 1993; de la Torre,
1994).
The decreased blood flow and compromised cerebrovascular microanatomy, together
with the predictive consequences of reduced nutrient transport, may contribute to cognitive
disturbances by causing impaired neuronal metabolism. In the present study, we used an
animal model to investigate the relationship between pathological cerebrovascular
microanatomy and functional deficits of cognitive processes. We subjected rats to chronic
cerebral hypoperfusion and challenged the animals in a learning task. The animals were
monitored for one year after two-vessel occlusion (2VO) surgery, after which they were killed
to examine capillary ultrastructure in the hippocampus. Particular attention was aimed at
investigating the presumed correlation between microvascular pathology and learning
performance.
Experimental Procedures
Surgery
In this study, 12 male Wistar rats (Harlan) were used. The animals were group-housed,
received food and water ad libitum, and were kept on a regular 12-h/12-h light–dark cycle. At
the age of three months, rats were anaesthetized with a combination of sodium pentobarbital
(30 mg/kg, i.p.) and Hypnorm (Solvay–Duphar, Weesp, The Netherlands; 0.4 mg/kg, i.m.).
Chronic hypoperfusion was induced in seven animals by the earlier described (Ni et al.,
1994; Pappas et al., 1996) permanent bilateral occlusion of the common carotid arteries
(2VO). After ventral cervical incision, the carotid arteries were carefully separated from their
sheath and vagal nerves, and double ligated with silk sutures. The remaining five rats
received the same surgical procedure without actual ligation and served as sham-operatedExperimental Cerebral Hypoperfusion
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controls. Local analgesics were given by applying Xylocaine gel on the sutures. After
surgery, rats were left to recover for a period of one month. All rats were checked daily on
their physical health condition.
Morris water maze learning
One month after surgery, the animals were trained in the Morris water maze to locate a
hidden platform. The water maze consisted of a polyester circular pool (diameter: 140 cm;
height: 35 cm) with a featureless black inner surface. Prominent extra maze cues were
positioned on the wall of the testing room to enable the rats to learn the platform’s location.
Swimming paths were registered by a computerized video imaging analysis system
(EthoVision, Noldus Information Technology BV, Wageningen, The Netherlands). The pool
was filled with water at 27 
oC to a height of 25 cm. The hidden escape platform (diameter: 9
cm) was submerged 2 cm below the water surface and was invisible from the water level. All
rats received two trials, with a constant intertrial interval of 1 h, for five consecutive days.
The animals were gently placed in the water in one of four quadrants, facing the wall of the
pool; the starting quadrant was varied randomly over the trials. Rats were allowed 180 s to
find the escape platform. Rats, which failed to locate the platform, were placed on the
platform for 30 s. For all trials, escape latency, swim speed and distance travelled before
reaching the platform were measured.
Two months after surgery, all rats were again tested in the water maze. Special care was
taken to maintain exactly the same extra maze cues as in the first training period. On the first
day of this second training period, the platform was located in the same quadrant as in the
first training period. On day 2, the location of the platform was changed. Thereafter, animals
were tested for another three days (six trials) with the platform at the same location as on the
second day.
Finally, 12 months after surgery, the animals were exposed for the third time to the water
maze. The rats again had to learn the location of the hidden platform (which was situated in
a different position to that in the initial learning trials) in a series of two daily trials for five
consecutive days.
Electron microscopic preparation
Fourteen months after surgery, sham-operated and 2VO rats were deeply anaesthetized
with 60 mg/kg pentobarbital (i.p.) and initially perfused transcardially with 0.1 M phosphate
buffer with 0.4% heparin, immediately followed by 1% paraformaldehyde and 2%
glutaraldehyde in 0.1 M phosphate buffer (pH 7.38). Brains were removed and cut into 50-Chapter 2
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mm sections with a Vibratome. Vibratome sections were routinely embedded in glycide ether
(the equivalent of Epon Serva 812) for ultrastructural examination.
Morphometric procedure
After light microscopic examination of the embedded Vibratome sections, selected
regions of the dorsal hippocampus were collected for semithin and ultrathin sectioning.
Selection of the hippocampal region was made from transverse sections at Bregma  -3.60
according to the Paxinos and Watson rat brain atlas. The areas selected were trimmed en
bloc, cut into semithin sections and stained with Toluidine Blue. Guided by these survey
sections, the blocks were further trimmed to the desired proportions to match the size of the
carrier mesh grids. Ultrathin sections were collected on 200-mesh grids and contrasted with
5% aqueous uranyl acetate and Reynolds’ lead solution. The ultrastructure of the
hippocampal capillaries was examined in a Philips 201 electron microscope. Based on
previous examinations (De Jong et al., 1990; De Jong et al., 1991; De Jong et al., 1992; De
Jong et al., 1997), capillaries were classified into the following categories: (i) intact
capillaries, (ii) capillaries with degenerative pericytes, (iii) capillaries with local depositions of
basement membrane material with either fibrous (fibrosis) or homogeneous (basement
membrane thickening) appearance and (iv) a miscellaneous group of capillaries with rare
deviations of the endothelial cytoplasm. The number of intact microvessels or those
displaying one of the above abnormalities was counted directly from the electron microscope
screen of the CA1 and dentate gyrus (DG) region, by an investigator blind to the identity of
the rat. This quantification was repeated in three adjacent ultrathin sections in order to
compensate for fortuitous distribution patterns as a consequence of using mesh grids. A total
of approximately 90 capillaries per CA1 and 45 capillaries per DG region were quantified per
brain. From these quantitative data, we calculated the percentage of capillaries that
displayed structural degeneration.
Statistical analysis
The Morris maze learning curves were expressed as medians, and the significance of
differences was tested with the non-parametric Mann–Whitney U-test. The percentage of
intact or aberrant capillaries was also evaluated using the Mann–Whitney U-test. The
correlation between capillary ultrastructure and the Morris maze performance was tested
using linear regression analysis. Statistical significance was defined as P < 0.05.Experimental Cerebral Hypoperfusion
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Results
Morris water maze learning
One month after the occlusion of both carotid arteries, sham-operated animals quickly
learned to locate the hidden platform, which is shown in Figure 2.1.A. In the analysis of the
water maze data, the distance travelled to find the platform was taken as a measure of
cognitive performance because of its independence of swimming speed. Major acquisition of
the spatial information in sham rats took place in the first two days, as indicated by a sharp
decrease in distance travelled before finding the plat-form. This acquisition levelled off after
two days. The 2VO rats also learned to locate the hidden plat-form, but the levelling off
occurred after four days (Fig. 2.1.A). On day 5 of the first training period, sham animals
immediately swam towards the platform when placed in the maze, while the 2VO rats swam
a significantly longer distance before finding the platform.
Two months after surgery, sham animals swam a relatively short distance to find the
platform (Fig. 2.1.B), indicating a good retention of spatial memory. On the first day of
training, 2VO rats travelled a significantly longer distance than sham animals (Fig. 2.1.B; P <
0.02). On day 2, the location of the platform was altered, a situation that prompted both
groups to travel a longer distance (Fig. 2.1.B). The magnitude of this response was not
significantly different for the two groups. On days 3–5, both groups found the platform at its
new location, although the performance of the 2VO animals remained significantly impaired
compared with the sham controls on days 3 and 5 (P < 0.02 and 0.01, respectively).
When tested one year after carotid occlusion, sham rats improved their performance in a
similar fashion as during the first two training periods, with the largest improvement on day 2.
The performance of the 2VO animals on day 2 was not ameliorated when compared with
day 1, and differed significantly from the sham animals (P < 0.02). A small improvement of
2VO rats was detected on days 3 and 4, but on the last day of testing these rats scored even
lower than on day 1. The retention seen at the beginning of the third trial session showed no
difference between the two groups. During all three training periods, no differences were
observed between the two groups with regard to swim speed, leading to the conclusion that
motor functions were not disturbed by the surgical procedure.
Capillary ultrastructure in the hippocampus
The ultrastructure of hippocampal capillaries was examined exactly 14 months after
surgery, when the animals were actually 17 months of age. From earlier studies, it is known
that,  at  this  chronological  stage,  capillaries start   to  manifest  age-related  ultrastructuralChapter 2
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Figure 2.1. The median values of sham-operated and 2VO groups that were trained (two trials per
day on five consecutive days) one month (A), two months (B) or one year after surgery.
alterations (De Jong et al., 1990; De Jong et al., 1991; De Jong et al., 1992). As described in
detail previously (De Jong et al., 1990; De Jong et al., 1991; De Jong et al., 1992), we
distinguish two basically different categories of capillary degeneration that occur during
aging: (i) degenerative pericytes (Fig. 2.2.B) and (ii) deposits in the capillary basement
membrane (Fig. 2.2.C, D).
The first category is characterized by membranous degenerative material enclosed by a
basement membrane. Within these structures, cytoplasmic elements such as mitochondria
can be recognized. The category of microvascular deposits includes microvascular fibrosis
(i.e. banded collagen fibrils deposited within the basement membrane; Fig. 2.2.C) and local
basement membrane thickening (Fig. 2.2.D).
Approximately 50% of all hippocampal capillaries were ultrastructurally intact in the sham-
operated animals. In the DG, no significant difference was found between sham and 2VO
rats (Fig. 2.3.A; P < 0.27), whereas in the CA1 region, significantly fewer intact capillaries
were encountered in the 2VO animals (Fig. 2.3.A; P < 0.03).
The incidence of capillaries with degenerative pericytes was higher in the 2VO animals in
both hippocampal regions examined (Fig. 2.4.B), which was significant for the CA1 (P  <
0.05) and strongly suggested a trend for the DG (P < 0.07).
The occurrence of capillaries with deposits, the term we use as a collective phrase for
basement membrane thickening and/or collagen accumulation in the basement membrane,
was prominently and significantly increased exclusively in the CA1 area (Fig. 2.4.C; P  <
0.03), and not in the DG (P < 0.34).Experimental Cerebral Hypoperfusion
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Figure 2.2. (A) Normal appearance of a cerebral capillary. The endothelial nucleus (EN) is
surrounded by endothelial cytoplasm (EC), which in turn is circumvented by a thin basement
membrane (*). The capillary wall is surrounded by astrocytic end-feet (as). (B) Pericytic degeneration
shown by membranous degenerative material, as well as lysosomes, (Ly), are seen. (C)
Microvascular fibrosis showing a large amount of collagen fibrils (C) within the basement membrane
(p). (D) Local thickenings (*) of the basement membrane. L, capillary lumen; m, mitochondrion.
Correlation between the Morris water maze performance and capillary ultrastructure
Correlations between morphological capillary pathology and behavioural performance
were based on the last training period in the water maze prior to the fixation of the brains. It
would appear that the difference in spatial memory recorded on day 2 of the last training
period was the most important to feature the cognitive impairment of the 2VO animals, since
on this day the sham animals improved their performance considerably, unlike the 2VO rats.
For this reason, we correlated the integrity of hippocampal capillaries with the distance
travelled in the water maze by the 2VO animals on day 2.
No correlation between capillary integrity and water maze performance was found for the
DG (Fig. 2.4.D–F). However, we observed a strikingly negative correlation between the
percentage of intact capillaries in  the  hippocampal  CA1  area  and the distance travelled inChapter 2
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Figure 2.3. Median values of the percentage of intact microvessels (A), capillaries with degenerative
pericytes (B) and capillaries with deposits within the basement membrane (C) in sham and 2VO rats
14 months after surgery in the hippocampal CA1 area and DG. *P, 0.05.
the maze on day 2 (Fig. 2.4.A). This correlation (r  = 0.952) was highly significant (P  <
0.0009), indicating that within the 2VO group the performance in the Morris maze is better in
rats with the fewest capillary abnormalities.
When regression analysis was performed on the different categories of capillary
abnormalities, it became clear that the observed correlation was based on the percentage of
capillaries with deposits percentage of capillaries with degenerative pericytes (Fig. 2.4.B; r =
0.935, P < 0.002) and not on the (Fig. 2.4.C; r = 0.44, P < 0.321).
Discussion
This study aimed to investigate the effects of chronic cerebral hypoperfusion on cognitive
function and the anatomical integrity of hippocampal capillaries. Therefore, we have
monitored the cognitive capacity of young adult Wistar rats that underwent permanent
ligation of both common carotid arteries (2VO) for a period of one year. One month after
surgery, a minor but non-significant impairment in the acquisition of spatial information was
registered in the 2VO rats. After two months, the 2VO group showed an impaired spatial
memory that persisted throughout the training period. One year after surgery, acquisition
curves demonstrated a small, significant impairment in the 2VO group. In conclusion, chronic
hypoperfusion induced by 2VO gave rise to impairment of spatial memory throughout the
entire 12-month observation period following surgery.
2VO surgery in rats leads to a chronic reduction in cerebral blood flow to 70% of the
original flow rate. Such chronic hypoperfusion in rats has been reported to impair spatial
memory in the Morris maze as early as seven days after surgery (Pappas et al., 1996; de laExperimental Cerebral Hypoperfusion
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Figure 2.4. The distance travelled in the Morris water maze on day 2 of the final training period
plotted against the percentage of capillaries in either the hippocampal CA1 area (A–C) or DG (D–F)
that were intact (A, D) or displayed capillary deposits (B, E) or degenerative pericytes (C, F) in sham
(open circles) and 2VO (filled circles). For the calculation of the linear regression coefficient r, only the
values of the 2VO rats were considered.
Torre et al., 1997), whereas radial maze performance was compromised several months
post-surgery (Ni et al., 1994; Pappas et al., 1996). Pappas et al. (1996) performed surgery
on middle-aged rats, indicating that the age of the animal at the time of surgery is relevant to
strong cognitive impairment, whereas an extended survival period (one year in the present
study) did not noticeably aggravate cognitive failure. Cerebral hypoperfusion was
demonstrated to induce memory impairment in additional, different memory tasks. Chronic
hypoperfusion with cerebral blood flow of 70–80% of original values yielded impaired
learning in the passive avoidance paradigm two months after vascular intervention in gerbils
(Kudo et al., 1990; Kudo et al., 1993). Sekhon et al. (1997b) observed an increased
exploratory behaviour in the open field and an impaired working memory in the T-maze in
rats six months after surgery, by using a very elegant model (an arterio-venous fistula in the
neck of rats, by which cerebral blood flow is reduced to 25–50%).
In the present study, we assessed the occurrence of well-defined ultrastructural
abnormalities of the capillary wall in the rat hippocampus after 12 months of hypoperfusion,
and found that chronic hypoperfusion induced the degeneration of pericytes and the
development of capillary deposits in the hippocampal CA1 area but not in the DG.Chapter 2
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Previously, other studies described microvascular changes following either reversible
occlusion of the middle cerebral artery 30 or the common carotid arteries 36 in rats, leading
to a period of post-ischemic hypoperfusion. Under these experimental conditions, damaged
surfaces of arteriolar smooth muscle cells and tortuous capillaries were observed using
scanning electron microscopy (Takahashi et al., 1997). The same study also demonstrated
that postischaemic hypo-perfusion induces non-reversible damage and separation of
pericytic cell bodies from the capillary wall. Degeneration of capillary pericytes is known to
be age related (Farrell et al., 1987; De Jong et al., 1990; De Jong et al., 1991; De Jong et
al., 1992; De Jong et al., 1997) and also occurred in the presently studied sham animals
(aged 17 months) in both the CA1 and DG. It is reasonable to assume that the pericytic
degeneration observed with transmission electron microscopy (TEM) in this study is the
morphological correlate of the aberrations which Takahashi et al. (1997) detected using
scanning electron microscopy. It seems likely that pericytes leave the capillary wall in order
to act as microglia cells in the neuropil. This hypothesis corroborates the separation of
pericytic cell bodies from the wall and indicates that the TEM images of degenerative
pericytes in the present study are the remnants of cellular debris of pericytic origin. A similar
suggestion was put forward after careful examination of cortical capillaries from the
Alzheimer patients, where capillaries seemed to be activated by nearby deposited amyloid
(Zarow et al., 1997). Chronic hypoperfusion yielded more hippocampal capillaries with
degenerative pericytes, which, however, did not correlate with cognitive impairment. The
latter suggests that pericytic pathology does not directly interfere with memory formation.
TEM evaluation after middle cerebral artery occlusion revealed swelling of endothelial
cells followed by an increased number of microvilli on the luminal site of the endothelial cell
membrane (Sakaki et al., 1997). Similar microvilli were found to correlate with the duration of
the ischemic episode (Dietrich et al., 1984). To our knowledge, only two other animal studies
have examined the effect of chronic hypoperfusion on cerebral capillaries. Firstly, in cats, a
period of up to 15 days of hypoperfusion yielded collapsed capillaries along with several
features of neuronal and glial degeneration (Romanski and Stamenov, 1995). Secondly,
using the aforementioned arteriovenous fistula model, Sekhon et al. (1997a) found that the
capillary density increased significantly in the CA1 of rats that were subjected to 26 weeks of
hypoperfusion. Combined with the observation that several capillaries lack astrocytic end-
feet, the authors concluded that hypoperfusion leads to neovascularization. Others found an
increased capillary density in the cerebral cortex after hypobaric hypoxia and suggested
capillary segment elongation (Mironov et al., 1994). Such an increased capillary density mayExperimental Cerebral Hypoperfusion
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serve as compensation for the originally weaker microvascular architecture of the CA1
(Coyle, 1978; Imdahl and Hossmann, 1986; Mossakwski et al., 1994).
The deposition of collagen or basement membrane-like material in the capillary basement
membrane is an aging-related phenomenon (De Jong et al., 1990; 1990; De Jong et al.,
1991; De Jong et al., 1992; De Jong et al., 1997). We found such pathological deposits in
both the DG and CA1 of sham-operated animals. The incidence of capillary deposits in the
DG of 2VO rats was comparable to that of sham animals, but in contrast they were
significantly increased in the CA1 area. In fact, the number of capillaries displaying deposits
was almost doubled. In view of the earlier mentioned increased capillary density (Sekhon et
al., 1997a), it is important to emphasize that our data provide information about the integrity
of the total capillary population in a given region, without taking into account eventual
changes in capillary density. In other words, it may very well be that chronic hypo-perfusion
yields more (Sekhon et al., 1997a), but also more damaged, capillaries in the CA1 region
(present study). The present data suggest that the rat CA1 is a brain region where not only
neurons, but also capillaries, seem to be extremely vulnerable to hypoperfusion.
The importance of intact hippocampal capillaries became clear from the remarkable
correlation between the Morris water maze performance and the percentage of capillaries
with basement membrane deposits. The present findings indicate a correlation between
behavioural deficits and capillary deposits in 2VO rats. Although other factors (e.g., impaired
visual abilities (Ohta et al., 1997)) may also contribute to poor performance on the water
maze, it would appear from our data that the compromised microvasculature in CA1 affects
spatial memory function. The striking correlation between impaired spatial memory and
increased percentage of degenerated capillaries in the CA1 as found in the present study
indicates that chronic hypoperfusion may accelerate aging-related behavioural and
microvascular deterioration. This hypothesis supports the increased occurrence of aging-
related lipofuscin pigment in CA1 neurons of chronically hypoperfused rats (Sekhon et al.,
1997c). Moreover, the finding that chronic cerebral hypoperfusion in rats leads to increased
accumulation or induction of amyloid precursor protein (Kalaria et al., 1993) suggests a
relation to AD as well. Based on these and other data, de la Torre (de la Torre, 1994)
formulated the hypothesis that an impaired cerebral microcirculation plays a key role in the
development of AD, which is further supported by the present data. Finally, the observation
that AD patients show significantly more capillaries with deposits in the basement membrane
(De Jong et al., 1997), as do rats with chronic brain hypoperfusion (present study), strongly
supports the microvascular theory of AD.Chapter 2
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Conclusions
We found a small but consistent impairment in spatial memory after chronic 2VO. Long-
term hypo-perfusion accelerated the development of aging-related ultrastructural
abnormalities of capillaries that seemed to target the hippocampal CA1 area. We conclude
that not only neurons, but also capillaries in the CA1 are extremely vulnerable to an impaired
microcirculation. Moreover, the cognitive performance of hypoperfused rats correlated very
closely with the condition of the capillaries in the CA1 region, implying that capillary integrity
is one of the major determinants of brain functioning in conditions where cerebral circulation
may be compromised.
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Abstract
Cerebral capillaries represent a major interface between the general circulation and the
central nervous system and are responsible for sufficient and selective nutrient transport to
the brain. Structural damage or dysfunctioning carrier systems of such an active barrier
leads to compromised nutrient trafficking. Subsequently, a decreased nutrient availability in
the neural tissue may contribute to hampered neuronal metabolism, hence to behavioral and
cognitive functional deficiencies. Here we focus on the ultrastructural abnormalities of
cerebral microvessels in Alzheimer’s disease (AD; n=5) and Parkinson’s disease (PD; n=10).
The capillary microanatomy in samples from the cingulate cortex was investigated by
electron microscopy and severe damage to the vessel walls was observed. Characteristic
pathological changes including capillary basement membrane thickening and collagen
accumulation in the basement membrane were enhanced in both AD and PD. The incidence
of capillaries with basement membrane deposits was two times higher in AD and PD than in
age matched controls. Degenerative pericytes in all groups appeared at a similar frequency.
The data indicate that basement membrane deposits, as opposed to pericytic degeneration,
represent an important pathologic feature of AD and PD and suggest that capillary
dysfunction may play a causal role in the development of these two major
neurodegenerative diseases.
Key words: Alzheimer’s disease, capillary ultrastructure, cerebral hypoperfusion, Parkinson’s
diseaseCerebral Capillary Pathology in Alzheimer’s Disease
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Introduction
Morphological abnormalities of cerebral capillaries and related deficient cerebral
circulation observed in dementia, and in Alzheimer’s disease in particular, has gained
increasing attention in recent years. Investigation of the influence of altered cerebral
circulation and abnormal cerebromicrovascular microanatomy on learning and memory
includes both clinical scanning and postmortem examinations, as well as experimental
animal studies.
Clinical research can highlight important physiological parameters of the cerebral
circulation of patients by the use of non-invasive scanning. Thus, SPECT studies
demonstrated that the regional cerebral blood flow of demented subjects was considerably
decreased compared to controls. The reduction in flow rate was found most pronounced in
the hippocampus and temporal cortex, regions that are known to be first and most severely
affected in Alzheimer’s disease (DeKosky et al., 1990; Braak and Braak, 1991; Eberling et
al., 1992; Ohnishi et al., 1995). In addition, the degree of hypoperfusion in the hippocampus
correlated well with the stage of dementia (Ohnishi et al., 1995). The remarkable finding that
insufficient cerebral circulation can very well be associated with memory deficits and
cognitive impairment stimulated further research in laboratory animals. By occluding the
carotid arteries, the negative effect of decreased cerebral blood flow on cognitive processes
could be reproduced in rats (De Jong et al., 1999; de la Torre et al., 1992; Pappas et al.,
1996). The created chronic experimental cerebral hypoperfusion resulted in impaired spatial
memory of the animals in a water maze paradigm and the increase of errors in the later
phase of learning in the radial maze spatial memory test both of which are indicative of
hippocampal dysfunction (De Jong et al., 1999; Pappas et al., 1996).
The above-presented data show that sufficient cerebral perfusion appears to be
essential for proper memory processing. Due to a lower perfusion rate, the adequate nutrient
transport to the brain can suffer setback, which may cause hampered neuronal metabolism
and consequent cognitive disturbances. Indeed, the cerebral metabolic rate for oxygen and
glucose and the density of glucose transporter sites in the cerebral capillary walls were
found to be distinctly reduced in AD (Fukuyama et al., 1994; Harik, 1992; Horwood and
Davies, 1994; Kalaria, 1996; Mooradian et al., 1997). Such deprivation of the neuronal tissue
can derive from either the lower flow rate itself (implying a reduced volume of blood to reach
the brain capillaries) or the compromised permeability of the capillary walls due to abnormal
structural features (de la Torre and Mussivand, 1993). Most probably, the two factors areChapter 3
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dynamically and progressively connected and equally jeopardize nutrient trafficking in the
brain.
Cerebral hypoperfusion has been implicated in the development of cerebral capillary
damage (De Jong et al., 1997; De Jong et al., 1999) and the morphological characterization
of capillaries in dementia has also revealed distinctive pathology. Structural damage to brain
microvessels in AD and Pick’s disease was described at the light microscopic level as
twisting, tortuous structure, fragmentation and atrophy of capillaries, whereas in amyotrophic
lateral sclerosis/parkinsonism-dementia complex, mainly severe fragmentation of the vessels
was encountered (Buée et al., 1997). The data suggest that although capillary damage
obviously accompanies cognitive deficiencies, it is not specific to a particular type of
dementia. Capillary damage would rather appear as a general, dementia-associated
pathological property.
The irregular appearance of brain capillaries seen in the light microscope relates to
alterations in the microvessel walls observed by electron microscopic techniques (EM).
Electron microscopical examination of cerebral microvessels in humans was mainly
restricted to AD where the observed microanatomical irregularities of endothelial cells,
capillary basement membrane (BM) and pericytes were extensively described (Claudio,
1996; De Jong et al., 1997; Perlmutter and Chui, 1990). Basement membrane pathology can
occur in the form of thickening on the abluminal surface of capillaries and is thought to be
the result of either increased secretion or decreased turnover of BM components. The
abnormal folding and layering of the BM leads to BM duplication, while BM splitting creates
vacuoles within the BM, often filled with collagen fibers (Kalaria and Pax, 1995; Perlmutter
and Chui, 1990). Pericytic degeneration can usually be identified at its earlier stages by
inclusion bodies accumulating in the cytoplasm and a totally disintegrated intracellular
structure with the progress of damage (De Jong et al., 1990).
Although the listed abnormalities at EM level were reported mainly in AD, the question is
raised whether such microvascular disintegration is a specific feature of AD or more
common to other neurodegenerative diseases, with particular attention to several types of
dementia. Preliminary studies from our lab have already indicated that cerebrocortical
microvessels show BM thickening, vacuolization and pericytic degradation in clinical
Parkinson’s disease with cortical Lewy bodies (PD) and cerebrovascular disease (CVD), in
addition to AD (De Jong et al., 1997; Farkas et al., 1999). We intend to provide here an
extended overview of the aberrations of cerebral capillary walls in AD and PD with or without
AD-like neuropathology.Cerebral Capillary Pathology in Alzheimer’s Disease
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Materials and methods
Electron microscopical (EM) investigation was performed on human post-mortem tissue
samples obtained from the cingulate cortex of Alzheimer’s disease patients (AD, n=5),
Parkinson’s disease patients (PD, n=6), PD with cerebral pathology of Alzheimer’s disease,
(PDd, n=4), and non-demented age-matched controls (C, n=5). The composition of the four
groups is shown in Table 3.1. The groups randomly consisted of both male and female
patients ranging from 63 to 87 years old. The clinical diagnosis of the patients was confirmed
by routine post mortem analysis of the brains. The neuropathological examination
determined the presence and distribution of Lewy bodies in the brainstem, limbic regions
and the neocortex according to previously defined guidelines (De Vos et al., 1995; McKeith
et al., 1996). Furthermore, the allocortical spread of neurofibrillary tangles (NFT) indicating
Braak stages and the distribution of neocortical plaques in view of the age and clinical
history of the patients (CERAD scale) were carefully evaluated (Braak and Braak, 1991;
Mirra et al., 1991). The experimental groups were formed based on the assessed
neuropathological data.
Samples were collected at autopsy in Karnovsky fixative (2% glutaraldehyde and 1 %
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4) and transferred to fresh solution prior
to EM procedure. Tissue blocks were cut into 50 µm sections with a vibratome and routinely
imbedded in glycide ether. Embedded samples covered the entire cortical depth and were
cut to semithin thickness followed by azur and methylene blue staining for layer orientation.
Non-serial, ultrathin sections were collected on 200 mesh copper grids and were contrasted
with 5% aqueous uranyl acetate and Reynolds lead solution. Cortical capillaries were
examined with a Philips 201 electron microscope. The quantitative method used here was
previously established in rat and human brain material and proved to be an effective
approach to evaluate capillary wall alterations as a result of aging and cerebral
hypoperfusion (De Jong et al., 1990; De Jong et al., 1997; De Jong et al., 1999). The
advantage of the method is that it screens systematically the entire depth of the cortex
covering all the cortical layers and counting every capillary encountered. Moreover, a high
number of microvessels can be investigated to present a general overview of capillary
ultrastructure. Approximately 100 capillaries per case were screened throughout the cortical
layers focusing on basement membrane (BM) and pericyte pathology as defined below. The
analysis was performed blind by two independent investigators.Chapter 3
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Table 3.1. Neuropathological characterization of the patients included in the study. Abbreviations: AA:
amyloid angiopathy; Amyl.: cerebral beta-amyloid deposits; B: brainstem predominant Lewy bodies;
BP: blood pressure; HT: hypertension; ecAS: extracerebral atherosclerosis; icAS intracerebral
atherosclerosis; L: limbic Lewy bodies; LB score: Lewy Body score; N: neocortical Lewy bodies; NFT:
neurofibrillary tangles; SN pathol.: substantia nigra pathology.
Casus Age
(yrs)
Gender Clinical
Diagnosis
BP LB
Score
NFT Amyl. CERAD Braak
Stage
AA Vascular
Factors
SN
Pathol.
20.820 67 m Septichaemia 100/60
20.841 66 m Myocardiac
infarct
HT
20.848 64 m Myocardiac
infarct
HT
96.37 63 m Myocardiac
infarct
160/75
97.454 78 f Lung cancer 130/75
20.804 77 m Alzheimer’s 170/80 - +++ +++ definite V + - -
20.815 78 f Alzheimer’s 160/90 - +++ +++ definite V ± ecAS++ -
20.883 87 f Alzheimer’s 180/85 - ++ +++ probable IV - - -
21.055 83 m Alzheimer’s 170/90 - ++ +++ probable IV + - -
96.83 85 m Alzheimer’s 150/75 - +++ +++ definite V + ecAS+++ -
20.675 68 f Parkinson’s 140/70 N - + - III - icAS+ +++
20.708 76 f Parkinson’s 170/75 L - - - II - - +++
20.822 77 m Parkinson’s - N - +++ - III - icAS+ +++
96.56 68 m Parkinson’s 125/85 L + +++ possible II - - +++
96.82 85 f Parkinson’s 150/90 B - + - I-II + - +++
96.126 64 m Parkinson’s 160/60 L - - - 0 - icAS+ ,
microinfarct BG
+++
20.637 66 m Parkinson’s 130/70 N + +++ probable III + - +++
20.678 70 f Parkinson’s 150/80 N ++ +++ definite IV + - +++
20.884 80 f Parkinson’s 175/80 N ++ +++ probable III + ecAS++, icAS+ +++
21.077 86 f Parkinson’s 190/95 L + ++ probable III-IV + - +++Cerebral Capillary Pathology in Alzheimer’s Disease
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The number of vessels with aberrations was counted directly on the screen of the electron
microscope. Only transversely cut microvessels were analyzed and capillaries partially
covered by the mesh of the carrying grid were disregarded. The following categories of
capillary abnormalities were distinguished based on previously accepted and detailed
conditions hypoperfusion (De Jong et al., 1990; De Jong et al., 1997; De Jong et al., 1999):
1. Local basement membrane thickening (BMT, Fig. 3.1.B) which is defined by the here
listed criteria: the BM shows local thickening if the luminal and abluminal outline of the BM
are not running parallel, as shown in Fig. 3.1.B. Regions of the BM where the BM splits to
embrace pericytes were not considered because the BM appears usually thicker at such
segments. In case of the presence of an imbedded pericyte, only the outer BM was
investigated, the layer separating the endothelial cell and the pericyte was not. Random,
irregular branching and folding of the BM (Fig. 3.1.C) were also considered as BMT. BMT
was also determined according to the following measurements: EM photographs of
deformed microvessels were randomly taken and the width of the BM was measured at a
segment with regular thickness and at a visibly enlarged part of the same vessel. The
assessed values for a healthy segment ranged between 126-323 nm while thickening was
indicated between 253-843 nm. The BM was considered to feature BMT when the measured
thickness at the enlarged part was at least two times wider than that assessed at the
unaffected segment of the same capillary. The method was routinely applied on the EM
screen. 2. Fibrosis (Fig. 3.1.D). The term refers to excessive collagen type IV accumulation
between two layers of the BM identified by its typical periodicity, or collagen invasion to the
vascular cells from a split BM (Fig. 3.3.C and D). When a capillary demonstrates both BMT
and fibrosis, fibrosis overrules BMT and the capillary is counted only as one with fibrosis. 3.
Degenerative pericytes (Fig. 3.1.E) show abnormal, fractional inclusion bodies or swelling.
Lipofuscine granules in the pericytic cytoplasm were not regarded as aberrant features. The
term  deposits  was applied to the merged group of BMT and fibrosis, and capillary
aberrations for the combination of deposits and degenerative pericytes.
After counting the absolute number of vessels per category, the amount of damaged
microvessels was expressed as percentages of the total number of capillaries encountered
for each class of vascular pathology. The data was statistically analyzed with the non-
parametric Mann-Whitney-U test to define significance values (p≤0.05).Chapter 3
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Figure 3.1. Schematic drawings representing categories of capillary wall pathology. A: a healthy
capillary. B: basement membrane thickening pointed at by arrows. C: abnormal duplication and
branching of the basement membrane. D: fibrosis. E: pericytic degeneration. Abbreviations: l: capillary
lumen; e: endothelial cell; n: endothelial nucleus; p: pericyte; ∗: basement membrane.
Results
The ultrastructural abnormalities of cerebral capillaries were examined in post mortem
cingulate cortex samples of three groups of neurological patients. Basement membrane
deposits (BMT and fibrosis) and pericytic degeneration of AD, PD and PDd cases were
compared to that of age-matched controls. Linear correlation between age and the ratio of
abnormal capillaries could not be observed. The data of individual cases are summarized in
Table 3.2. and 3.3.Cerebral Capillary Pathology in Alzheimer’s Disease
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Table 3.2. Summary of the individual data of control cases and Alzheimer’s disease (AD) patients. ∗:
p≤0.05, Aberr.: microvascular aberrations, BMT: basement membrane thickening
Case No. Group Gender Age BMT (%) Fibrosis
(%)
Deposits
(%)
Pericytic
deg. (%)
20.820 control m 67 3.00 1.00 4.00 41.00
20.841 control m 66 13.25 0.00 13.25 32.53
20.848 control m 64 7.29 5.21 11.46 26.04
96.37 control m 63 8.13 17.89 26.02 26.02
97.454 control f 78 12.00 5.00 17.00 60.00
mean 67 8.73 5.82 14.35 37.12
SEM 1.82 3.19 3.60 6.35
20.804 AD m 77 15.96 4.26 20.21 12.77
20.815 AD f 78 36.36 10.23 46.59 11.36
20.883 AD f 87 10.64 5.32 15.96 68.09
21.055 AD m 83 14.95 16.82 31.77 7.48
96.83 AD m 85 14.29 30.25 44.54 33.61
mean 82 18.44 13.38 31.81 26.66
SEM 4.57 4.77 6.19 11.31
p ∗0.028 0.175 ∗0.047 0.347Chapter 3
64
Table 3.3. Summary of the individual data of Parkinson’s disease cases with (PD/III) or without (PD)
dementia. ∗: p≤0.05, Aberr.: microvascular aberrations, BMT: basement membrane thickening
Case No. Group Gender Age BMT (%) Fibrosis
(%)
Deposits
(%)
Pericytic
deg. (%)
20.675 PD f 68 16.13 8.60 24.73 54.84
20.708 PD f 76 16.09 2.30 18.39 4.60
96.126 PD m 64 20.41 11.22 31.63 22.45
20.822 PD m 77 29.41 2.94 32.35 26.47
96.56 PD m 68 3.64 34.55 38.18 28.18
96.82 PD f 85 24.66 8.90 33.56 42.47
mean 73 18.39 11.42 29.76 29.84
SEM 3.62 4.85 2.88 7.05
p ∗0.045 0.273 ∗0.018 0.584
20.637 PD+dem. m 66 13.83 6.38 20.21 63.83
20.678 PD+dem f 70 30.77 19.23 50.00 5.77
20.884 PD+dem f 80 24.49 0.00 24.49 38.78
21.077 PD+dem f 86 16.19 25.71 41.90 24.76
mean 75.5 21.32 12.83 34.15 33.29
SEM 3.89 5.87 7.06 12.22
p ∗0.014 0.268 ∗0.050 0.624Cerebral Capillary Pathology in Alzheimer’s Disease
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Figure 3.2. Ultrastructural basement membrane abnormalities in neurological disorders compared to
controls. *≤0.05, AD: Alzheimer’s disease; PD: clinical Parkinson’s disease with cortical Lewy bodies;
PDd: PD with typical AD neuropathology; BMT: basement membrane thickening.
Figure 3.3.B demonstrates typical BMT of an AD patient compared to a normal, control
basement membrane (Figure 3.3.A). The ratio of microvessels with BMT was doubled in the
three pathological groups compared to controls, reaching significant values (Figure 3.2.A). A
representative example of extensive fibrosis is shown in Figure 3.3.C and 3.3.D. The ratio of
vessels with such collagen accumulation remarkably increased in AD, PD and PDd but
showed considerable variance among individual cases (Figure 3.2.B). The combination of
BMT and fibrosis, defined as deposits in the capillary walls may provide a more objective
approach to describe basement membrane pathology, as the two features are considered to
be progressively related. Deposits in the basement membrane exhibited a remarkable and
significant increase in AD, PD and PDd, as shown in Figure 3.2.C. The amount of capillariesChapter 3
66
with deposits in these three groups was more than two times higher than that of controls. On
the other hand, degenerative pericytes were encountered to a similar proportion in all groups
including the controls suggesting no specific involvement of pericytic degradation in any of
the studied neurological conditions (Figure 3.2.D). An example of a degenerative pericyte is
shown in Figure 3.3.E.
In general, the cerebral capillaries of AD, PD and PDd patients were affected, and
demonstrated specific basement membrane pathology. Disease related vascular damage
was restricted to the basement membrane and did not involve the pericytes. Deposits in the
capillary walls, as well as BMT were highest in the PDd group, although this group did not
differ significantly from either the AD or the PD patients.
Figure 3.4. Correlation between the age of the individual patients and the percentage of intact
capillaries in the examined samples from the cingulate cortex.
The control group that we assembled was not strictly age-matched due to limitations at
performing autopsy. However, all cases exceeded the age of 60 years and were considered
aged. A correlation analysis was performed in order to rule out that the vascular aberrations
observed here present an age-related phenomenon: no significant correlation could be seen
between the age of the patients and any of the defined categories of cerebral capillary
damage. Figure 3.4. shows a representative correlation graph concerning the percentage of
intact capillaries.Cerebral Capillary Pathology in Alzheimer’s Disease
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Figure 3.3. Photomicrographs demonstrating illustrative pathologic ultrastructural alterations of
human cerebral capillary walls. The basement membrane in each photograph is pointed at by
arrowheads. A: a healthy capillary of a control sample (magnification: 36.000x). B: basement
membrane thickening of an Alzheimer’s patient (magnification: 26.500x). C: Transversely cut collagen
bundles invading the pericytic cytoplasm (magnification: 54.500x). D: basement membrane
duplication with transversely cut collagen fibers (magnification: 48.000x). E: A swollen, degenerating
pericyte with inclusion bodies in the cytoplasm (magnification: 12.500x). Abbreviations: er: erythrocyte
in the capillary lumen; e: endothelial cytoplasm; en: endothelial nucleus; p: pericyte.Chapter 3
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Discussion
We have shown in the present study that the capillary ultrastructure in the limbic cingulate
cortex of AD, PD and PDd patients is severely compromised. In addition to dementia related
disorders, PD is also shown here to be subject to cerebrovascular microanatomical
alterations, particularly BM depositions. The cingulate cortex proves to be a proper area for
investigation because neuropathological alterations characteristic of AD or PD, namely
neuritic plaques, neurofibrillary tangles or Lewy bodies, can be all observed in the region.
The spread of neurofibrillary tangles, an accepted marker for the pathologic staging of AD,
covers the complete limbic cortex with the progression of the disease and affects the entire
isocortex at the later stages (Braak and Braak, 1991). The appearance of Lewy bodies, the
cortical lesion that can accompany PD, concerns the cingulate gyrus, as well (Braak et al.,
1997).
Research on capillary anatomy and cortical regional cerebral perfusion rate has chiefly
focused on their relationship with dementia therefore information about the phenomenon in
other human neurological disorders is relatively scarce. However, PET studies showed
decreased regional cerebral blood flow (rCBF) and oxygen utilization in PD (Leenders et al.,
1985). Moreover, Kawabata and co-workers (1991) conducted important SPECT
examinations and found that rCBF of PD subjects with or without dementia was significantly
reduced in the temporal and parietal cortices or the frontal and temporal cortices,
respectively. Varma et al. (Varma et al., 1997) also showed cortical blood flow alterations in
PD with dementia. The described observations appear to be rather similar to AD in that the
temporal, parietal and frontal cortical lobes are primarily affected (DeKosky et al., 1990;
Eberling et al., 1992; Ohnishi et al., 1995).
In order to place our pathological results into a physiological context and to be able to
hypothesize cause-effect relationships, experimental animal studies are needed. Bilateral,
chronic carotid artery occlusion in rats (2VO) has proved to be a cerebral hypoperfusion
model that creates dementia-like symptoms such as learning impairment and memory
deficits. Besides the typical spatial memory deficits demonstrated by water maze and radial
maze tasks in 2VO rats (De Jong et al., 1999; Pappas et al., 1996) symptoms of progressive
neurodegeneration similar to that seen in human dementia were also observed, such as
characteristic apoptotic pyramidal cell damage in the hippocampus CA1, the primary site of
neuropathological changes in AD (Braak and Braak, 1991; de la Torre et al., 1992; Bennett
et al., 1998). Furthermore, additional features of AD like increased immunoreaction to glial
fibrillary acidic protein and amyloid precursors protein accumulation were reported after 2VOCerebral Capillary Pathology in Alzheimer’s Disease
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(de la Torre et al., 1992; Kalaria et al., 1993). The described, hypoperfusion-related cognitive
malfunction was also accompanied by cerebral capillary damage as demonstrated by De
Jong et al. (De Jong et al., 1997; De Jong et al., 1999). Taken the experimental data
together, a group of properties reminiscent of particular aspects of AD is assembled (de la
Torre, 1999). Therefore it is tempting to speculate that the ultrastructural capillary
abnormalities in human samples presented here and previously by others (Claudio, 1996;
De Jong et al., 1997; Perlmutter and Chui, 1990) are most likely associated with chronic
cerebral hypoperfusion. As cerebral hypoperfusion in animals created massive capillary
damage in the brain (De Jong et al., 1997; De Jong et al., 1999) it may be conceived that
alterations in rCBF possibly act as a causal factor inducing microvessel malformations not
only in AD but also in PD and PD with dementia.
Morphological capillary abnormalities cannot only be linked to cerebral hypoperfusion but
may also account for compromised metabolic rates in the neural tissue. Reduced glucose
metabolism in AD brains has been a well-established phenomenon by now (Rapoport et al.,
1991; Blesa et al., 1996). Although the existence of reduced glucose metabolism in PD is a
topic of debate and contradicting PET results are available (Peppard et al., 1990; Sasaki et
al., 1992; Eberling et al., 1994), PD with dementia has consistently been shown to be
accompanied with a reduced cerebral glucose metabolism (Peppard et al., 1990; Sasaki et
al., 1992; Thomas et al., 1996). A lower metabolic rate for glucose may be caused by
hypoglycemia (resulting from the above described hypoperfusion) or defective transport
through distorted capillary walls. Both the physical features of capillaries, such as BMT
shown here, and the functional damage to endothelial transport molecules can explain the
latter possibility. Glucose transporters of the endothelial cells (GLUT-1) suffer dramatic
changes in AD as indicated by the lower level of GLUT-1 in the cerebral cortex (Harik, 1992;
Horwood and Davies, 1994; Mooradian et al., 1997), but GLUT-1 density measurements in
PD have, to our best knowledge, not yet been reported.
Microvascular atrophy can be evoked not only by cerebral hypoperfusion but also by
compromised metabolic routes of microvascular cells. The components of the capillary BM
(collagen type IV, laminin and heparan sulfate proteoglycan) are secreted by the three cell
types of the microvessels: the endothelial cells, the pericytes and the astrocytes (Zarow et
al., 1997). Perlmutter and Chui (1990) ways to produce the molecules being under the
influence of toxic external stimuli. Prominent examples are β-amyloid action on endothelial
cells leading to endothelial dysfunction (Thomas et al., 1996; Thomas et al., 1997) or the
effect of oxygen free radicals on endothelial cells causing chromosomal aberrations and the
induction of micronuclei (Karlhuber et al., 1997). Thus, β-amyloid effect or oxidative stressChapter 3
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can alter the internal metabolism of the endothelial cells, which may imply, among others, a
corrupt process of BM constituents. Remarkably, the latter mentioned oxidative stress is
considered to be a contributing factor to the development of both AD and PD (Gorman et al.,
1996; Gsell et al., 1997; Owen et al., 1997). Along with the induction of neuronal damage,
accumulating oxygen radicals may interfere with capillary ultrastructure by expressing a toxic
influence on endothelial metabolism in AD and PD.
We found that capillaries with deposits occurred considerably more frequently in AD, PD
and PDd than in controls but the incidence of degenerating pericytes was not disease-
specific. Our pericytic data do not stand in agreement with previous reports describing AD
associated, β-amyloid induced pericytic damage in cell culture (Verbeek et al., 1997). The
source of discrepancy may lie in the methodological approach, although our theory that the
presence of degenerating pericytes does not relate to dementia is supported by the lack of
correlation between existing pericytic degeneration and learning performance in rats (De
Jong et al., 1999). Thus, BM deposits, rather than pericytic irregularities, represent a crucial
microvascular pathological property in neurological disorders.
We conclude that in addition to the neural tissue, the cerebral capillary network is also
prone to structural degradation under neurological conditions like AD, PD and PDd. The
microvascular BM suffers the most pronounced and dramatic damage as opposed to
pericytes and emerges as a central target of vascular pathological changes in the disorders.
The described structural basement membrane malformations can lead to pathophysiological
consequences such as compromised nutrient transport, insufficient neuronal metabolism
and subsequent cognitive disturbances. Because of the multiple consequences, cerebral
capillary damage must be considered a significant property or contributing factor in the
development of Alzheimer’s disease, and possibly Parkinson’s disease.
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Abstract
The brain, as an intensely active organ is highly dependent on a sufficient nutrient and
oxygen availability in order to reach its optimal working capacity. It is well known that the
vital supply of energy substrates is provided by the circulatory system, which splits up into a
fine, terminal capillary network in target tissues. These capillaries are considered as
important sites since the actual nutrient trafficking takes place through their walls. That is
why an intact, preserved structure of the microvessels is crucial to fulfill their function. Since
the brain is known to be particularly vulnerable to sub-optimal oxygen and glucose delivery,
the intact morphology of capillaries is of paramount importance.
Several observations have indicated that the cerebral capillary ultrastructure is damaged
in Alzheimer’s disease (AD). Curiously, the regional cerebral blood flow of AD patients is
also significantly lower than in age-matched control individuals. Based on these data, it has
been suggested that the decreased blood supply and the cerebrovascular alterations
contribute to the development of dementia. However, we have observed similar capillary
damage in Parkinson’s disease patients and chronically hypertensive rats in addition to AD
cases, as presented here. These findings indicate that cerebral capillary damage is not
exclusive for AD but occurs under other neurodegenerative disorders and hypertension, as
well. We hypothesize that ultrastructural abnormalities of cerebral capillaries are causally
related to decreased cerebral blood flow and create a condition, which favors
neurodegenerative mechanisms including the development of dementia.Risk Factors for Cerebral Capillary Breakdown
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Introduction
Cerebrovascular structural abnormalities have frequently been reported in demented
patients diagnosed to have Alzheimer’s disease (AD) (Perlmutter and Chui, 1990; Claudio,
1996; Kalaria, 1996; Buée, 1997). Capillary damage in AD brains consistently occurs in the
form of capillary basement membrane thickening and collagen type IV accumulation, also
known as fibrosis. These pathological alterations implicate several functional consequences:
the thickening of the basement membrane can physically hinder nutrient transport to the
neural tissue or the clearance of potentially toxic waste products from the brain, and may
structurally affect the efficacy of important carrier systems of the blood-brain barrier. For
example, a decreased density of glucose transporter sites supports the latest assumption
and suggests reduced glucose availability in the affected brain regions (Harik, 1992;
Horwood and Davies, 1994; Mooradian et al., 1997). Hence, the imposed metabolic crisis
may be reflected by data indicating decreased cerebral glucose uptake and oxygen
utilization in Alzheimer brains (Rapoport et al., 1991, Fukuyama et al., 1994; Blesa et al.,
1996).
However, the observed cerebral capillary damage is not exclusive for AD. Similar
ultrastructural alterations of the cerebral microvessel walls were described in aging and
experimental cerebral hypoperfusion in rats (De Jong et al., 1990; De Jong et al., 1999).
Cerebral hypoperfusion has drawn major attention in AD research, too. Regional cerebral
blood flow measured by SPECT in AD patients demonstrated significant decrease in the
hippocampal formation and temporal cortex, regions first and most severely affected in the
disease (DeKosky et al., 1990; Eberling et al., 1992; O’Brien et al., 1992; Ohnishi et al.,
1995). Interestingly, cerebral hypoperfusion was also found to coincide with hypertension
due to possible, high blood pressure-related lack of autoregulation of cerebral blood flow or
atherosclerosis (Nobili et al., 1993; Nakane et al., 1995). Supportive experimental evidence
was obtained in spontaneously hypertensive rats where the observed reduced cerebral
blood flow was reported to coincide with an additional tendency for poor learning skills
(Fujishima et al., 1995; Katsuta, 1997).
In the present study, we overview the structural alterations of brain capillaries in
neurodegenerative diseases and hypertensive rats and attempt to establish a comparison
between them in the light of cerebral hypoperfusion.Chapter 4
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Cerebrovascular Pathology in Neurodegenerative Diseases
The condition of cerebrocortical capillaries of AD and PD patients was investigated in
post mortem samples from the cingulate cortex. The patients were selected based on
neurological diagnosis and subsequent standard neuropathological characterization (Braak
staging, CERAD scale, Lewy body score and substantia nigra pathology) (Braak and Braak,
1991; Mirra et al., 1991; de Vos et al., 1995; McKeith et al., 1996). The PD cases were
further differentiated based on the presence of neuropathological alterations characteristic of
AD. Thus, four separate groups were established: an AD group (n=5), a PD group without
AD-like neuropathology (n=6), a PD group with AD-like neuropathology (PDd, n=4) and
controls (n=5).
The samples were processed for electron microscopic analysis: the tissue was imbedded
in glycide ether and cut to ultrathin sections. The sections were mounted on copper grids
and contrasted with 5 % aqueous uranyl acetate and Reynolds lead solution. The analysis
was performed with a Philips 200 electron microscope.
We focused on deviations of the capillary walls and defined the following criteria: 1. when
the basement membrane (BM) demonstrated local thickening exceeding double width
compared to an intact BM segment of the same capillary, or showed duplications or
branching, we considered the abnormality as basement membrane thickening (BMT) (Fig.
4.1.B). 2. The  appearance  and  accumulation  of  collagen  fibers  in  the  BM,  occasionally
Figure 4.1. Schematic drawings demonstrating the ultrastructural abnormalities of cerebral capillaries.
A: an intact vessel. B: basement membrane thickening (BMT). C: collagen accumulation in the
basement membrane (fibrosis). D: degenerative pericyte. Abbreviations: ∗: basement membrane, e:
endothelial cell, l: capillary lumen, n: endothelial nucleus, p: pericyte.Risk Factors for Cerebral Capillary Breakdown
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invading the cytoplasm of an embraced pericyte, was taken as fibrosis (Fig. 4.1.C). 3.
membranous inclusion bodies and swollen pericytic profiles indicated pericytic degeneration
(Fig. 4.1.D). One hundred capillaries per case were screened and the percentage of
capillaries with any of the above-described abnormalities was calculated.
The data show that the percentage of microvessels with BMT and fibrosis has
considerably increased in AD as well as in PD and PDd (Fig. 4.2). The occurrence of BMT
was almost three times higher in the neurological diseases than in controls pointing to an
obvious and remarkable increase of BMT (Fig. 4.2.A). Similar tendency was observed in
fibrosis, but the individual variance prevented statistical significance (Fig. 4.2.B). In contrast,
the percentage of capillaries with degenerating pericytes was found comparable in all groups
(Fig. 4.2.C) suggesting no specific involvement of pericytic degeneration in the pathology of
AD or PD. Thus, the capillary wall, specifically the basement membrane appears to be the
major site of cerebrovascular damage in the investigated neurodegenerative disorders.
Cerebrovascular Pathology in Hypertension
The effects of hypertension were investigated on the cerebral capillaries of the
frontoparietal cortex of Wistar-Kyoto (WKY, n=6) and spontaneously hypertensive stroke
prone rats (SHR-SP, n=6). Blood pressure measurements were taken on the tail on every
fourth week for a period of 20 weeks, starting when the animals were 40 weeks old. On the
60
th week, the rats  were  perfused  with  2%  paraformaldehyde,  0.05%  glutaraldehyde and
Figure 4.2. Cerebral capillary damage in Alzheimer’s disease (AD) and Parkinson’s disease with or
without Alzheimer-like neuropathology (PDd and PD, respectively). A: percentage of capillaries with
basement membrane thickening (BMT). B: percentage of capillaries with fibrosis. C: percentage of
capillaries with degenerative pericytes. ∗<0.05, ∗∗<0.02.Chapter 4
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0.2% picric acid in 0.1 M phosphate buffer. The brains were cut on a vibratome at 50 µm and
the slices were routinely embedded in glycide ether. Ultrathin sections were prepared of the
frontoparietal cortex, mounted on 200 mesh copper grids and contrasted for EM analysis.
For the examination of microvessels, we followed the guidelines described above for the
human samples, thus, the same three categories of capillary abnormalities were established:
basement membrane thickening (BMT), fibrosis and degenerative pericytes. The percentage
of capillaries with abnormal features was expressed as percentages of the total number of
capillaries encountered.
The cortical capillaries of hypertensive animals suffered a considerable damage. The
frequency of BMT increased with 25 % in the SHR-SP group (Fig. 4.3.A) while the individual
capillaries were endowed with more advanced forms of BMT compared to the alterations
observed in the WKY group. Usually, larger segments of a particular capillary demonstrated
clearly more pronounced alterations in the SHR-SP animals. Fibrosis, which was nearly
absent in normotensive controls increased remarkably in the hypertensive cases (Fig. 4.3.B).
At the same time, the condition of pericytes proved to be unaffected by high blood pressure
(Fig. 4.3.C). The occurrence of capillaries with BMT or fibrosis correlated with the blood
pressure values taken before perfusion (Fig. 4.4.A and 4.4.B), whereas, pericytic
degeneration showed no such relationship (Fig. 4.4.C).
Figure 4.3. Cerebral capillary breakdown in spontaneously hypertensive rats at 60 weeks of age. A:
percentage of capillaries with basement membrane thickening (BMT). B: percentage of capillaries with
fibrosis. C: percentage of capillaries with degenerative pericytes. WKY: Wistar-Kyoto rats (control);
SHR-SP: spontaneously hypertensive, stroke prone rats. ∗<0.05, ∗∗<0.01.Risk Factors for Cerebral Capillary Breakdown
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Figure 4.4. Correlation between the percentage of intact capillaries and behavior/systolic blood
pressure. WKY: Wistar-Kyoto rats (control); SHR-SP: spontaneously hypertensive, stroke prone rats.
Discussion
Here we have shown that neurological conditions such as AD and PD are accompanied
by a progressive degeneration of cerebrocortical capillary wall ultrastructure in a similar
manner. Furthermore, comparable microvessel damage was observed in the frontoparietal
cortex of chronically hypertensive rats. Figure 5 demonstrates typical examples of these
degenerative features.
The microanatomical capillary damage observed here and previously by others
(Perlmutter and Chui, 1990; Claudio, 1996; Kalaria, 1996; Buée, 1997) coincides with
alteration of additional, functional vascular factors in AD and possibly in PD. For example,
clinical measurements of regional cerebral blood flow by the non-invasive SPECT method
have indicated that AD is accompanied by a decreased regional cerebral blood flow in the
hippocampal formation and temporal cortex (DeKosky et al., 1990; Eberling et al., 1992;
O’Brien et al., 1992; Ohnishi et al., 1995). This phenomenon was also described in the
temporal cortex of PD patients (Kawabata et al., 1991; Varma et al., 1997) but the data
coming from different research groups is not uniform on this issue (Bissessur et al., 1997).
The theory that the vascular ultrastructural changes, like those described in the present
study, and reduced cerebral blood flow are functionally related, was tested in an animal
model. Experimental cerebral hypoperfusion was created by a bilateral carotid artery
occlusion (2VO) (De Jong et al., 1999; de la Torre et al., 1992; Ni et al., 1994) which yields
to 25-30 % reduction of regional cerebral blood flow (Ni et al., 1994), corresponding well withChapter 4
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the values recorded in AD. Subsequently, the condition of hippocampal capillaries was
examined and a significant increase of BMT and fibrosis was found (De Jong et al., 1999).
Therefore we propose that hypoperfusion is a causal factor in the development of capillary
alterations observed in the 2VO model, and possibly in AD and PD.
Reduced cerebral blood flow was also recorded in hypertensive patients by PET and the
133Xe-inhalation method (Nobili et al., 1993; Nakane et al., 1995). In addition, parallel
experiments revealed a comparable hypertension-induced cerebral hypoperfusion in
spontaneously hypertensive rats (Fujishima et al., 1995; Katsuta, 1997). Our own findings in
the hypertensive animals show that the cerebral capillary wall is damaged in a similar
fashion to hypoperfused rats, as well as to AD/PD patients: the basement membrane is
thickened and contains collagen deposits. Fibrosis gives a considerable contribution to
aberrations in the hypertensive animals, which is, nonetheless, more pronounced and
uniform among cases than either in experimental hypoperfusion or the here presented
neurological diseases (AD or PD). At the same time, the increase in BMT appears higher in
2VO rats and AD/PD than in a hypertensive condition. We suggest that these differences
emerge due to different stages and degree of cerebral hypoperfusion. BMT and fibrosis are
thought to be in a functional relationship and their relative ratio can change in the course of
time as pointed out by De Jong et al. in aging rats (De Jong et al., 1990).
Our hypothesis that the same mechanisms are involved in the generation of capillary
damage in the 2VO model of cerebral hypoperfusion, spontaneous hypertension in SHR-SP
rats and AD/PD finds support in the following behavioral data. Both 2VO rats and SHR-SP
animals were independently tested in the Morris water maze and radial arm maze for their
learning skills (de la Torre et al., 1992; Wyss et al., 1992; Ni et al., 1994; Pappas et al.,
1996; Ohta et al., 1997; De Jong et al., 1999). The experiments provided corresponding
results in the sense that both the 2VO animals and the SHR-SP rats performed worse than
their controls in the learning paradigms. By putting the findings into a sequential order, we
may speculate that cerebral hypoperfusion gives rise to cerebrocapillary damage which, in
turn, is responsible for a mild decay of learning skills probably by preventing the optimal
transport of sufficient nutrients to the neural tissue and subsequent neuronal dysfunction.Risk Factors for Cerebral Capillary Breakdown
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Figure 4.5. Computer images of electron microscopic photographs taken of cerebral capillaries in rat
and human samples. A: an intact capillary wall of a WKY rat. B: basement membrane thickening
(BMT) of an SHR-SP rat. C: an early stage of pericytic degeneration of an SHR-SP rat. D: longitudinal
view of collagen bundles in the basement membrane of an SHR-SP rat. E: BMT in an AD sample. F:
collagen  fibers  in  cross  section  in   the  basement  membrane  of  an   AD  patient.    Abbreviations:
∗: capillary lumen, e: endothelial cell, p: pericytic profile, arrowheads: basement membrane.
In conclusion, we propose that cerebral hypoperfusion is a mild but persistently prevailing
condition shared by neurological disorders - AD or PD - and chronic hypertension, and that
the constantly low flow rate triggers pathologic malformations of the cerebral capillary walls.
This chain of degenerative events may be an underlying mechanism of mild memory deficits
in chronic hypertension and PD, and probably contributes to a largely enhanced cognitive
failure pre-established by numerous additional neuropathological factors in AD (Fig. 4.6).Chapter 4
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Figure 4.6. Causal events of cerebrovascular parameters leading to mild cognitive disorders.
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Calcium Antagonists Decrease Capillary Wall Damage in Aging
Hypertensive Rat Brain
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Abstract
Chronic hypertension during aging is a serious threat to the cerebral vasculature. The
larger brain arteries can react to hypertension with an abnormal wall thickening, a loss of
elasticity and a narrowed lumen. However, little is known about the hypertension-induced
alterations of cerebral capillaries. The present study describes ultrastructural alterations of
the cerebrocortical capillary wall, such as thickening and collagen accumulation in the
basement membrane of aging spontaneously hypertensive stroke-prone rats. The ratio of
cortical capillaries with such vascular pathology occurred significantly more frequently in
hypertensive animals.
Nimodipine and nifedipine are potential drugs to decrease blood pressure in
hypertension but their beneficial effects in experimental studies reach beyond the control of
blood pressure. Nimodipine and nifedipine can alleviate ischemia-related symptoms and
improve cognition. These drugs differ in that nifedipine, but not nimodipine reduces blood
pressure at the here-used concentration while both drugs can penetrate the blood-brain
barrier. Here we show that chronic treatment of aging hypertensive stroke-prone rats with
nimodipine or nifedipine could preserve microvascular integrity in the cerebral cortex.
Key words: hypertension, cerebral capillary, ultrastructure, calcium channel antagonist,
cerebrovascular protectionCerebrovascular Breakdown in Hypertension
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Introduction
Chronic hypertension has a profoundly detrimental effect on cerebral circulation and
brain function. For experimental approaches to study hypertension, the spontaneously
hypertensive stroke prone rat strain (SHR-SP) proved to be an apt animal model to
investigate the consequences of prevailing hypertension on behavior, neuronal integrity and
cerebrovascular parameters. Preliminary studies demonstrated that chronic hypertension in
60 weeks old SHR-SP evoked microvascular pathology such as capillary basement
membrane thickening and collagen deposits in the basement membrane (Farkas et al.,
2000a; Farkas et al., 2000b). Interestingly, similar cerebrovascular malformations and
related behavioral impairment were reported in normotensive, senescent rats (De Jong et
al., 1990a; De Jong et al., 1990b; De Jong et al., 1992a; De Jong et al., 1992b; Luiten et al.,
1994), which support the theory that chronic hypertension accelerates the progressive aging-
related deterioration of the central nervous system. In addition, both in hypertensive and in
aged animals it was observed that cognitive decline coincided with changes in neuronal
calcium homeostasis. Studies employing the L-type calcium channel antagonist nimodipine
demonstrated that nimodipine could remarkably moderate not only signs of
neurodegeneration as a consequence of hypertension or aging, but also the aging-related
microvascular abnormalities (De Jong et al., 1990a; De Jong et al., 1990b; De Jong et al.,
1992a; De Jong et al., 1992b; Luiten et al., 1994; Luiten et al., 1996).
Preliminary findings on morphological microvascular changes in SHR-SP (Farkas et al.,
2000a; Farkas et al., 2000b) raised further questions. First, is the severity of the pathological
changes in capillaries related to the age of the experimental animals? Second, does cerebral
microvascular breakdown directly stem from chronic hypertension or is it caused by a
neurogenic derangement of calcium homeostasis secondary to hypertension? To resolve
these questions, we analyzed the cerebral capillary ultrastructure of two age groups (40
weeks old and 60 weeks old) of hypertensive and normotensive rats. Furthermore, we
applied a long-term treatment of two dihydropyridine type calcium channel blockers
nimodipine and nifedipine on additional experimental groups.
The use of dihydropyridine type calcium channel blockers as anti-aging treatment was
based on the finding that calcium influx through voltage sensitive calcium channels appeared
to be a major contributor to the dysregulation of neuronal calcium concentration during aging
(Schuurman and Traber, 1994; Disterhoft et al., 1996; Luiten et al., 1996). The typical, aging-
related decline of neural functions (memory capacity, sensorimotor functions) can stem from
the imbalance of the intracellular calcium homeostasis, which became a target ofChapter 5
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pharmacological treatment (Schuurman et al., 1994). Nimodipine and nifedipine can protect
cellular integrity by binding to the L-type calcium channels thus blocking the potentially
harmful calcium influx to cells. We aimed at making use of the unique properties of the two
drugs that they penetrate the blood-brain barrier (BBB) (Janicki et al., 1988; Larkin et al.,
1992; Uchida et al., 1997) and can act on neural elements (Scriabine and van den Kerckhoff,
1988). Nimodipine does not affect blood pressure, while nifedipine lowers blood pressure in
the here used concentration. Based on the treatments, we evaluated the ultrastructural
lesions of the cerebral capillary basement membrane in the frontal cortex of 60 weeks old
SHR-SP rats and examined the potentially protective effects of the drugs on the cerebral
microvasculature.
Materials and methods
The study was designed to test the effect of aging and the potentially beneficial effects
of two L-type calcium channel antagonists, nifedipine and nimodipine on the ultrastructure of
cerebral capillaries in male hypertensive rats (SHR-SP, breeder: Møllegaard, Skønevønd,
Denmark). In order to assess age-related vascular malformations, four groups of rats were
used. These groups were the following: 40-week old SHR-SP rats (SP-40; n=6), 40-week old
Wistar Kyoto rats (WKY-40; n=6), 60-week-old WKY rats (WKY-60-plac; n=6) and 60-weel-
old SHR-SP rats (SP-60-plac; n=8). The WKY animals served as normotensive controls. The
animals were group-housed, lived under a standard 12 h light-dark cycle and had access to
water and food ad libitum.
The behavioral profile of the animals was characterized by a small open field test, a
novelty-induced behavioral arousal paradigm. The rats were individually placed into a new
cage (24.5 x 24.5 x 30 cm) and were observed for 60 min on week 40 (WKY-40, SP-40) or
week 60 (WKY-60, SP-60). The actual behavioral activity pattern they were displaying
(rearing, grooming, sniffing, walking, immobility) was registered every 10 seconds. A
behavioral score was calculated for each kind of explorative activity, which reflected how
often the animal showed that particular behavior in the frame of the 60 min observation time.
The systolic blood pressure values (SBP) of groups WKY-40 and SP-40 were taken on
week 40 before sacrifying the animals. The SBP of groups WKY-60-plac and SP-60-plac
were repeatedly measured on every fourth week between the age of 40 and 60 weeks. The
SBP values were assessed with the tail-cuff method on animals slightly anesthetized by
ether. Then the rats were anesthetized by an i.p. overdose of sodium pentobarbital and
sacrificed by a transcardiac perfusion of physiological saline containing 1 % heparin followedCerebrovascular Breakdown in Hypertension
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by a solution of 1 % paraformaldehyde, 0.05 % glutaraldehyde and 0.2 % picric acid in 0.1 M
phosphate buffer (PB) (pH 7.4). The brains were stored in 1 % paraformaldehyde and 2 %
glutaraldehyde in 0.1 M PB at 4 
oC until further processing.
Other groups of WKY and SP animals running parallel with the above WKY-60-plac and
SP-60-plac groups received either a nifedipine or a nimodipine treatment for 20 weeks
between the age of 40-60 weeks. The compounds were mixed in the regular rat chow. The
daily drug-intake of the animals was defined as 20-25 mg. The small open filed test of
novelty-induced exploration was performed together with the above mentioned four groups.
SBP was also measured on every fourth week and the last value was used for later
correlation analysis. Three groups of SHR-SP rats were used: 6 animals were fed with
nifedipine-containing chow (SP-60-nife) and 6 animals with nimodipine-containing food (SP-
60-nimo). Each of these groups had their normotensive WKY controls, (WKY-60-nife, n=6;
WKY-60-nimo, n=6). The food and water intake of the animals, as well as their body weight
was regularly monitored to verify comparable drug intake of the separate groups. Because of
group housing, the food and water intake of individual animals was calculated by dividing the
absolute amount of food and water consumed in a cage by the number of animals in the
cage. At the age of 60 weeks, the animals were anesthetized, perfused, and their brains
post-fixed as described above.
Brain slices were cut at 50 µm with a vibratome, routinely dehydrated and embedded in
glycide ether. Samples of the frontal cortex at 0.2 mm rostral to Bregma were then selected
and mounted on glycide ether blocks. Non-serial, ultrathin sections were collected on 200
mesh copper grids and examined with a Philips 201 and a Philips CM 10 electron
microscope.
One hundred capillaries per case were screened throughout the cortical layers focusing
on the microvascular basement membrane (BM) and pericyte pathology as defined in detail
previously (Farkas et al., 2000a). Briefly, the following categories of capillary abnormalities
were distinguished: local basement membrane thickening (BMT) if the luminal and abluminal
outline of the BM were not running parallel at a given segment of the membrane, as shown
in Fig. 5.1.B. BMT was additionally characterized by measuring the thickness of the BM: the
width of a healthy BM segment ranged between 50-100 nm while thickening typically varied
between 150-550 nm. Fibrosis referred to excessive collagen type IV accumulation between
two layers of the BM identified by its periodicity, or collagen invasion to the vascular
pericytes from a split BM (Fig. 5.1.C). When a capillary demonstrated both BMT and fibrosis,
fibrosis overruled BMT and the capillary was counted only as one with fibrosis. DegenerativeChapter 5
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pericytes showed abnormal, membranous-appearing inclusion bodies or swelling (Fig.
5.1.D). The region investigated did not show signs of cerebrovascular infarcts.
The density of capillaries was determined as the number of transversal capillary profiles
counted on a standard surface area of 0.2 mm
2 spanning all cortical layers. The diameter of
the capillary lumen of 15-24 microvessels of a standard surface area was also measured.
The surface areas were standardized with the help of the grid mesh.
The data was statistically analyzed by the computer program SPSS. The quantitative
results of capillary ultrastructure were calculated as percentages of the total number of
vessels investigated, expressed as median values and evaluated using the Mann-Whitney-U
test. SBP was analyzed by repeated measurement ANOVA, changes in capillary diameter
and density by one-way-ANOVA while the correlation graphs were tested with the Pearson
correlation test.
Figure 5.1. Schematic drawings demonstrating the transversal profile of an intact cerebral capillary
(A), local basement membrane thickening indicated by arrowheads (B), fibrosis pointed at by
arrowheads (C) and pericytic degeneration (D). Abbreviations: e: endothelial cell, en: endothelial
nucleus, l: capillary lumen, p: pericyte, pn: pericytic nucleus, ∗: basement membrane.Cerebrovascular Breakdown in Hypertension
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Results
The analysis of the novelty-induced exploration showed that two of the behavioral
parameters, namely rearing and grooming, significantly differed between groups. Figure
5.2.A represents the frequency of rearing behavior. Age-related decrease of rearing could
not be detected when comparing WKY-40 with WKY-60-plac or SP-40 with SP-60-plac but
clear and significant reduction was seen in SP-40 and SP-60-plac when compared to their
WKY controls. In addition, nimodipine or nifedipine treatment could increase rearing
behavior to normotensive levels. Grooming activity presented in Figure 5.2.B also appeared
to be independent of age under normotensive conditions (WKY), but was considerably
reduced in SP-60-plac compared to SP-40 and also to WKY-60-plac. Thus, the decrease in
grooming activity in old SP could be associated with both age and hypertension. Nimodipine
and nifedipine administration restored the grooming score to normotensive values in the SP-
60-nimo and SP-60-nife groups.
Figure 5.2. Novelty-induced
exploratory behavioral
profile expressed as rearing
frequency (A; ∗: p<0.05, ∗∗:
p<0.01) and grooming
frequency (B; ∗: p<0.05)
during 60 min observation.Chapter 5
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The SBP values are presented in Figure 5.3.A & B. The SBP of the onset SP-40 group
was about 60 mmHg higher than in WKY-40. During the experimental period (20 weeks) the
SBP did not increase in any of the groups. Neither nimodipine, nor nifedipine administration
altered the SBP of aging WKY animals while nifedipine – but not nimodipine – decreased the
SBP in the aging SHR-SP animals already 1 month after the beginning of the treatment.
Figure 5.3. Systolic blood
pressure values measured
in the onset groups (A; ∗∗:
p<0.01), and the
dihydropyridine treated
groups (B, ∗: p<0.05 WKY-
60-plac x SP-60plac, $:
p<0.05 SP-60-plac x SP-60-
nimo, +: p<0.05 SP-60-plac
x SP-60-nife).Cerebrovascular Breakdown in Hypertension
95
Figure 5.4. Average food- and water intake per animal, and body weight expressed as group mean
values during the 20 weeks experimental period. A: food intake of the WKY animals. B: food intake of
the SP animals. C: water intake of the WKY animals. D: water intake of the SP animals. E: body
weight of the WKY groups. F: body weight of the SP groups. Significant differences in body weight
based on repeated measurement ANOVA: WKY-60-plac x SP-60-plac: F=43.363, ∗∗p≤0.000; WKY-
60-nife x SP-60-nife: F=12.48, ∗p≤0.005; SP-60-plac x SP-60-nimo: F=7.156, ∗p≤0.02.Chapter 5
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Figure 5.4.A &B is showing the food intake of the six 60 weeks old experimental groups
while Figure 5.4.C & D is demonstrating the water intake throughout the calcium antagonist-
treatment period. It is important to notice that comparing the WKY-60-nimo and WKY-60-nife
groups, and the SP-60-nimo and SP-60-nife groups also with each other, the animals ate
and drank the same amount indicating comparable drug intake. There was no difference in
body weight among the WKY groups (Fig. 5.4.E) but when comparing the SP groups, SP-60-
nimo rats were significantly heavier than SP-60-plac animals as analyzed by repeated
measurement ANOVA (F=7.156, ∗p<0.02). There was no difference between the SP-60-
nimo and SP-60-nife groups (Fig. 5.4.F).
Figure 5.5 provides electron microscopic photomicrographs of microvascular
degenerative features assessed in this study. The age-related changes in capillary integrity
were assessed by comparing the 40 and 60 weeks old groups. Figure 5.6 shows that the
WKY-60-plac demonstrated an increased level of BMT, an unchanged degree of fibrosis,
and a significantly higher incidence of pericytic degeneration when compared to WKY-40.
When comparing SP-40 and SP-60-plac, the difference in capillary basement membrane
pathology appeared to be more pronounced than that seen in the normotensive WKY rats.
Capillaries with BMT occurred three times more frequently in the SP-60-plac than in the SP-
40 and the ratio of fibrosis doubled. An increased percentage of microvessels with
degenerating pericytes was also found, which was similar to the WKY groups.
Hypertension-related microvascular degeneration could be investigated by evaluating the
differences between the SHR-SP and WKY animals (Fig. 5.6.A, B & C). The analysis was
completed in both age groups. At the age of 40 weeks, we found no change in BMT while we
saw increased fibrosis in the SP-40. The level of pericytic degeneration was basically not
altered. The difference in the percentage of the individual morphological aberrations
between WKY-40 and SP-40 rats did not reach significance. At 60 weeks of age, the
percentage of both BMT and fibrosis remarkably increased in the SP-60-plac compared to
the WKY-60 while the occurrence of degenerative pericytes remained similar.
The graphs seen in Figure 5.6.D, E & F also characterize the relationship between
microvascular morphological degeneration and SBP. (Here, not only the placebo
experimental groups but also the treated groups, which are described in detail bellow, were
plotted.) BMT and fibrosis showed a positive and significant correlation to SBP while the
percentage of microvessels with degenerative pericytes appeared to be independent of SBP.Cerebrovascular Breakdown in Hypertension
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Figure 5.5. Scanned images of original electron microscopic photographs. A: intact cerebral capillary
of a WKY-40 animal. B: BMT of an SP-40 rat. C: BMT seen in the cortex of an SP-40 rat. D & E:
fibrosis as it appears in SP-60-plac animals. F & G: degenerative pericytes in SP-60-plac rats.
Abbreviations: e: endothelial cell, p: pericyte, ∗: capillary lumen, arrowheads: vascular basement
membrane.Chapter 5
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The protective effects of nimodipine and nifedipine on cortical capillary ultrastructure can
be visualized if we compare control and treated animals (Fig. 5.6.A, B & C). In WKY, the
influence of either of the two drugs on BMT or fibrosis could not be demonstrated. However,
nifedipine appeared to be able to decrease pericytic degeneration in WKY-60-nife when
compared to WKY-60-plac. Thus, it seems that at physiologically optimal SBP values,
nimodipine and nifedipine do not alter the ultrastructure of the capillary basement membrane
but nifedipine appears to be a drug that acts on pericytes. Treatment of the hypertensive
animals with the two drugs yielded to remarkable improvement in capillary morphology.
Nimodipine decreased the incidence of BMT from 40 % (SP-60-plac) to 33 % (SP-60-nimo)
but the compound had no significant effect either on fibrosis, or on degenerating pericytes.
Nifedipine treatment led to observations similar to that of nimodipine. BMT was significantly
decreased in SP-60-nife while fibrosis was unaffected. Interestingly, nifedipine improved the
condition of pericytes (SP-60-nife), which finding was not seen after nimodipine treatment
(SP-60-nimo).
Figure 5.7.C & D show the average capillary diameters calculated for each experimental
group. The values ranged between 9.955 µm (SP-60-nimo) and 10.91 µm (WKY-60-nife).
The microvascular lumen was consistently narrower in the hypertensive animals than in the
normotensive controls, which neither nimodipine nor nifedipine treatment could noticeably
influence. When capillary diameters were related to SBP of the individual rats, a negative
correlation was established. The density of capillaries considerably varied but when the
three WKY-60 groups and the three SP-60 groups were combined, an increased number of
capillary profiles was detected in the given cortical area in the hypertensive animals. The
correlation of capillary number per area unit with SBP did not reveal clear correspondence
with an elevated SBP.
Discussion
Here we have assessed ultrastructural damage of rat cerebrocortical capillaries under
chronic hypertensive conditions. The morphological abnormalities described in this study,
namely fibrosis and BMT were also identified in larger brain vessels in hypertensive humans
(Roggendorf et al., 1998). Similar microvascular abnormalities were reported previously in
the   cerebral  cortex  of  aging,   spontaneously   hypertensive   rats,   which  was,  however,Cerebrovascular Breakdown in Hypertension
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Figure 5.6. The incidence of capillary basement membrane pathology (A, B) and pericytic
degeneration (C) at the age of 60 weeks expressed in median percentages, and the correlation
between systolic blood pressure and microvascular morphology (D, E, F); ∗: p<0.05; ∗∗: p<0.01.Chapter 5
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Figure 5.7. Capillary diameter values (C, ∗: p<0.05; ∗∗: p<0.01) and capillary density (D, p<0.05).
restricted to a qualitative description of capillary pathology (Knox et al., 1980). The present
study provides quantitative data, which show that BMT and collagen deposits occur
considerably more frequently in aging hypertensive rats than in normotensive age-matched
controls. Moreover, such vascular irregularities were not increased in 60 weeks oldCerebrovascular Breakdown in Hypertension
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normotensive rats when compared to a 40 weeks old normotensive group. On the other
hand microvascular BMT and fibrosis markedly increased in 60 weeks old hypertensive
animals compared to 40 weeks old SHR-SP rats. Based on this finding, it may be concluded
that hypertension accelerates capillary damage in the brain.
Our results also indicate that chronic nifedipine or nimodipine treatment can prevent the
progression of capillary wall damage in the rat cerebral cortex. It is known that
dihydropyridines decrease blood pressure by binding to L-type calcium channels on vascular
smooth muscle cells and inhibit vascular contractility (Katz et al., 1985; Fleckenstein and
Fleckenstein-Grun, 1988; Alborch et al., 1995), which, in turn, gives rise to vasodilatation
and reduced vascular resistance (Van Zwieten and Pfaffendorf, 1993). However, the two
drugs have selective effects: varying doses of nifedipine have been shown to consistently
decrease blood pressure while nimodipine action on tension appeared to be concentration
dependent (Grabowski and Johansson, 1985; Freedman and Waters, 1987; Scriabine and
van den Kerckhoff, 1988; Liu et al., 1989; Frohlich, 1991). At the dose used in the present
study, only nifedipine, but not nimodipine decreased SBP. Although both compounds
improved the condition of cerebral capillaries in a similar fashion, only the nifedipine-
mediated microvascular protection correlated with decreasing SBP while nimodipine action
was independent of pressure. Thus, the processes underlying the protective effect of the two
drugs on cortical capillaries must be based on more than just lowering blood pressure.
The location of L-type calcium channels in the microvascular domain, which are the
principal targets of nimodipine and nifedipine, may offer further explanations for the different
protective mechanisms of the two drugs. The primary building blocks of capillaries are the
endothelial cells, which seem not to be endowed with L-type channels, although the
occurrence of the L-type channels on the endothelium is a matter of conflicting evidence.
Preparations of isolated bovine vessels or rat pulmonary artery indicated either the presence
(Bossu et al., 1992; Murphy et al., 1994) or the absence (Harrison et al., 1991) of L-type
calcium channels on endothelial cells but a generally promoted concept claims the latter
conclusion (Alborch et al., 1995). Accepting the lack of L-type channels on the endothelial
surface, it is doubtful that nifedipine or nimodipine can directly act on the endothelium.
Nifedipine was described to block cellular calcium influx by binding to L-type calcium
channels on peripheral vascular smooth muscle. By doing so, nifedipine attenuates the
contractility of these vascular elements, which leads to decreased blood pressure (Katz et
al., 1985; Fleckenstein and Fleckenstein-Grun, 1988; Alborch et al., 1995). Thus, it seems
attractive to reason that vascular protection in our nifedipine treated animals was achieved
by reducing SBP, which assumption would agree with the correlation found between theChapter 5
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percentage of intact vessels and SBP. However, the finding that nimodipine treatment
achieved similar microvascular protection in our paradigm without lowering SBP asks for
another explanation. Since nimodipine and nifedipine were described to penetrate the brain
(Janicki et al., 1988; Scriabine and van den Kerckhoff, 1988; Scriabine et al., 1989; Larkin et
al., 1992; Uchida et al., 1997) where they can block calcium influx at neuronal elements
(Scriabine et al., 1989; Schuurman and Traber, 1994; Disterhoft et al., 1996), the
mechanisms stimulated by the drugs to preserve capillary integrity may very well lie at CNS
level. Astrocytes are closely related to cerebral microvessels and participate in the formation
and maintenance of the BBB. The astrocytic endfeet embrace the vascular basement
membrane and were described to be able to regulate the intracerebral vascular tone and
cerebral blood flow indicated by the expression of serotonergic and cholinergic receptors on
the perivascular endfeet (Janzer, 1993; Cohen et al., 1996; Luiten et al., 1996; Cohen et al.,
1999; Elhusseiny et al., 1999; Pardridge, 1999). Furthermore, astrocytes were also reported
to secrete basement membrane components (Zarow et al., 1997).
The calcium homeostasis of brain cells including astrocytes can be compromised in
ischemia. A mild, chronic ischemic condition in hypertension may emerge from a reduced
cerebral blood flow (CBF) reported in hypertensive patients as well as hypertensive rats
(Nobili et al., 1993; Fujishima et al., 1995; Nakane et al., 1995; Katsuta, 1997). The here-
used dihydropyridines nimodipine and nifedipine were shown to increase CBF in SHR rats
and rabbits (Tanaka et al., 1986; Thorane et al., 1986; Ooboshi et al., 1990; Weinstein,
1995) while clinical trials with nimodipine demonstrated that the drug improved CBF without
having an influence on systemic blood pressure (Freedman and Waters, 1987; Scriabine
and van den Kerckhoff, 1988; Frohlich, 1991). These latter results are intriguing in the light
of our data which show that nimodipine prevented microvascular breakdown without
affecting SBP.
Cerebral hypoperfusion, thus also occurring in hypertension, is known to impose a mild
ischemic condition. The metabolic effects of reduced cerebral blood flow were studied in
animal models of chronic bilateral carotid artery occlusion. Using this hypoperfusion model,
De la Torre and co-workers reported, for example, a decreased cytochrome oxidase activity
in neuronal mitochondria suggesting a mild ischemic condition in chronic cerebral
hypoperfusion (de la Torre et al., 1997), which implies an increased intracellular calcium
concentration that can impose harmful effects on mitochondrial function. Furthermore, the
elevated calcium concentration is known to activate detrimental metabolic cascades and is
accompanied by free radical generation (Siesjo et al., 1995). The calcium-generated
synthesis and accumulation of the easily translocating NO and its toxic products (Beckman,Cerebrovascular Breakdown in Hypertension
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1991; Love, 1999) can attack the integrity of the BBB: it may cause astrocytic dysfunction
[43] and increased endothelial permeability (Wei et al., 1986; Imaizumi et al., 1996,
Lagrange et al., 1999). The here presented microvascular pathology in SHR-SP animals can
be associated with such a chain of events. Nimodipine treatment can supposedly prevent the
intracellular calcium accumulation, thus moderating free radical production (Zhu et al., 1999)
and consequent cerebral capillary injury.
The possibility that a decreased CBF-induced, mild but persistent ischemic condition
would contribute to the capillary damage seen here could be reflected by changes in
capillary density since cerebral ischemia has been shown to promote microvascular
proliferation. For example, hypoxia has been demonstrated to lead to the enlargement and
proliferation of the microvascular endothelial cells and a consequent increase of cerebral
capillary density (Harik et al., 1995). Capillary density was also reported to correlate with the
metabolic rate for glucose (Hudetz, 1997). Our data indicate a hypertension-related
decrease in capillary diameter and an increase of capillary density in the cortical region
investigated. These observations can raise the following assumptions. Considering that the
endothelial cells and pericytes presumably possess contractile properties (Kelley et al.,
1987), a generally narrower capillary lumen may reflect vasoconstriction typically associated
with hypertension. The decreased capillary diameter can be responsible for a lower CBF,
which would give rise to a mild, chronic ischemia represented by the elevated capillary
density. Of course, such hypothesis can only be fully appreciated if the detection of typical
indicators of ischemia (reduced glucose utilization and oxygen consumption) gives support
to the vascular observations. Nevertheless, a persisting but moderate ischemic condition
may well be causal to the here-described capillary damage, which could be prevented by
dihydropyridines.
In summary, it has been shown in this study that hypertension can accelerate age-
related, ultrastructural capillary malformations. Microvascular degeneration appears in the
form of vascular basement membrane pathology, such as BMT and fibrosis. Chronic
treatment with dihydropiridine drugs, in this case with nimodipine and nifedipine can prevent
the progression of microvascular damage by reducing the ratio of cerebral capillaries
featuring BMT. Thus, in addition to the well-described beneficial effects of dihydropiridines
on neuronal networks, nimodipine and nifedipine have been shown to improve the condition
of cerebral capillaries in chronic hypertension. The underlying mechanism of the process
may be related to an increase in CBF, which leads to an improved neural regulation of
cerebrovascular function. The precise chain of events, however, is still to be elucidated.Chapter 5
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6.1.  Microvascular ultrastructure and its implications in blood-brain barrier function
in Alzheimer’s disease
6.1.1. Microvascular cell types
The vascular system of the AD brain can exhibit a variety of histopathological properties,
which can have serious physiological consequences. Atherosclerosis in the extracranial
vessels supplying the brain (Kalaria, 1996; Hofman et al., 1997; Breteler, 2000) or amyloid
angiopathy in mid-size brain arteries (Vinters, 1987; Coria and Rubio, 1996; Opeskin, 1996)
not only physically thicken the vascular wall, but also contribute to marked blood flow
disturbances by narrowing or even blocking the vessel lumen, initiating cerebral hemorrhage
or massively increasing the rigidity of the arterial wall. Besides the macrovascular lesions,
the malformations of the cerebral microvessels in AD have also been known for a relatively
long time, but the exact identification of the nature and composition of the artifacts
embedded in the microvascular walls has still not been completely agreed upon. In the light
microscope, microvascular abnormalities in AD appeared as atrophic thin vessels,
glomerular loop formations, fragmented vessels and twisted or tortuous vessels (Buée et al.,
1997). Early ultrastructural studies often mentioned an “irregular” appearance or distorted
abluminal surface of the terminal arterioles and capillaries in the AD brain, which referred to
the loss of the smooth contour characteristic of healthy vessels (Scheibel, 1987; Hashimura
et al., 1991; Kimura et al., 1991). The initial morphological aberrations found in AD can be
summarized briefly as follows. The smooth muscle cells (SMC) responsible for vascular
contractility were found to show abnormal focal constrictions and a general degeneration
(Miyakawa et al., 1988; Hashimura et al., 1991; Kimura et al., 1991), the astrocytic endfeet
often appeared swollen (Higuchi et al., 1987; Yamashita et al., 1991) and the pericytes
displayed either atrophy (Miyakawa et al., 1988) or were encountered at a higher frequency
in capillary profiles of AD patients than controls (Stewart et al., 1992). The endothelial cells
demonstrated atrophy, swelling or contained irregular nuclei (Miyakawa et al., 1988;
Hashimura et al., 1991). The basement membrane (BM) of brain capillaries exhibited a
robust thickening and local disruption (Mancardi et al., 1980; Miyakawa et al., 1988; Scheibel
et al., 1989; Yamashita et al., 1991) while the perivascular plexus often disappeared
(Scheibel, 1987; Scheibel et al., 1989).
Detailed analysis of the morphological abnormalities provided a more precise account of
the structural microvascular changes in AD. The endothelium stands in focus for its
indispensable participation in creating the BBB, therefore the pathological alterations in theChapter 6
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endothelial structure can very well correspond with BBB failure such as transient leakage.
The AD-related degeneration of the capillary endothelium pointed out in the earlier studies
was verified by the absence of the otherwise obvious immunoreactivity of specific endothelial
cell markers (CD34 and CD31) (Kalaria and Hedera, 1995). Furthermore, the cytoplasmic
compartments of the endothelial cells were quantitatively investigated, which revealed that
although the absolute number of mitochondria was not changed (Mancardi et al., 1985;
Stewart et al., 1992), the area of mitochondrial profiles, as well as the density of
mitochondria in the endothelial cytoplasm were significantly reduced in AD (Stewart et al.,
1992). Because the absolute mitochondrial counts were not deviating from normal, control
values, the reduced mitochondrial density could indicate either endothelial swelling or
mitochondrial shrinkage, both implying impaired BBB capacity. The number of pinocytic
vesicles was reported to remain comparable to controls (Stewart et al., 1992), but later a
strong inverse correlation was established between mitochondrial and vesicular content
(Claudio, 1996), which may represent failing BBB barrier function for the following reasons.
The increased number of pinocytic vesicles in cerebral microvessels was regarded as a form
of BBB disruption (Hirano et al., 1994), while the mitochondria represent the endothelial
metabolic center providing energy for the maintenance of the BBB. When the number of
mitochondria decreases relative to the pinocytic vesicular content in the endothelial cell or
inversely, the pinocytic vesicles multiply relative to the number of mitochondria, less energy
is available for minimizing the non-specific vesicular “leakage” across the BBB represented
by the pinocytic vesicles. An additional sign of a disrupted BBB in AD may be the
compromised morphology of tight junctions (Claudio, 1996). The number of tight junctions
per standard vessel length was also remarkably decreased but the length of the junctions
itself did not alter (Stewart et al., 1992).
Furthermore, the degeneration of microvascular pericytes was noted in AD brains but
when the ratio of capillary profiles containing degenerative pericytes was compared to age
matched controls, no difference between the two sample groups was seen (Figure 6.1)
(Farkas et al., 2000c). Conversely, previous observations showed that the number of
pericytic processes increased in AD brains (Stewart et al., 1992). The two sets of data do not
stand in conflict, however, because the increase was notable in intact and not degenerating
pericytic profiles. These findings together indicate that AD probably does not enhance the
already existing, age-related pericytic pathology, but the proliferation of the healthy
perivascular cells can still be amplified in the disease, possibly as a compensatory
mechanism, working against BBB disruption.Summary and Conclusion
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Figure 6.1. Electron microscopic photographs of pericytes in the cingulate cortex of Alzheimer’s
disease patients. A: a relatively spared pericytic profile. B: a pericyte with extensive cytoplasmic
inclusions in the close proximity of the nucleus. C: a degenerated pericyte. Abbreviations: e:
endothelial cell; en: endothelial nucleus; er: erythrocyte; p: pericyte; ∗￿￿￿ EDVHPHQW￿ PHPEUDQH￿
Arrowheads are pointing at the outline of pericytes.
6.1.2. Microvascular basement membrane pathology
The prominent thickening of the basement membrane (BMT) considerably affected the
capillaries in the cerebral cortex of AD subjects and was consistently reported by a number
of research groups analyzing either biopsy tissue or post mortem material (Figure 6.2.A;
Figure 6.3) (Mancardi et al., 1980; Perlmutter and Chui, 1990; Claudio, 1996; Farkas et al.,
2000c). Chapter 3 of this thesis also provides supporting evidence. The advancement of
BMT appeared to be neurodegeneration- rather than AD-specific, since Parkinson’s disease
patients and spontaneously hypertensive stroke prone rats also developed microvascular
BMT in the cerebral cortex being in many ways comparable to that found in AD subjects
(Figure 6.2) (Farkas et al., 2000a-Chapter 4; Farkas et al, 2000c-Chapter 3). Furthermore,
BMT was locally associated with the neuropathological events in AD. The temporal gyrus
with severe AD-like neurodegeneration was shown to selectively contain microvessels with
BMT in contrast to healthy microvessels in the intact cerebellum (Zarow et al., 1997). Among
the potential candidates as molecular constituents of BMT, collagen can be mentioned on
the first place for the following reasons. Firstly, the deposition of collagen fibrils in the BM
was noticeable in the form of fiber bundles (microvascular fibrosis) on the electron
microscope screen (Farkas et al, 2000c-Chapter 3), and the biochemical detection of the
collagen content of cerebrocortical microvascular fractions also showed a significant, AD-
related  increase,   particularly  of  collagen type  IV,  the  basic  element  of  the  healthy BMChapter 6
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Figure 6.2. The percentage of cerebral capillaries with basement membrane deposits (BMT and/or
fibrosis) in different conditions. Abbreviations: Panel A: AD: Alzheimer’s disease; C: human non-
demented control; PDd: human Parkinson’s disease with dementia. Panel C: 2VO: permanent
bilateral common carotid artery occlusion, two vessel occlusion; SHAM: sham operated control
animals. Panel D: WKY: Wistar Kyoto normotensive rat strain; SP: spontaneously hypertensive
stroke-prone rat strain. ∗<0.05, ∗∗<0.01.
(Kalaria and Pax, 1995). The other molecular BM constituents such as heparan sulfate
proteoglycans (HSPGs) and laminin can also be overexpressed in AD brains. For example,
the levels of the HSPG agrin were found altered in association with microvascular damage in
AD hippocampus and prefrontal cortex (Berzin et al., 2000). Furthermore,
immunocytochemical labeling detected the presence of HSPGs and laminin not only in the
vascular walls but also in senile plaques in AD samples (Snow et al., 1988; Perlmutter et al.,
1991; Jucker et al., 1996; Fukuchi et al., 1998). The HSPG proteins accumulated in close
approximation to capillaries and were colocalized with extravascular amyloid in the frontal,
temporal and parietal cortices of AD patients (Perlmutter et al., 1990). Further examination of
the different HSPGs showed that typically agrin, less frequently glypican and syndecans but
not perlecan was widely expressed in cerebral blood vessels, senile plaques and
neurofibrillary tangles of AD brains (Verbeek et al., 1999). The wide distribution of these
extracellular matrix proteins indicates that other cell types than the typical vascular
compartments can express HSPGs and laminin. In fact, HSPGs were immunolocalized to a
subset of astrocytes and neurons (Snow et al., 1988) and reactive astrocytes were also
described   to   produce   laminin  (Jucker  et  al.,  1996).  Hence,  the  potential  pathologicalSummary and Conclusion
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accumulation of HSPGs and laminin in the microvascular wall could very well originate from
the perivascular astrocytes or neuronal plexus.
6.1.3. Beta-amyloid peptide deposits in the cerebromicrovascular wall
Besides the intrinsic BM components like collagen, HSPGs and laminin, other sorts of
proteins thought to be exogenous to the microvascular wall can also be deposited into the
BM. The toxic beta-amyloid peptide (Aβ), the hallmark of AD typically occurring in
extracellular cerebral plaques, is often encountered as amorphous material or fine fibrils in
the capillary BM of AD patients (Yamaguchi et al, 1992; Perlmutter, 1994; Natte et al.,
1999b; Inoue et al., 1999). Such Aβ deposits, also designated as cerebral microangiopathy,
may alternately account for BMT, though probably not all forms of it since BMT is known to
occur in Parkinson’s disease and chronic hypertension, as well (Farkas et al., 2000a; Farkas
et al., 2001).
Competing theories attribute the origin of Aβ causing cerebral microangiopathy to either
the circulating blood, the vessel wall itself or the brain parenchyma (Burgermeister et al.,
2000). The blood-borne Aβ hypothesis finds support in the experimental data that the
plasma Aβ concentration is markedly increased in AD patients (Kuo et al., 1999), that
experimentally infused Aβ can be traced back  in the cerebral vascular walls  (Mackic et al.,
Figure 6.3. Electron microscopic images of basement membrane deposits in Alzheimer’s disease. A:
basement membrane thickening. B: basement membrane splitting. C: fiber deposits in the basement
membrane. Abbreviations: a: astrocytic endfoot; e: endothelial cell; er: erythrocyte; p: pericyte; ∗:
basement membrane. Arrowheads are pointing at the sites of basement membrane pathology.Chapter 6
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1998), and that transport or BBB leakage caused by Aβ toxicity, were also demonstrated
(Zlokovic, 1996; Pluta et al., 1996; Jancso et al., 1998; Poduslo et al, 1999; Strazielle et al.,
2000). Advocates of the vessel wall hypothesis promoting the concept that perivascular cells
can locally produce the accumulating Aβ (Kalaria et al., 1996) have also gathered compelling
evidence to confirm their theory. The mRNA of the amyloid precursor protein (APP) was
detected with in situ hybridization in endothelial cells, in SMC’s and pericytes isolated from
AD brains (Natte et al., 1999a), which established the indispensable existence of APP in the
vascular domain for potential Aβ production. Another research group identified the APP
protein itself in the vascular SMC’s of leptomeningeal vessels (Shoji et al., 1990) while
further evidence supported the idea of a myocytic origin of Aβ by showing that SMC’s of
aged dogs accumulated Aβ immunoreactive material of endogenous origin when being kept
in cell culture (Wisniewski et al., 1995; Wisniewski et al., 2000). Conflicting results, however,
argue for other mechanisms for Aβ deposition in SMC’s like the ability of SMC’s to readily
internalize and assemble Aβ probably via receptor-mediated endocytosis (Urmoneit et al.,
1997). Even if SMC’s are indeed able to process Aβ themselves, they can be held
responsible only for cerebral amyloid angiopathy (CAA), that is Aβ accumulation in larger
leptomeningeal or cortical vessels, and probably not for microangiopathy. Instead, the
miscellaneous group of pericytes or the single layer of endothelial cells could presumably
participate in the microvascular processing of Aβ. Even though the pericytes were suggested
to have the ideal features to take up APP and process the protein to Aβ (Perlmutter, 1994),
experimental evidence is scarce to support this claim. The possible endothelial origin of Aβ
seems also problematic since no proof other than the expression of the APP gene in the
presence of interleukin-1 together with the detection of APP mRNA in the endothelial cells
was gathered (Goldgaber et al., 1989; Natte et al., 1999a). Thus, the source of Aβ in the
cerebral capillary BM must be rather the result of Aβ-trafficking via the BBB, either from the
plasma to the brain, or conversely from the nervous tissue to the cerebral circulation.
Furthermore, it also seems likely that even though the cerebrovascular cell types may not
produce Aβ themselves, Aβ is still seriously toxic to all the endothelium, the SMC’s and the
pericytes (Kalaria, 1997; Price et al., 1997; Suo et al., 1997; Thomas et al., 1997; Verbeek et
al., 1997; Jancso et al., 1998) and can contribute to the pathological breakdown of the BBB
and compromised microvascular integrity seen in AD.Summary and Conclusion
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6.2.  Animal models for cerebral hypoperfusion
6.2.1. Cerebral blood flow after vascular occlusion
Frequently used animal models:
Since it has been anticipated that there is a dynamic interaction between hypertension,
reduced CBF, cerebral microvascular pathology, cognitive performance and memory
capacity, experimental models were established to investigate the causal relationship
between these factors. The laboratory animal models offer the possibility to take the
correlation analysis between CBF, vascular parameters and cognitive performance
accomplished in human studies one step further since correlation analysis offers only a
description of the coincidence of particular factors, but not causality per se. Our theory
presented in Chapter 4 contemplates that chronically reduced CBF can trigger the
degeneration of the capillary ultrastructure in the brain. Creating a reduction of cerebral
blood flow in laboratory animals can test such a presumed sequence of events best. The
ligation of the different large arteries that supply the brain is routinely applied under
experimental conditions to achieve various degrees of cerebral hypoperfusion (Figure 6.4).
The bilateral occlusion of the common carotid arteries (two vessel occlusion, 2VO) is a
well characterized method in rats and gerbils, but the gerbil model is more suitable for
ischemia research for the following reasons. The posterior communication between the
basilar artery and the carotid artery system is often missing in gerbils, meaning an
incomplete circle of Willis (Mayevsky and Breuer, 1992). This anatomical peculiarity has
substantial functional implications such as the incapability of the basal cerebral circulation to
compensate for a reduced blood supply via either the carotid or the basilar arterial system.
Therefore 2VO in gerbils severely affects the anterior cerebral circulation causing acute
ischemic attacks. Due to this phenomenon the rat rather than the gerbil has been chosen to
reconstruct chronic cerebral hypoperfusion comparable to the human situation. The 2VO
surgery in rats produces a less marked hypoperfusion compared to the cerebrovascular
insufficiency imposed by the three vessel occlusion technique (3VO), the ligation of the
subclavian artery combined with the occlusion of the two common carotid arteries (de la
Torre et al., 1992; Tsuchiya et al., 1992; Ohta et al., 1997). The ligation of the middle
cerebral artery (MCAO) is also in practice but has been more regularly applied as an
ischemic stroke model due to its acute, severe consequences (Nagahiro et al., 1998).Chapter 6
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Figure 6.4. Experimental rat models to impose permanent cerebral hypoperfusion. A: bilateral
common carotid artery occlusion, two-vessel occlusion (2VO). B: cerebrovascular insufficiency by
occlusion of the common carotid arteries (a) and the subclavian artery (b), three-vessel occlusion
(3VO).
The 2VO paradigm is frequently discussed in the context of AD because of the apparent
prevalence of cerebral hypoperfusion in the disease (de Jong et al., 1997; Farkas et al.,
1999, de la Torre et al., 1999). Nonetheless, the 2VO experiments should not be literally
interpreted as representative of a definite carotid artery occlusion in AD patients since the
carotid flow in AD may be hampered but not totally blocked. The 2VO model stands for the
visualization of the cerebrovascular and behavioral consequences of the reduced CBF,
whatever its trigger may be. In fact, the cause of the lowered CBF in AD is not certain but the
possibilities may very well include (cardio)vascular factors such as hypertension and
atherosclerosis - even in the carotid sinus (Hofman et al., 1997; Skoog, 1997; Breteler,
2000), as well as Aβ-induced vascular constriction (Paris et al., 2000), or degenerating
neural regulation.Summary and Conclusion
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The time course of experimental cerebral hypoperfusion:
When the cerebral blood supply through the carotid arteries is experimentally shut off, a
compensatory redistribution of blood in the circle of Willis and perhaps other processes that
counteract the sudden drop in CBF can be expected. In order to estimate how long it takes
for the cerebral circulation to normalize CBF and to see to what degree blood flow can be
restored following 2VO, it is worth following the temporal dynamics of cerebral perfusion
after the surgery. The expected recovery of CBF can be carefully reconstructed based on
the data available in literature (Figure 6.5). The earliest research paper on the topic reported
a striking 90-95% drop in cortical rCBF at 1 or 3 hours after the ligation (Sadoshima et al.,
1983), which, however, could not be reproduced by later studies. Most follow-up studies
point to the following time course of CBF alteration after bilateral carotid ligation (Figure 6.5).
The cortical rCBF was 34% of the control value at 2.5 hours after surgery, increased to
about 52% 2 days later, reached roughly 64-66% at 1 week and 80% 3 months after 2VO.
Although the latest cortical rCBF value obtained 3 months after the ligation was still lowered,
it did not differ significantly from the control values any more (Tsuchiya et al., 1992, Tsuchiya
et al., 1993, Ohta et al., 1997). The decrease of rCBF in the hippocampus appeared to be
less dramatic than in the cortex but the degree of hypoperfusion was still considerable. The
hippocampal perfusion rate fell to 52% of the control 2.5 hours after the 2VO surgery, 70% 2
days later, a still significant 74% after 1 week and a non-significant 75% at 3 months survival
Figure 6.5. The reconstruction of the temporal dynamics of cerebral blood flow after bilateral carotid
artery occlusion (2VO). A: hippocampus. B: cerebral cortex.Chapter 6
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time (Tsuchiya et al., 1992; Tsuchiya et al., 1993; Ohta et al., 1997). When the hippocampal
Ammon’s horn (CA region) and the dentate gyrus were separately examined, the CA area
showed a slightly lower rCBF than the dentate gyrus (Tsuchiya et al., 1992; Tsuchiya et al.,
1993). The blood flow of the same regions in the above-introduced cerebrovascular
insufficiency (3VO) model exhibited the following alterations. The rCBF in the hippocampus
CA1 section reached only 38% of the control value 3 weeks after imposing 3VO but
recovered to normal level 9 weeks after the surgery. The cortical flow suffered a setback to
85% at 3 weeks but also returned to control level at 9 weeks (de la Torre et al., 1992).
The comparison of young and aged rats in the 3VO paradigm delivered interesting
observations. While the CBF of 1 month old rats recovered to normal values already at 9
weeks after the surgical intervention as presented above, 14 months old animals could not
compensate for the reduced cerebral blood supply in the given time frame, what is more,
their hippocampal and cortical rCBF decreased even further. Particularly the cortical
hypoperfusion was striking with its very low rates of 26% at 3 weeks and only 20% at 9
weeks survival time while the hippocampal rCBF stagnated from 66% to 40% (de la Torre et
al., 1992). The possible explanation may point out the loss of regulatory capacity in the aging
brain which can extend to delayed or even impaired compensatory mechanisms against a
lowered cerebral perfusion pressure and blood supply. The regulation of rCBF would
normally sustain the gradual return of rCBF to control values as seen in young animals.
As mentioned in Chapter 1.2.1., longitudinal clinical studies on the etiology of AD raised
the issue of the involvement of cardiovascular factors in the disease process. Chronic
hypertension in particular is a condition, which was recently associated with cerebrovascular
deficiencies in AD. Hypertension could accomplish its detrimental effects on cerebral vessels
via creating cerebral hypoperfusion, an existing condition in hypertensive patients, as well as
in experimental animals with spontaneously high blood pressure (Nobili et al., 1993;
Fujishima et al., 1995; Nakane et al., 1995; 1995; Katsuta, 1997). Specially the results
obtained with spontaneously hypertensive rats (SHR) demonstrated that the cortical rCBF
was reduced in the SHR animals compared to normotensive controls (WKY), and the
cerebral hypoperfusion affected more extensive regions with the advancement of age,
observed in groups of 4 and 16-17 months old SHR rats (Katsuta, 1997). Furthermore, a
long-term antihypertensive treatment of SHR rats restored the cortical rCBF to values of
normotensive controls, which also showed a significant linear correlation with the decreasing
mean arterial pressure (Fujishima et al., 1995). Though the SHR rat strain is not strictly a
cerebral hypoperfusion model, the coincidence of chronic hypertension and the reduced
CBF in this rat strain can reinforce the idea that peripheral vascular factors or enhancedSummary and Conclusion
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vasoconstriction contribute to the disturbance of cerebral perfusion, which phenomenon can
be extrapolated to the aging brain and dementia cases. Finally, the intriguing resemblance of
deteriorated cerebral microvascular morphology and memory disturbances assessed in SHR
and 2VO rats encourage this line of reasoning further (Farkas et al., 2000a-Chapter 4;
Farkas et al., 2000b, Farkas et al., 2001-Chapter 5), and are discussed in detail below.
6.2.2. Metabolic markers in experimental cerebral hypoperfusion
In addition to the degree of cerebral hypoperfusion, the regional cerebral glucose
utilization (rCGU) in separate brain regions was also measured in 2VO animals. The data
obtained in the experiment showed that rCGU in cortical regions followed the reduction in
rCBF 1 week after the vascular ligation but no significant changes occurred in the
hippocampus. In fact, the cerebral cortex emerged as the most sensitive area, which is
reflected by the constantly reduced rCGU measurements in its 6 separate parts measured,
while only 5 out of the other 18 brain regions examined demonstrated significant reduction in
glucose utilization. However, correlation analysis between CGU and CBF averaged to the
whole brain showed a very significant linear relationship in both SHAM control and 2VO
animals (Tsuchiya et al., 1993).
Others examined the activity of cytochrome oxidase, the terminal enzyme of the
mitochondrial electron transport chain, which generates ATP via oxidative phosphorylation.
Quantitative histochemistry revealed that 4 weeks after the 2VO surgery cytochrome oxidase
activity was selectively reduced in the hippocampal CA1 area and the posterior parietal
cortex (de la Torre et al., 1997). The diminishing mitochondrial enzyme activity probably
reflected impaired ATP synthesis and a suboptimal neuronal energy metabolism. The fact
that the changes were detected in areas deeply involved in spatial memory processing
(hippocampus CA1) probably accounts for the compromised spatial learning performance of
these animals tested in the Morris water maze (de la Torre et al., 1997).
6.2.3. Cerebral microvascular damage due to experimental cerebral hypoperfusion
The 2VO model proved to be a very suitable method to determine the effects of a
decreased CBF on the ultrastructure of cerebral capillaries. Unlike the acute MCAO often
imposed in stroke research, where after a short blockage of blood flow the subsequent
reperfusion phenomenon is also studied, the chronically applied 2VO paradigm induces a
relatively mild but permanent brain hypoperfusion. Further difference between the MCAO
and 2VO is that, in contrast with MCAO, stroke does not normally occur in normotensive
animals as a result of 2VO.Chapter 6
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In one of our studies (de Jong et al., 1999-Chapter 2), the microanatomy of brain
capillaries was investigated with electron microscopy (EM) 14 months after creating cerebral
hypoperfusion by 2VO. The hippocampus was chosen as the area of interest due to its
selective neuronal and metabolic vulnerability represented by the neuronal damage and the
reduced cytochrome oxidase activity observed here under 2VO condition (Pappas et al.,
1996; de la Torre et al., 1997). Within the hippocampus two distinct regions, the CA1 and the
dentate gyrus were analyzed and compared with each other. The microvascular
histopathological features that we quantified were basement membrane (BM) deposits and
pericytic degeneration. The category of BM deposits represented a merged group of
basement membrane thickening (BMT) and microvascular fibrosis described in detail above
(Chapter 6.1.2.), while pericytic degeneration was defined as irregular membranous
inclusions in the pericytic cytoplasm. The ratio of capillaries displaying both of the two types
of abnormalities (that is BM deposits or degenerating pericytes) was calculated and
expressed as the percentage of the total number of capillaries analyzed. Out of the two
hippocampal regions only the CA1 exhibited a significant increase in both capillary BM
deposits and degenerating pericytes in the 2VO animals. When the ratio of intact capillaries
was expressed, a 20% decrease of healthy vessels was found in the CA1 region of the 2VO
rats (Figure 6.2.C). On the other hand, no significant changes in microvascular ultrastructure
emerged in the dentate gyrus indicating the selective vulnerability of the CA1
microvasculature to a reduced cerebral perfusion in the hippocampus.
As a technical consideration to the 2VO experiments, it must be noted that the
microvascular consequences of 2VO are not always restricted to the brain but can affect the
eye, as well (Slakter et al., 1984). The shrinkage of the optic nerves or the extensive
disruption of the microvasculature in the eyes associated with pathological retinal
appearance reported in 2VO rats (Slakter et al., 1984; Ohta et al., 1997) gains special
importance when the animals are trained in a learning paradigm that involves visual cues.
The problem can be circumvented by evaluating the visual aptitude of the animals in the
given learning task in order to prove that the expected cognitive failure indeed correlates to
the cerebral capillary damage and not to a potential retinal impairment.
The cerebral capillary breakdown demonstrated under the 2VO condition and previously
in aging rats was also encountered in spontaneously hypertensive stroke prone rats (SHR-
SP) (Farkas et al., 2001-Chapter 5). The functional link between these three different
conditions sharing the common pattern of cerebral capillary pathology may well be cerebral
hypoperfusion although firm and direct evidence is still lacking to support this view. Similar to
the studies with aged rats (De Jong et al., 1990), our SHR-SP experiments also focused onSummary and Conclusion
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the frontoparietal cortex where BMT significantly increased at the age of 60 weeks with 10%,
microvascular fibrosis at 40 and 60 weeks with 3 and 9% respectively, while the occurrence
of degenerative pericytes remained the same comparing the hypertensive animals to a
normotensive age-matched group. The damage to the basement membrane expressed as
basement membrane deposits (BMT and/or fibrosis) is shown in Figure 6.2.D. The finding
that the amount of capillary wall deposits correlated to the systolic blood pressure in the
hypertensive SHR-SP group supports the theory of a causal relationship between
physiological peripheral and cerebral morphological vascular factors.
The disruption of cerebral capillary integrity could be prevented by the chronic application
of nimodipine or nifedipine both in normotensive, aging Wistar and in hypertensive SHR-SP
rats (Figure 6.6) (De Jong et al., 1990,  De Jong et al., 1991;  Farkas et al., 2001-Chapter 5).
Figure 6.6. The vascular protection in cortical microvessels of 20 weeks chronic treatment with the
calcium channel blockers nimodipine and nifedipine. Abbreviations: WKY: Wistar Kyoto normotensive
rats strain; SHR-SP: spontaneously hypertensive stroke-prone rat strain, 40: 40 weeks old animals;
60-plac: 60 weeks old animals fed by placebo diet for 20 weeks; 60-nimo: 60 weeks old animals fed
by nimodipine containing diet for 20 weeks; 60-nife: 60 weeks old animals fed by nifedipine containing
diet for 20 weeks.Chapter 6
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Nimodipine and nifedipine are two L-type calcium channel antagonists from the
dihydropyridine family that can block excessive calcium influx either at vascular smooth
muscle cells, or at neural elements when penetrating the brain parenchyma.
Dihydropyridines moderate vasoconstriction and blood pressure by targeting the vascular
smooth muscle layer (Katz et al., 1985; Fleckenstein and Fleckenstein-Grun, 1988; Alborch
et al., 1995) while in the brain they can also serve as potent neuroprotective agents by
preventing the building up of an extreme intracellular calcium concentration in neurons and
astrocytes (Scriabine et al., 1989; Schuurman and Traber, 1994; Disterhoft et al., 1996). The
latter possibility requires that the drugs penetrate the BBB, which was shown for both
nimodipine and nifedipine (Janicki et al., 1988; Larkin et al., 1992; Uchida et al., 1997).
The beneficial effect of the two drugs on cerebral capillaries thus promoted the concept
that a dysregulation of intracellular calcium concentration contributed to the cerebral
microvascular degeneration. The fact that nimodipine did not decrease blood pressure at the
concentration used in our study - yet it successfully preserved cerebral capillary integrity -
suggested drug action at CNS rather than peripheral vascular level (Farkas et al., 2001-
Chapter 5). The possible CNS compartments where nimodipine or nifedipine could act
include astrocytes or neurons but probably not the cerebrovascular endothelial cells
themselves, where the presence of L-type calcium channels (the target of dihydropyridines)
is debatable (Alborch et al., 1995). Since the astrocytic end feet are deeply involved in BBB
maintenance, the possibility emerges that the dihydropyridine compounds could protect the
capillaries by preserving the astrocytic regulation of the BBB. Alternatively, neuronal
populations projecting to the perivascular plexus could also serve as the target of the
calcium channel blockers.
Cerebral hypoperfusion, also seen under chronic hypertensive conditions, can create a
mild cerebral ischemia associated with an increased intracellular calcium concentration that
can impose harmful effects on mitochondrial function. Furthermore, the elevated calcium
concentration is known to activate detrimental metabolic cascades and is accompanied by
free radical generation (Siesjo et al., 1995). The calcium-generated synthesis and
accumulation of the easily translocating NO and its toxic products (Beckman, 1991; Love,
1999) can attack the integrity of the BBB: it may cause astrocytic dysfunction (Schubert et
al., 1994) and increased endothelial permeability (Wei et al., 1986; Imaizumi et al., 1996;
Lagrange et al., 1999). The here presented microvascular pathology in SHR-SP animals can
be associated with such a chain of events. Dihydropyridine treatment can supposedly
prevent the intracellular calcium accumulation in astrocytes and/or neurons innervating the
cerebral microvascular domain, thus moderating free radical production (Zhu et al., 1999)Summary and Conclusion
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and consequent cerebral capillary injury. The improvement of the calcium homeostasis of
these neural elements also controlling capillary blood flow may also explain the improvement
in brain perfusion, which was shown to increase in SHR rats and rabbits after nimodipine or
nifedipine treatment (Tanaka et al., 1986; Thoren et al., 1989; Ooboshi et al., 1990;
Weinstein, 1995).
Hence, we can draw the conclusion that cerebral capillary damage can be initiated by an
imbalance in the intracellular calcium homeostasis of astrocytes and neurons, which reaches
its effect on microvascular ultrastructure via the release of toxic free radicals, the disturbance
of the neurogenic regulation of CBF and the degree of brain perfusion.
6.2.4. Learning capacity and neuropathology under experimental cerebral hypoperfusion
Learning and memory impairment after carotid occlusion:
The testing of learning and memory capacity of 2VO animals, and the detection of
neuronal damage complete the major fields of investigation on the degenerative features
that may arise as a consequence of cerebral hypoperfusion. The main focus of the
behavioral and histological experiments has been on the hippocampus and the cerebral
cortex for their selective vulnerability shown by CBF measurements and metabolic activity
assessed in the 2VO paradigm. The learning tests most frequently used in cerebral
hypoperfusion studies had been specially designed to unravel mainly hippocampus-related
spatial learning processes (Kesner et al., 2000).
The eight-arm radial maze task (Figure 6.7.A) makes use of the motivation of food-
deprived animals to search for food pellets in the maze. The rats must learn through
consecutive trials which arms of the maze are baited and enter those arms only once. The
animals commit an error if they make revisits to the baited arms in case not all the other
pellets have been found, or if they make non-baited arm visits when non-baited arms are
also included in the paradigm. When 2VO rats were trained to learn the test starting either 3
days or 3 months after surgery, they committed significantly more errors than their controls
and were not able to improve their performance to control levels even after 15 trials (Table
6.1) (Ni et al., 1994; Ohta et al., 1997; Nanri et al., 1998). However, when the animals had
mastered the task before the onset of 2VO (pre-trained rats), and they were placed back on
the maze 3, 7 or 21 days after the surgery as a retention test, they quickly managed to
perform like the SHAM controls. Surprisingly these pre-trained animals demonstrated a
marked setback between 63-168 days after 2VO, when they made significantly more
mistakes than the controls (Ni et al.,  1994,  Pappas et al.,  1996;  Bennett et al., 1998).  TheChapter 6
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Figure 6.7. The eight-arm radial maze (A) and the Morris water maze (B).
extensive behavioral data on learning performance indicated that the acquisition of spatial
memory rather than the memory retention phase was disturbed shortly after 2VO in the eight
arm radial maze, and that the long-term effect of cerebral hypoperfusion severely impaired
retention from approximately 2 months on following the onset of 2VO.
The Morris water maze spatial learning paradigm (Figure 6.7.B) also tests spatial
memory acquisition and retention, but exploits another sort of motivation, namely the urge toSummary and Conclusion
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Table 6.1. Learning impairment after permanent common carotid artery occlusion (2VO) in the rat
References Age of
animals at the
onset of 2VO
Type of
behavioural test
Time between 2VO
and the start of
behavioural testing
2VO results compared
to SHAM controls
Ni et al., 1994. 7 weeks-9
months
Eight arm radial
maze
3 days-4 months more errors, impaired
learning
Morris water maze 14, 28, 70, 112 and
161 days
longer escape latencies,
impaired learning
Pappas et al.,
1996.
9-10 months
Eight arm radial
maze
7, 21, 63, 105 and
154 days
more unbaited arm
entries, impaired
learning
Morris water maze 2 weeks/3 months longer escape
latencies/severe
learning impairment
Ohta et al., 1997. 9 weeks
Eight arm radial
maze
3 months more errors, impaired
learning
De Jong et al.,
1999.
3 months Morris water maze 1 month/2 months/1
year
longer escape latencies,
impaired learning
de la Torre et al.,
1997.
19 months Morris water maze 1, 2 and 3 weeks longer escape latencies,
impaired learning
de la Torre et al.,
1998.
14 months Morris water maze 2, 4 and 6 weeks no significant difference
escape from an unpleasant situation. Solving the maze involves considerably more stress for
the animals than the eight-arm radial maze, possibly enhancing group differences further
(Pappas et al., 1997). The Morris water maze protocols also vary between research groups
but the basic concept of the test remains the same: the acquisition period includes a set of
trials when the rats must learn the location of a hidden platform submerged under the water
surface in a circular swimming pool. The escape latency or the distance covered from
introducing the rat into the water till finding the platform is measured at each trial to visualize
learning performance. During the retention trial (also called probe trial) successive to the
training sessions the platform is removed from the pool, and the time the animals spend in
the area previously containing the platform is taken as indicative of retention capacity. The
acquisition of the task in the Morris water maze showed significant impairment at different
time points ranging from 2 weeks to 12 months after the carotid occlusion (Figure 2.1, Table
6.1) (Pappas et al., 1996; Ohta et al., 1997; De Jong et al., 1999-Chapter 2). The probe trial
executed at 2 weeks or 3 months after 2VO invariably confirmed compromised spatialChapter 6
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orientation skills (Ohta et al., 1997). Hence, the results collected in the Morris water maze
paradigm also revealed that cerebral hypoperfusion markedly compromised spatial learning
and memory retention.
Cerebral histopathology in experimental cerebral hypoperfusion:
Parallel with the memory deficits, the neuronal integrity under the 2VO condition
degenerated as well. Histological examination of brain slices revealed white matter
rarefaction (Ohta et al., 1997; Nanri et al., 1998) and a progressive neuronal damage in the
hippocampus and the cerebral cortex (Tsuchiya et al., 1992; Ni et al., 1994; Pappas et al.,
1996; Pappas et al., 1997; Ohta et al., 1997; Bennett et al., 1998; Nanri et al., 1998). More
specifically, the hippocampus CA1 area displayed neuronal shrinkage (Ni et al., 1994; Nanri
et al., 1998), biochemical and morphological signs of apoptotic cell death such as DNA
strand breaks, chromatin condensation and cytoplasmic shrinkage (Pappas et al., 1997;
Bennett et al., 1998), pyramidal cells loss (Ni et al., 1994; Pappas et al., 1996; Ohta et al.,
1997; Bennett et al., 1998) and a decreased immunoreactivity for microtubule-associated
protein 2 (MAP2), a marker protein of neuronal dendrites (Nanri et al., 1998). Reactive
gliosis accompanying the neuronal damage in the hippocampal CA1 segment was enhanced
as well (Tsuchiya et al., 1992; Ohta et al., 1997), also shown by the significant increase in
glial fibrillary acidic protein (GFAP) immunoreactivity (Pappas et al., 1996; Nanri et al.,
1998). The listed abnormalities also characterized – although to a lesser degree - the
neurodegenerative processes in the cerebral cortex (Tsuchiya et al., 1992; Ni et al., 1994;
Nanri et al., 1998). In addition to the marked neurodegeneration as a consequence of
cerebral hypoperfusion, recent investigation disclosed extracellular deposits of the amyloid
precursor protein (APP) (Pappas et al., 1997), and a progressive accumulation of Aβ
peptides in aging 2VO rats detected by Western blot analysis (Bennett et al., 2000).
Correlation between learning skills and neuronal/vascular pathology in the cerebral
hypoperfusion model:
Correlation analysis between the memory data and the histopathological changes
following chronic cerebral hypoperfusion highlighted the hippocampal CA1 area as the
central site where neuronal damage coincided with impaired learning capacity. This is in
agreement with the well-established notion that the hippocampus CA1 is the specific
structure where spatial learning takes place (Van der Zee et al., 1992, Shapiro and
Eichenbaum, 1999; Kesner et al., 2000). The increasing number of apoptotic cells andSummary and Conclusion
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GFAP immunoreactivity in the CA1 segment significantly related to the eight arm radial arm
maze performance of the 2VO animals (Pappas et al., 1996, Bennett et al., 1998).
Furthermore, the data obtained in the Morris water maze indicated a marked relationship
between spatial learning and hippocampal microvascular breakdown also selectively in the
CA1 region but not in the dentate gyrus. The BM deposits significantly correlated with
impaired memory in the hippocampus CA1 (Figure 2.4). The coincidence of neuronal
damage and microvascular breakdown in the hippocampus CA1, accompanied by
compromised spatial learning skills suggests that these three read-outs of cognitive status
and cellular integrity are functionally related in the chronic 2VO model, where the onset of
cerebral hypoperfusion acts as the trigger for microvascular pathology, neuronal damage
and impaired learning. These degenerative changes, which develop as the consequence of
cerebral hypoperfusion, also find correlates in human dementia such as cerebral capillary
breakdown, compromised neuronal integrity and failing cognition. Although the
neuropathology of AD is a lot more complex, cerebral hypoperfusion probably augments the
advancement of the aspects of dementia as shown by the 2VO model.
6.3.  Mechanisms possibly responsible for CBF reduction and capillary damage
6.3.1. The cholinergic hypothesis of cerebral blood flow regulation and its implications in
Alzheimer’s disease
A marked deficiency in cholinergic neurotransmission is one of the distinguishing
degenerative features of AD. The loss or shrinkage of cholinergic neurons in the basal
forebrain and the medial septum and the disappearance of cholinergic projection fibers from
the nucleus basalis (NBM) to the neocortex and from the medial septum to the hippocampus
were widely investigated in view of the concomitant memory deficits typical of AD (Gaykema
et al., 1992; Muir et al., 1993; Whitehouse, 1998). Whereas studies on the substantial
contribution of the cholinergic pathways to cognitive processes have a long history, the
capacity of this network to influence CBF has only recently gained more attention. It has
been recognized that the activation of the substantia innominata/NBM complex (SI/NBM)
could increase regional CBF by inducing vasodilatation in cortical microvessels (Figure 6.8)
(Biesold et al., 1989; Vaucher et al., 1994; Vaucher et al., 1995; Barbelivien et al., 1999).
The striking coincidence of a reduced cortical CBF and cholinergic neurodegeneration of the
NBM both seen in AD patients has stimulated more extensive research on this field.
The involvement of acetylcholine (ACh) as a neurotransmitter in the control of regional
CBF was demonstrated by the administration of cholinergic drugs such as scopolamine,Chapter 6
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physostigmine or eptastigmine. When a group of human subjects was treated with
scopolamine, a non-selective muscarinic ACh receptor blocker, a 20% decrease of CBF in
the frontal cortex was detected (Honer et al., 1988). On the other hand, the application of the
ACh-esterase inhibitors physostigmine and eptastigmine, which increase the extracellular
level of endogenous ACh, lead to a significant increase of CBF in a wide variety of brain
regions in the rat and man (Blin et al., 1997; Scremin et al., 1993; Peruzzi et al., 2000).
Although these experiments provided convincing evidence for the involvement of ACh in
CBF regulation, the origin and exact target structures of the neurotransmitter still remained
to be clarified.
The source of cholinergic innervation to cortical vessels was identified by either the
lesion or the stimulation of the cholinergic basal nuclei, and the consequent measurement of
changes in CBF (Biesold et al., 1992; Vaucher et al., 1994; Vaucher et al., 1995; Vaucher et
al., 1997a; Barbelivien et al., 1999). These experiments can be regarded complementary to
the drug treatment studies but it must be kept in mind that although the largest cell
population in the SI/NBM complex is cholinergic, other cell types (e.g. GABAergic) also
mingle with them and are represented to a lesser extent. Thus, it should be anticipated that
the lesioned or electrically stimulated nucleus basalis neurons might not exclusively employ
ACh as their neurotransmitter.
Figure 6.8. Decrease in
cerebrocortical blood flow
due to unilateral
biochemical lesion of the
nucleus basalis
magnocellularis (NBM).
The drop in CBF in the
lesioned hemisphere is
given as side-to-side
difference compared to
the intact, contralateral
side. Abbreviations: FRC:
frontal cortex, PC:
parietal cortex. (adopted
from Peruzzi et al., Ann.
N. Y. Acad. Sci. 903:394-
406, 2000).Summary and Conclusion
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The unilateral lesion of the SI/NBM by ibotenic acid injection in rats offered the possibility
to compare CBF in the lesioned side to the intact, contralateral hemisphere. According to the
expectations, a significant drop in cortical CBF was detected in the ipsilateral hemisphere 1-
5 weeks after the lesion (Figure 6.8) (Gomi et al., 1991; Peruzzi et al., 1996; Peruzzi et al.,
2000) giving support to the assumption that the basal forebrain can modulate regional CBF
in the neocortex. Hence, the loss of cortical cholinergic innervation in AD may contribute to
the reported reduced CBF in the disease in a similar fashion. Data accomplished
simultaneously by other experiments employing stimulation of the SI/NBM corroborated the
same line of reasoning. Electrical stimulation of the SI/NBM via chronically implanted
electrodes (Vaucher et al., 1994; Vaucher et al., 1995; Vaucher et al., 1997a) or the
neurochemical activation of the SI with the cholinergic agonist carbachol (Barbelivien et al.,
1999) both resulted in a significant increase of regional CBF in the cerebral cortex and
subcortical, extrapyramidal structures. The outcome of these studies thus securely
established the concept of a cholinergic neurogenic component of CBF autoregulation,
which originated in the basal forebrain and predominantly affected cerebral cortical areas.
Nevertheless, the question was still left open whether projections from the SI/NBM were
direct or indirect and whether ACh was the final neurotransmitter at the perivascular sites or
an intermediator at preceding synapses.
The physiological studies described above already tackled this problem and arrived at the
conclusion that the nature of innervation from the basal forebrain was probably region-
dependent. More specifically, the existence of a direct projection to the cortical
microcirculation - as opposed to subcortical structures - was suggested based on the pattern
of uncoupling between CBF and CGU after electrical stimulation (Vaucher et al., 1997a). In
addition, the frontoparietal cortex was pinpointed as the more specific cortical target of
cholinergic innervation to microvessels because scopolamine administration preceding
chemical activation of the SI could abolish the increase of CBF in the frontoparietal but not in
other cortical areas (Barbelivien et al., 1999). Nonetheless, the final evidence for the direct
and indirect pathways from the SI/NBM to cortical microvessels was provided by anatomical
tract tracing experiments (Vaucher and Hamel, 1995) and the demonstration of cholinergic
receptors in the microvascular domain itself (Luiten et al., 1996; Elhusseiny et al., 1999). In
the frontoparietal cortex, perivascular nerve terminals arising from the basal forebrain were
visualized with electron microscope after injecting Phaseolus vulgaris leucoagglutinin (PHA-
L), the widely used anterograde tracer, into the SI. These PHA-L positive nerve endings
were furthermore comparable with terminals immunoreactive for choline acetyltransferase
(ChAT) (Vaucher and Hamel, 1995). The microvascular postsynaptic elements of cholinergicChapter 6
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Figure 6.9. The cholinergic innervation of cortical cerebral vessels. A: Cholinergic projection from the
nucleus basalis/substantia innominata complex to capillaries in the frontoparietal cortex of the rat. B:
Cholinergic synaptic elements in close approximation to a cortical capillary. C: Electron microscopic
image of a cortical capillary with an astrocytic endfoot immunopositive for muscarinic acetylcholine
receptors (dark deposits). Abbreviations: a: astrocytic endfoot; ACh-ax: axon terminal employing
acetylcholine as neurotransmitter; cap: capillary; e: endothelial cell; FRC: frontoparietal cortex; l:
capillary lumen; mAChR’s: muscarinic acetylcholine receptors; NBM/SI: nucleus basalis/substantia
innominata complex; p: pericyte; ∗: basement membrane.
neurotransmission were identified as muscarinic ACh receptors (mAChR’s) by conducting
receptor binding studies on isolated rat cerebrocortical microvessels (Grammas et al., 1983).
Further research localized the mAChR proteins exclusively on the perivascular astrocytic
endfeet (Figure 6.9) (Luiten et al., 1996; Van der Zee and Luiten, 1999) while the mRNA of
several mAChR subtypes could be detected in cultured endothelial cells and smooth muscle
cells in addition to astrocytes (Elhusseiny et al., 1999).
Putting all these findings together, the outline of a well-defined cholinergic pathway from
the basal forebrain to the frontoparietal cortical microvasculature emerges, which is capable
of increasing regional CBF in the given cortical area. Projecting the picture of this anatomical
and physiological circuitry of neurogenic CBF autoregulation to AD brains, the attractive
theory that cholinergic deficits in AD have pathophysiological cerebrovascular consequences
appears to be justified. The cholinergic neurodegeneration in the basal forebrain canSummary and Conclusion
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therefore account for the decreased CBF at least in the frontal lobe, but the degeneration of
indirect projections from the SI/NBM to cortical microvessels via interneurons that release
NO (Vaucher et al., 1997b; Tong and Hamel, 1999) may also be contribute to the failure of
CBF control in other cortical areas, such as the temporal lobe.
6.1.2.  Hypertension- and intracellular calcium homeostasis-related mechanisms in the
development of cerebral microvascular pathology
Evidence from clinical studies
Vascular factors, which may contribute to the development of dementia, have gained
growing attention in recent years (de la Torre, 1999; Van Kooten et al., 1998). Particularly
hypertension, being a frequently occurring condition with advancing age has come into focus
for its major role in the development of stroke and its association with atherosclerosis.
Clinical studies were aimed at clarifying a presumed relationship between chronic
hypertension and the onset of dementia because an elevated blood pressure was thought to
interfere with proper cerebral circulation and neuronal metabolism. This idea found
compelling support in the observation that vascular dementia (VD) consistently coincided
with high blood pressure (Forette et al., 1995; Herbert and Brayne, 1995; Lis and Gaviria,
1997; Fujishima and Tsuchihashi, 1999). The role of hypertension in the pathogenesis of
Alzheimer’s disease (AD), another prominent type of dementia appeared to be more
complicated to elucidate. Several epidemiological studies investigated the interaction of
elevated blood pressure and AD but a final agreement about a causal relationship has not
been reached, yet. Nevertheless, based on several studies (Elias et al., 1993; Launer et al.,
1995; Skoog et al., 1996) a hypothesis was proposed that the blood pressure of AD patients
probably varies according to the stage of the disease and that hypertension characteristically
precedes the diagnosis of cognitive impairment with at least 10 years (Skoog, 1997).
According to this theory, patients suffering from chronic hypertension during their midlife
have a higher chance for developing AD at older age. The theory proposed by Skoog (1997)
was further underscored by the detection of an increased amount of senile plaques and
neurofibrillary tangles in the brains of hypertensive individuals (Sparks et al., 1995). Thus,
chronically high blood pressure can be considered as a condition, which increases the
potential to develop dementia. Such tendency was also indirectly shown by the preventive
effect of anti-hypertensive drugs on the incidence of AD (Forette et al., 1998).
Patients suffering from chronic hypertension can often display signs of additional
vascular abnormalities. For example, high blood pressure is generally accompanied by
arteriosclerosis or deformations of larger peripheral vessels exerting additional harmfulChapter 6
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effects on the circulation. The rigid vessel walls and the considerably narrowed lumen
diameter further hinder the maintenance of a normal blood pressure by increasing peripheral
resistance. Besides such systemic damage, abnormally high pressure can also threaten an
optimal cerebral blood supply, as it was show in hypertensive individuals. When the cerebral
blood flow (CBF) of hypertensive patients was measured with PET or the 133Xe-inhalation
method, and the data compared to those of normotensive individuals, reduced flow rate was
recorded in the hypertensive patients (Fujii et al., 1990; Nobili et al., 1993; Nakane et al.,
1995). In addition, the drop in CBF was less pronounced in high blood pressure patients who
were receiving an anti-hypertensive treatment (Nobili et al., 1993). In line with the hypothesis
that hypertension can act as a risk factor for AD, in vitro and in vivo experiments were
designed to investigate the effect of circulating β-amyloid - the peptide typically accumulating
in AD brains - on blood pressure. Isolated aorta preparations and in vivo β-amyloid infusion
demonstrated the vasoconstrictive effect of β-amyloid (Arendash et al., 1999; Thomas et al.,
1996).
Experimental data of spontaneously hypertensive rats
Animal studies lead to similar observations: the CBF of spontaneously hypertensive
(SHR) rats appeared to be reduced, as well, where the compromised cerebral circulation
was already detectable at 4 months of age (Fujishima et al., 1995; Katsuta, 1997). This latter
finding suggests that an accelerating age effect in a hypertension-induced drop in CBF is not
crucial; instead, hypertension itself can already create an unfavorable cerebral circulation.
Nevertheless, the enhanced breakdown of cerebral circulation at older age should not be
neglected considering that even lower CBF values were measured in aged hypertensive
animals (Katsuta, 1997). Further indication of a decreased CBF can be an elevated lactate
concentration in the jugular venous blood, which indicates cerebral anaerobic glycolysis. An
increased jugular lactate concentration was also described in hypoperfused SHR rats
(Dickinson, 1996). A conceivable explanation of reduced CBF in hypertension may be that a
typical atherosclerosis of the carotid arteries contributes to the development of insufficient
cerebral blood supply. Another interpretation may argue for a damaged cerebrovascular
autoregulation. Dickinson (1996) however discussed a preserved cerebrovascular
autoregulatory capacity of the brain and suggested an alternative deficient vascular process.
According to this view, the cyclic opening and shutting of cerebral capillaries normally cares
for a regular oscillation in the cerebral arteriolar caliber, which process seems to be
compromised in the SHR animals. Whatever the underlying mechanism may be, a reduced
CBF appears to consistently accompany chronic hypertension.Summary and Conclusion
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  The striking similarity between capillary damage and compromised spatial memory in the
2VO condition and SHR-SP rats was established in Chapter 5. Further evidence to support a
causal coincidence of cerebral capillary damage and behavioral changes under chronic
hypertension was also assessed in a novelty-induced behavioral arousal paradigm in our
lab. The rats were observed for 60 minutes in a small open field and their behavioral activity
was recorded. Such a novelty-induced activity test can help to estimate the exploratory
arousal of the animals. The analysis of the collected data showed that rearing and grooming
behavior occurred significantly less frequently in the SHR-SP group than in the control
animals (Figure 6.10) which is regarded indicative for a suppressed behavioral activity.
Because a decaying exploration normally occurs with aging, the lower arousal level of the
SHR-SP rats noted here may refer to an accelerated aging process that results from chronic
hypertension. Furthermore, a positive correlation was established between the rearing
scores and the percentage of healthy cerebral capillaries in the frontal cortex indicating a
higher behavioral activity coinciding with a higher incidence of intact cerebral capillaries
(Figure 5.6). These findings show that the decaying condition of cerebral microvessels in
hypertension can indeed compromise the optimal operation of neuronal networks and the
consequent behavioral characteristics.
As presented in Chapter 5, chronic treatment with the selective calcium channel
antagonists nimodipine and nifedipine could prevent the development of capillary basement
membrane pathology in the hypertensive rats. Several arguments were taken into
consideration to explain the cellular mechanisms that can be regarded responsible for the
beneficial effect of the drugs. One line of reasoning asserted that neuronal elements
innervating the fine vasculature of the cerebral cortex were targeted by nimodipine and
nifedipine, and the improvement of the intracellular calcium homeostasis of these neurons
ascertained a better regulation of blood flow and the preservation of the microvascular
ultrastructure. Reflecting back to Section 6.3.1. of this chapter, it is very well possible that
the cholinergic neurons of the NBM/SI complex, which represent an important site of cortical
vasoregulation, could benefit of the chronic dihydropyridine treatment and contributed to the
maintenance of healthy capillary ultrastructure in the SHR-SP rats by suppressing
enhanced, hypertension-related vasoconstriction. Therefore it is assumed that
dihydropyridine drugs in a low dose, which does not affect mean blood pressure, can
improve the condition of the cerebral microcirculation by acting on regulatory centers such
as the NMB/SI. The results achieved by the application of nimodipine and nifedipine further
indicate an important role of a balanced intracellular calcium homeostasis in cerebrovascular
integrity.Chapter 6
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Figure 6.10. Rearing (A) and grooming (C) activity of hypertensive SHR-SP rats (•) compared to
normotensive WKY (o) in the novelty induced behavioral arousal test (small open field). The x-axis
shows the observation time. Behavioral scores were calculated for every 10 minutes of the 60-min
observation period. B: Rearing scores of the entire 60-min observation time. p:∗, 0.05. D: Grooming
scores of the entire 60-min observation time. p:∗, 0.05.
6.2. Conclusions
Cerebral microvascular pathology in aging and to a markedly pronounced degree in AD
include the physiological changes in cerebral perfusion - particularly the decrease of regional
cerebral blood flow in cortical areas, a reduction of cerebral glucose utilization, the loss of
vascular innervation with special focus to the cholinergic breakdown typical of AD and the
ultrastructural damage to capillaries in the cerebral cortex represented by extensive
basement membrane pathology. The coincidence of these changes contributes to an
improper blood-brain barrier function in an additive manner. A wide range of comprehensive
laboratory animal experiments attempted to unravel a causal interaction between these
pathological vascular changes. Figure 6.11, a scheme produced by integrating the data fromSummary and Conclusion
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our lab and those of others, shows a hypothetical chain of events rooted in vascular
deficiency, which can augment compromised memory capacity.
Variable conditions, which extend from chronic hypertension through the breakdown of
neurogenic cerebrovascular regulation to the effect of circulating toxic molecules such as the
β-amyloid peptide, can initiate general vasoconstriction. As such a vasoconstrictive reaction
obviously affects the resistance vessels supplying the cerebral circulation, the cerebral
perfusion rate (CBF) gradually decreases causing insufficient flow in the cerebral
microvascular network. As a next step, the reduced regional CBF can give rise to well-
defined microanatomical aberrations in the capillary ultrastructure of cortical areas (BMT,
perivascular collagen deposits). Consequently, capillary basement membrane pathology will
either physically hinder passive nutrient and electrolyte trafficking from blood to brain or
interfere with active transport processes by possibly deforming the biochemical structure of
transporter proteins. The neural compartments will be thus deprived of essential nutrients
with major focus on glucose, thus compromising their energy status and metabolic activity. A
decline in mitochondrial cytochrome oxidase activity and ATP production detected in
experimentally hypoperfused rats are persuasive signs of such neuronal metabolic crisis. If
the condition persists for long, the neurons exhaust their capacity to sustain the function of
carrier proteins responsible for setting the homeostatic intracellular ion balance, respond
with delay to extracellular stimuli, and the neural circuits lose plasticity. In the end, inevitable
structural neuronal disintegration, even cell death may follow. The outcome of the process
can be detected at the behavioral level as cognitive failure and memory dysfunction.
The connected pathological changes are obviously interrelated, implying that the
sketched circle of events is under no circumstances a one-way route, but a more complex
network ushered by potent feedback mechanisms. Nevertheless, the theory presented here
can be regarded as the backbone of the pathological cerebrovascular incidents associated
with aging and AD, which connects to suboptimal cognitive capacity. The breakdown of the
cerebral circulation and the condition of cerebral microvessels thus seem to enhance the
characteristic memory deficits that typify dementias like AD.Chapter 6
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Figure 6.11. Summary of the causal relationship between cerebral vascular pathological changes.Summary and Conclusion
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De ziekte van Alzheimer is een prominente neurologische aandoening tijdens
veroudering die samengaat met een geleidelijk afnemende geheugencapaciteit en
opmerkelijke neuropathologische veranderingen in de hersenen. Naast de pathologie
van het hersenweefsel is ook de bloedvoorziening van het brein bij deze ziekte sterk
verminderd. In dit  proefschrift wordt de ultrastructurele afbraak van de hersencapillairen
behandeld in de hersenen van patienten lijdende aan dementie en in proefdiermodellen
waarbij het functionele verband tussen een verminderde hersendoorbloeding en
microvasculaire morfologische afwijkingen wordt bestudeerd. Verder wordt in het
bijzonder aandacht besteed aan de rol van de intracellulaire calcium homeostase bij het
ontstaan van schade aan hersencapillairen.
De conditie van het uitgebreide netwerk van kleine bloedvaten in het brein is van
groot belang bij het transport van voedingstoffen (b.v. glucose, zuurstof, ionen) vanuit de
bloedbaan over de bloed-hersen barrière naar de zenuwcellen. Een optimale
doorbloeding en de morfologische conditie van de capillairen leveren een belangrijke
bijdrage aan deze cruciale transport processen. De wand van capillairen wordt gevormd
door een laag endotheelcellen die door een basale membraan worden omsloten. Onze
waarnemingen geven duidelijke aanwijzingen dat in de ziekte van Alzheimer en in de
ziekte van Parkinson een degeneratie van het basale membraan van de
microbloedvaten optreedt in de vorm van verdikking van het basale membraan en een
ophoping van collageenvezels (fibrose) in het basale membraan. Kwalitatieve analyse
van de afwijkingen toont aan dat in patiënten met bovengenoemde hersenziektes de
degeneratie van hersencapillairen meer dan verdubbeld is vergeleken met mensen van
dezelfde leeftijd zonder neurologische aandoeningen. Op basis van onze resultaten zijn
we tot de conclusie gekomen dat de degeneratie van de microvasculaire vaatwand niet
alleen maar met dementie gepaard gaat, zoals eerder werd voorgesteld, maar met een
breder spectrum van neurologische ziektes inclusief de ziekte van Parkinson.
Om de functionele wisselwerking tussen hersendoorbloeding en capillaire afwijkingen
te bestuderen, hebben we een proefdiermodel van experimenteel verlaagde
hersendoorbloeding (hypoperfusie) geïntroduceerd. We zijn uitgegaan van de hypothese
dat een verminderde bloedvoorziening in het brein de oorzaak zou zijn van de vasculaireNederlandse Samenvatting
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veranderingen die in de ziekte van Alzheimer werden geconstateerd. In dit diermodel
werden de halsslagaders van ratten chirurgisch afgebonden waarmee een vermindering
van 20-30% in hersendoorbloeding wordt bereikt. Vervolgens werd het ruimtelijke
geheugen van de ratten getest en de conditie van de hersencapillairen in de
hippocampus met elektronenmicroscopische technieken geanalyseerd. De hippocampus
werd gekozen omdat dit hersengebied een essentiele rol speelt bij leerprocessen en
verantwoordelijk wordt gesteld voor het ruimtelijk leervermogen.
Uit onze experimenten bleek enerzijds dat ratten met verminderde bloedvoorziening
naar de hersenen aanzienlijk meer tijd nodig hebben om de leertaak te beheersen, en
anderzijds dat de verhouding van capillairen met basale membraan afwijkingen
significant was toegenomen. Bovendien bestond er een lineair verband tussen de
leerprestatie van de dieren en de conditie van de hersencapillairen. Deze observatie
geeft dan ook zeer sterke aanwijzingen dat de integriteit van de capillairwand van
uitermate groot belang is voor de voorziening van voedingstoffen naar de hersenen en
het optimaal functioneren van de neuronen.
In ons volgende experiment is een ander vasculair aspect als risico factor voor de
ontwikkeling van dementie aan de orde gekomen. De afgelopen jaren werd de
hypothese geopperd dat verhoogde bloeddruk de kans op ontwikkeling van de ziekte
van Alzheimer sterk doet toenemen. Een interessante en opvallende ontdekking hierbij
is, namelijk dat bij patiënten lijdende aan hypertensie, maar ook bij rattenstammen die
spontaan hypertensie ontwikkelen, een vermindering van de hersendoorbloeding werd
geconstateerd. We hebben dus de ultrastructuur van hersencapillairen bij hypertensieve
ratten met de elektronenmicroscoop bestudeerd. Hierbij hebben we waargenomen dat
de vasculaire pathologie van de basale membraan in de hypertensieve dieren
vergelijkbaar was met die van ratten met cerebrale hypoperfusie. Ratten met verhoogde
bloeddruk vertoonden dan ook een verhoogd percentage beschadigde capillairen
vergeleken met normotensieve controle dieren.
Uit eerder onderzoek aan de conditie van hersencapillairen tijdens veroudering, bleek
dat chronische toediening van calcium antagonisten de schade aan de microvaatjes
vrijwel kon voorkomen. De toediening van nimodipine, een farmacon dat de cellulaire
instroom van calcium ionen bij vasculaire spiercellen en ook neuronen remt, leidde tot
een opmerkelijke verbetering van de conditie van de microvasculaire basale membraan.Nederlandse Samenvatting
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We hebben ook nimodipine en een vergelijkbaar medicijn, nifedipine aan het voer van
de ratten toegevoegd. Beide farmaca zijn in staat om bij een bepaalde concentratie de
bloeddruk te verlagen. Het verschil tussen nimodipine en nifedipine bestaat hierin dat
nimodipine de bloed-hersen barrière makkelijker penetreert, en dat het de bloeddruk pas
verlaagt bij een veel hogere concentratie dan nifedipine. In ons experiment hebben we
dezelfde concentratie van de twee farmaca gebruikt met het gevolg dat nifedipine een
positieve effect op de systolisch bloedruk van de dieren had, terwijl nimodipine geen
effect had op de bloeddruk. Analyse van de hersencapillairen bij onze hypertensieve
dieren bevestigde dat de calciumantagonisten het ontstaan van capillaire afwijkingen
kunnen voorkomen. Bovendien bleek dat deze vaatbeschermende invloed van beide
farmaca onafhankelijk is van bloeddrukverlaging. Deze waarneming leidt tot de
conclusie dat het positieve en beschermende effect van de calciumantagonisten niet
uitsluitend wordt bereikt door het effect van deze farmaca op  het niveau van vasculaire
spiercellen, maar waarschijnlijk door een gunstige werking van deze calciumblokkers op
het hersenweefsel. Aangezien astrocytes een structurele en functionele bijdrage leveren
aan de bloed-hersen barrière komen ze in aanmerking als potentiëel doelwit van de
calciumantagonisten. Astrocytes die tegen een intracellulaire calciumoverbelasting
beschermd worden, kunnen hun functie als regulatoire elementen van de bloed-hersen
barrière en als cellen die de basale membraan componenten synthetiseren, blijven
vervullen.
Samenvattend kan een uitgebreide hypothese worden opgesteld, die de functionele
wisselwerking tussen vasculaire risico factoren en de ontwikkeling van dementie tracht
te verklaren. Hypertensie kan de vasoregulatie in de periferie en in de hersenen in
negatieve zin beïnvloeden, wat aanleiding geeft tot een verminderde
hersendoorbloeding. Als gevolg daarvan wordt de ultrastructuur van de kleine
bloedvaten in het brein beschadigd, wat het transport van voedingsstoffen – met name
glucose – aan zenuwcellen hindert. Het gebrek aan glucose zorgt voor een trager en
afwijkend neuronaal metabolisme dat resulteert in verminderde activiteit van energie
producerende enzymen in de mitochondria en uiteindelijk in een reductie van het
neuronale niveau van de energiedrager ATP. Dit heeft een negatieve uitwerking op
neuronale plasticiteit wat een zichtbaar verminderde geheugencapaciteit kan
veroorzaken.Nederlandse Samenvatting
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Tot slot moeten we ons realiseren dat de hier bestudeerde vasculaire risico factoren
niet  de ultieme oorzaak voor ontwikkeling van dementie zijn. Het bovengenoemde
onderzoek rechtvaardigt echter de conclusie dat vasculaire factoren aanzienlijk kunnen
bijdragen aan de ontwikkeling van een verminderde geheugencapaciteit en daarmee
cognitief dysfunctioneren bij dementie bevordert.0DJ\DU￿Q\HOY ￿|VV]HIRJODOiV
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A dolgozat az agyi kapillárisok ultrastruktúrális elváltozásait írja le Alzheimer kóros
EHWHJHNEHQ￿￿LOOHWYH￿NtVpUOHWHV￿iOODW￿PRGHOOHNEHQ￿￿DPHO\HN￿D]￿$O]KHLPHUHV￿EHWHJHNUH￿MHOOHP]
csökkent agyi véráramlás hatását vizsgálják az agy mikroereinek szerkezetére.  Az állat
kísérletek segítségével igyekeztünk választ találni arra a kérdésre, hogy az elégtelen agyi
YpUiUDP￿IHOHO V￿OHKHW￿H￿D￿EHWHJHNEHQ￿PHJILJ\HOW￿DJ\NpUJL￿PLNURYDV]NXOiULV￿HOYiOWR]iVRNpUW￿￿pV
hogy ezek a patológiás elváltozások összefüggésbe hozhatóak-e az agyi erek illetve az agy
sejtjeinek intracelluláris kálcium homeosztázisával.
$O]KHLPHU￿ NyURV￿ pV￿ 3DUNLQVRQ￿ NyURV￿ EHWHJHNE O￿ V]iUPD]y￿ DJ\NpUJL￿ PLQWiNEyO
elektronmikroszkópos preparátumokat készítettünk, amelyekben a kapillárisok falának
ultrastruktúráját vizsgáltuk meg. Megfigyeléseink igazolták, hogy a kapillárisok bazális laminája
az említett betegségekben degenerálódik, amely a bazális lamina lokális megvastagodásában
pV￿ D￿ ED]iOLV￿ ODPLQiED￿ W|UWpQ ￿ ILEUy]XV￿ NROODJpQ￿ OHUDNyGiVEDQ￿ |OW￿ IRUPiW￿￿ $]￿ HOYiOWR]iVRN
kvalitatív analízise kimutatta, hogy Alzheimeres és Parkinsonos betegekben a degenerálódott
kérgi kapillárisok aránya 20%-kal magasabb volt, mint hasonló korú, neurológiailag tünetmentes
V]HPpO\HNEHQ￿￿8J\DQDNNRU￿D￿ED]iOLV￿ODPLQiEDQ￿HO IRUGXOy￿SHULFLWiN￿YL]VJiODWD￿D]W￿MHOH]WH￿￿KRJ\
EiU￿D￿SHULFLWiN￿V]HUNH]HWH￿LV￿MyO￿PHJILJ\HOKHW HQ￿GHJUDGiOyGLN￿D￿EHWHJVpJHNEHQ￿￿D]￿LO\HQ￿WtSXV~
HOYiOWR]iVRN￿PHQQ\LVpJH￿QHP￿WpU￿HO￿MHOHQW V￿PpUWpNEHQ￿D￿NRQWUROO￿FVRSRUWWyO￿￿$]￿HUHGPpQ\HN
alapján megállapítottuk, hogy a bazális membrán kóros elváltozása nem csak a demenciás
esetekre korlátozódik, ahogy azt korábban sejtették, hanem egyéb, neurodegenerációval járó
PHJEHWHJHGpVHNEHQ￿￿PLQW￿SpOGiXO￿D￿3DUNLQVRQ￿NyU￿￿LV￿PHJILJ\HKHW ￿
Számos irodalmi adat hívta fel a figyelmet arra, hogy az agy vérellátása Alzheimer kórban jól
körülhatárolható agykérgi régiókban visszaesik.  Hasonló megfigyeléseket tettek Parkinson
NyURV￿ EHWHJHN￿ HVHWpEHQ￿ LV￿￿ )HOPHU￿OW￿ DQQDN￿ D￿ OHKHW VpJH￿￿ KRJ\￿ H]HN￿ D]￿ HUHGPpQ\HN
kapcsolatba hozhatók az agyi mikroerek falának általunk is leírt megvastagodásával. A
funkcionális kapcsolat igazolására állítottuk fel agyi hipoperfúziós modellünket patkányban.
A kísérleti állatok mindkét oldali arteria carotis communisát permanensen elkötöttük, majd
HJ\￿ WpUEHOL￿ PHPyULD￿ WHV]WHW￿ N|YHW HQ￿ D]￿ iOODWRN￿ KLSSRFDPSXViEyO￿ HOHNWURQPLNURV]NySLiV
PHWV]HWHNHW￿NpV]tWHWW￿QN￿￿$￿P WpWL￿EHDYDWNR]iV￿N|YHWNH]WpEHQ￿D￿SDWNiQ\RN￿DJ\L￿SHUI~]LyMD￿D]
Alzheimeres betegeknél mért értékekhez hasonlóan esett vissza. A patkányok térbeli tanulása a0DJ\DU￿Q\HOY ￿|VV]HIRJODOiV
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kontroll csoporthoz képest visszamaradt. A hippocampus preparátumokban a kapillárisok
ED]iOLV￿ODPLQiMiEDQ￿D]￿$O]KHLPHUHV￿PLQWiNUD￿HPOpNH]WHW ￿PHJYDVWDGRWW￿V]DNDV]RNDW￿YDODPLQW
kollagén rost lerakódásokat (fibrózis) láttunk, melyek aránya az operált  állatokban
szignifikánsan meghaladta a kontroll állatokban mért értékeket. Az erek morfológiai eredményeit
az állatok tanulási tesztjének eredményeivel korreláltatva azt tapasztaltuk, hogy a degenerált
kapillárisok arányának növekedésével romlott az állatok térbeli memóriája.
A modell tehát rámutatott, hogy az agyi véráramlás csökkenése memória zavarokhoz
vezethet,  és az agyi kapillárisok anatómiai elváltozásait okozhatja. A korreláció analízis
HUHGPpQ\HL￿WRYiEEi￿~J\￿LV￿pUWHOPH]KHW N￿￿KRJ\￿D￿PLNURHUHN￿IDOiQDN￿PHJYDVWDJRGiVD￿IHOHO V
lehet a tanulási képességek romlásáért. Ezt a feltételezést alátámasztja, hogy az alkalmazott
WDQXOiVL￿WHV]W￿ D￿ KLSSRFDPSiOLV￿ PHPyULD￿ P N|GpVpU O￿ V]ROJiOWDW￿ LQIRUPiFLyW￿￿ WHKiW￿ DQQDN￿ D]
DJ\WHU￿OHWQHN￿D￿P N|GpVpU O￿￿DKRO￿D]￿HUHNHW￿YL]VJiOWXN￿￿$￿NDSLOOiULVRN￿IDOiQDN￿PHJYDVWDJRGiVD
a memória romlásában azáltal játszhat szerepet, hogy gátolja az optimális tápanyag, elektrolit
és vérgáz transzportot a vér-agy gáton keresztül, amely a neuronok funkciójához
elengedhetetlenül szükséges.
$]￿ DJ\L￿ YpUiUDPOiV￿ SDWNiQ\EDQ￿ QHP￿ FVDN￿ NtVpUOHWL￿ EHDYDWNR]iV￿ ~WMiQ￿ FV|NNHQWKHW ￿
Genetikailag szelektált, spontán hipertenziós patkányok agyának a perfúzióját szintén
DODFVRQ\DEEQDN￿ WDOiOWiN￿ D￿ QRUPRWHQ]tY￿ iOODWRNpQiO￿￿ $￿ N|YHWNH] ￿ NtVpUOHW￿QNHW￿ PL￿ LV￿ PDJDV
vérnyomású patkányokon végeztük.
+DW￿iOODWFVRSRUWRW￿iOOtWRWWXQN￿IHO￿￿PHO\HNE O￿QpJ\￿VSRQWiQ￿￿JHQHWLNDLODJ￿V]HOHNWiOW￿￿KLSHUWHQ]tY
(SHR-SP) és négy normotenzív, kontroll (WKY) csoport volt. A négy-négy csoport megoszlása
PLQGNpW￿NRQGtFLy￿HVHWpQ￿D￿N|YHWNH] NpSSHQ￿DODNXOW￿￿ HJ\￿ ￿￿￿KHWHV￿￿ILDWDODEE￿￿ HJ\￿￿￿￿ KHWHV￿
LG VHEE￿￿HJ\￿￿￿￿KHWHV￿QLPRGLSLQ￿NH]HOW￿￿pV￿HJ\￿￿￿￿KHWHV￿￿QLIHGLSLQ￿NH]HOW￿FVRSRUW￿￿$￿QLPRGLSLQ
és a nifedipin két, ma már jól ismert kálcium antagonista, amelyeket a magas vérnyomás
NH]HOpVpUH￿LOOHWYH￿DJ\YpU]pV￿ PHJHO ]pVpUH￿ NtVpUOHWH]WHN￿ NL￿￿ 0LQGNpW￿ DQ\DJ￿ NpSHV￿D￿ YpU￿DJ\
JiWRQ￿NHUHV]W￿O￿EHMXWQL￿D]￿DJ\ED￿￿DKRO￿D]￿/￿WtSXV~￿NiOFLXP￿FVDWRUQiNKR]￿N|W GYH￿PHJHO ]LN￿D
VHMWHNEH￿W|UWpQ ￿W~O]RWW￿NiOFLXP￿iUDPRW￿￿$]￿DODSYHW ￿N￿O|QEVpJ￿D￿NpW￿DQWDJRQLVWD￿N|]|WW￿D]￿
hogy alacsony koncentrációban csak a nifedipin csökkenti a vérnyomást, míg a nimodipin erre
nem képes. Ezt a megfigyelést saját kísérleteink is alátámasztották.
$￿ IHQW￿ OHtUW￿ iOODW￿ FVRSRUWRNEDQ￿￿ D￿ NRUiEEL￿ NtVpUOHWHLQNQHN￿ PHJIHOHO HQ￿
elektronmikroszkóposan elemeztük az agykérgi kapillárisok szerkezetét. A mikroereket a fent
említett elváltozások szerint (bazális membrán megvastagodás, fibrózis, pericita degeneráció)0DJ\DU￿Q\HOY ￿|VV]HIRJODOiV
(Summary in Hungarian)
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NDWHJRUL]iOWXN￿pV￿NYDQWLILNiOWXN￿￿$]￿HUHGPpQ\HN￿U|YLGHQ￿D￿N|YHWNH] NpSSHQ￿IRJODOKDWyN￿|VV]H￿
A hipertenzió fokozta a bazális lamina öregedésel járó patológiáját, ellenben nem volt hatással
D￿SHULFLWiN￿PRUIROyJLiMiUD￿￿0LQG￿D￿QLPRGLSLQ￿￿PLQG￿D￿QLIHGLSLQ￿NH]HOpV￿PHJHO ]WH￿D￿KLSHUWHQ]tY
iOODWRNEDQ￿ KDQJV~O\R]RWWDQ￿ MHOHQWNH] ￿ PLNURYDV]NXOiULV￿ HOYiOWR]iVRNDW￿￿ $￿ NpW￿ NiOFLXP
antagonista közül csak a nifedipin volt a pericitákra pozitív hatással. Továbbá az agyi
YDV]NXOiULV￿HOYiOWR]iVRN￿YpUQ\RPiV￿I￿JJ QHN￿PXWDWNR]WDN￿
Az itt alkalmazott kálcium antagonisták cerebrovaszkuláris hatásmechanizmusára saját
adataink mellett ismert irodalmi adatok segítségével  állítottunk fel hipotézist. Mivel
kísérletünkben a nimodipin nem csökkentette a vérnyomást, és a mikroerek endotéliumán az L-
típusú kálcium csatornák jelenléte vitatható, a nimodipin és a nifedipin jótékony hatása az erek
iOODSRWiUD￿YDOyV]tQ OHJ￿QHXURQRNRQ￿YDJ\￿DV]WURFLWiNRQ￿NHUHV]W￿O￿pUYpQ\HV￿OW￿￿%L]RQ\RV￿QHXURQ
csoportok és az asztrociták fontos szerepet játszanak az erek beidegzésében és funkcionális
szabályozásában. Ezen sejtcsoportok bizonyított neuroprotekciója az alkalmazott kálcium
antagonisták által hozzájárulhatott az erek védelméhez.
Az itt bemutatott kísérletek összefoglalásaként felvázoltunk egy teoretikus modellt, amely
feltételezi, hogy perifériás rizikófaktorok, mint például a magas vérnyomás, rontják az agyi
perfúzió szabályozását. Ennek következtében az agy vérellátása hanyatlik, és az agyi
kapillárisok ultrastruktúrája degenerálódik. A kapillárisok megvastagodott falán keresztül a
glükóz transzportja elégtelenné válik, amely a neuronok energia háztartására negatívan hat. Ez
a neuronális mitokondriumok csökkent citokróm-oxidáz enzimaktivitásban és ATP termelésében
W￿NU|] GLN￿ YLVV]D￿￿ DPHO\￿ D￿ QHXURQRN￿ FV|NNHQW￿ IXQNFLyMiKR]￿￿ SODV]WLFLWiVXN￿ J\HQJ￿OpVpKH]
vezet. Végül a folyamat eredménye gyengébb kognitív képességek kialakulásában  ölthet
IRUPiW￿￿ ￿ $￿ IRO\DPDW￿ |QPDJiEDQ￿ YDOyV]tQ OHJ￿ QHP￿ V]ROJiOKDW￿ QHXUROyJLDL￿ EHWHJVpJHN￿￿ PLQW
SpOGiXO￿D]￿$O]KHLPHU￿NyU￿￿NLLQGXOySRQWMDNpQW￿YDJ\￿DODSMDNpQW￿￿GH￿D￿EHWHJVpJUH￿MHOOHP] ￿HJ\pE
QHXURSDWROyJLiV￿HOYiOWR]iVRNNDO￿NRPELQiOYD￿V~O\RVEtWKDWMiN￿D￿EHWHJVpJ￿PHPyULiW￿pULQW ￿W￿QHWHLW
és lefolyását.Acknowledgements
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